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Abstract 
 
Cortisol secretion follows a distinct circadian rhythm characterised by a nadir in 
early sleep, gradually increasing concentrations during late sleep, peak levels at 
30-45 minutes post awakening (the cortisol awakening response: CAR) and a 
declining pattern thereafter.  Salivary cortisol enables determination of the 
diurnal pattern within the domestic setting, although the measurement presents 
methodological challenges that need to be addressed.  Further, the diurnal 
pattern of cortisol has been studied in relation to trait and state ill-being, rather 
than well-being.  Consequently the focus of this programme of research was to 
explore relationships between the diurnal pattern of cortisol secretion and 
measures of both state and trait well-being and to examine the impact of 
electronically determined participant adherence to protocol within the domestic 
setting.  In the first instance healthy, psychopathology-free young females were 
investigated but the work was extended to investigate the impact of aging on 
associations between cortisol secretion and well-being in healthy older females.  
 
Data from healthy female participants demonstrates for the first time that 
moderate delays (on average 8 minutes) between awakening and the start of 
saliva sampling (previously considered tolerable) result in erroneous over-
estimation of CAR magnitude and earlier timing of the CAR peak.  This minimal 
level of non-adherence was not detected by self-reported awakening time, 
suggesting that electronic monitoring of awakening is essential in CAR research.  
The effects of moderate delays on the CAR measurement were explored in a 
detailed study, the first to sample salivary cortisol secretion at five minute 
intervals in the immediate post-awakening period.  Over-estimation of the CAR 
magnitude and earlier peak were attributed to an observed approximate ten 
minute time lag between awakening and the start of the cortisol rise.  In contrast 
non-adherence to the sampling protocol across the day did not impact on 
measurement of the diurnal cortisol measures when measured at 3-12 hours 
post-awakening.   
 
In healthy young females neither state nor trait well-being/ill-being were 
associated with the CAR when using data strictly monitored for non-adherence 
during saliva sampling in the post-awakening period.  Additionally, state and 
trait well-being were not associated with the diurnal decline or mean levels of 
cortisol across the day.  These null findings could be attributed to the age of the 
sample.  Previous associations between well-being and diurnal cortisol patterns 
have been observed mostly in middle-aged and older adults.  
 
The new method of cortisol assessment in hair samples provided a 
retrospective trait measure of cortisol secretion, without the problems of non-
adherence to protocol.  No associations between three months hair cortisol 
secretion with well-being/ill-being were observed in young healthy females, in 
line with the results reported above using salivary cortisol.  However, in the 
older sample associations between hair cortisol and trait well-being were 
evident.  Higher levels of trait well-being were associated with higher hair 
cortisol, independently of ill-being, providing support for cortisol as an ‘energiser’ 
in healthy older female participants.  Together these findings provide evidence 
for the neurotoxicity hypothesis of cortisol secretion; well-being did not exert 
effects on cortisol secretion in early adulthood but effects were evident in late 
adulthood in healthy psychopathology-free female samples.  
 
The unique contribution of this programme of research lies in its consideration 
of methodological issues in the measurement of cortisol and well-being and its 
focus on positive psychology rather than the traditional psychopathology in 
relation to cortisol.   
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Chapter 1 Introduction I 
 
Cortisol, ill-being and well-being 
 
 
1.1 Overview  
 
This chapter begins with a brief introduction to the area of 
psychoneuroendocrinology.  It examines the role of the stress response 
systems in linking the mind/brain and health and briefly discuses the 
neuroendocrinological systems in mediating a stress response.  A detailed 
examination of a major response system, the hypothalamic-pituitary-adrenal 
(HPA) axis is provided.  Activation of the HPA axis results in the secretion of the 
steroid hormone cortisol, a major human glucocorticoid.  Next, the production of 
cortisol in the adrenal cortex, the regulatory mechanisms involved in the 
termination of physiological stress responses and the major physiological 
actions of cortisol are described.  As well as being a stress responsive hormone, 
in healthy individual’s cortisol secretory activity shows a marked circadian 
rhythm, this is discussed in relation to the regulatory mechanisms involved and 
implications in illness and disease.   
 
Traditionally psychology has focused on negative affective states and 
psychopathology; as such the physiological pathways involved are relatively 
well understood.  In recent years, the benefits of well-being and positive 
functioning are becoming evident.  However, the physiological pathways 
mediating this association are less well understood.  Ill-being and well-being are 
thought to be independent dimensions, thus the way in which well-being affects 
health and the physiological pathways involved may differ.  In the positive 
psychological literature two aspects of well-being are conceptualised hedonic 
(e.g. happiness and pleasure in life) and eudemonic (e.g. growth and meaning 
in life) well-being.  The way these two aspects of well-being may relate to health 
and the physiological pathways mediating this association are also explored. 
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1.2 Psychoneuroendocrinology  
 
The studies within this thesis fall under the area of psychoneuroendocrinology, 
which incorporates the interrelated disciplines of psychology, neurobiology, 
endocrinology, immunology, neurology, psychiatry and medicine to understand 
the links between the mind/brain and illness/health.  It attempts to understand 
the physiological pathways underpinning the mind/brain and health/illness links.  
Since the time of the Ancient Greeks, negative psychosocial factors have been 
thought to play a role in the etiology of illness and disease.  Since then, a 
compelling body of evidence documents associations between ill-being and 
adverse health-outcomes.  For example, several reviews of epidemiological 
studies conclude that negative affective states, such as depression and anxiety 
are putative risk factors for coronary heart disease, even after controlling for 
known risk factors such as cholesterol, blood pressure, and smoking (for 
reviews, see Hemingway & Marmot, 1999; Kubzansky & Kawachi, 2000; 
Rugulies, 2002).  A meta-analysis of 25 prospective studies of follow-up periods 
ranging from 2-16 years showed that subclinical and clinical depression were 
associated with increased risk of mortality (Cuijpers & Smit, 2002).  The 
Whitehall studies provided compelling evidence for the links between 
psychosocial factors and health outcomes.  These cross-sectional and 
longitudinal studies of British civil servants investigated the impact of negative 
affective states and social disadvantage on ill-health and disease.  High job 
strain, effort-reward imbalance, low decision making and injustice at work all 
independently predicted incidence of coronary heart disease (Kivimaki et al., 
2005; Kuper & Marmot, 2003).  Lower social-economic-status was associated 
with poorer health and morbidity (Marmot, Ryff, Bumpass, Shipley, & Marks, 
1997). 
 
Such work has been influential in investigating the physiological pathways that 
underpin the mind and body link.  Chronic stress activates the autonomic 
nervous system and neuroendocrine systems which have influences on multiple 
body systems (e.g. the immune system, the cardiovascular and metabolic 
systems), and dysregulation of them can lead to ill-health and disease 
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(Kristenson, Eriksen, Sluiter, Starke, & Ursin, 2004; McEwen, 2000; Padgett & 
Glaser, 2003).  The neuroendocrine system mediates the body’s physiological 
stress response.  The neuroendocrine system is the interaction of the nervous 
system and the endocrine system.  Together the endocrine and nervous 
systems provide mechanisms for communication between cells and organs. 
The endocrine system secrets biologically active substances (hormones) into 
the blood circulatory system.  The primary link between the nervous system and 
the endocrine system is via the hypothalamus of the brain and the glandular 
(endocrine), anterior pituitary.  
 
The body’s physiological response to an event or stimuli perceived as stressful 
activates two primary neuroendocrine systems, the sympathetic 
adrenomedullary (SAM) system and the hypothalamic-pituitary-adrenocortical 
(HPA) axis.  Activation of these systems result in major physiological effects on 
the body’s tissues and can lead to changes in immune function (Sapolsky, 
Romero, & Munck, 2000).  Activation of both these systems is via the 
hypothalamus but the stress response patterns differ.  The SAM response to 
stress is immediate, the adrenal medulla is activated and within seconds 
catecholamines (epinephrine and norepinephrine) are released resulting in 
changes in blood pressure, heart rate, sweating within a few minutes.  This 
stress response is the so-called fight-or-flight phenomenon.  Whilst activation of 
the HPA axis is slower, with cortisol being released from the adrenal cortex and 
peaks approximately 20-30 minutes after the onset of the stressor (Dickerson & 
Kemeny, 2004).  Most of the physiological actions of cortisol, however, are not 
exerted until about an hour after stressor onset (Sapolsky et al., 2000).  The 
HPA axis and its physiologically important end product cortisol are at the centre 
of the studies presented in this thesis and are discussed at length below.  
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1.3 The hypothalamic-pituitary-adrenocortical axis 
 
The hypothalamic-pituitary-adrenocortical (HPA) axis comprises the 
hypothalamus, anterior pituitary gland and adrenal cortex forming a 
neuroendocrine system.  The hormone cortisol is the main end product 
following activation of the HPA axis.  Triggers for activation of the HPA axis 
include immune system activation, pain, smoking, food intake, vigorous 
exercise, marked changes in cardiovascular tone, respiratory distress, 
awakening and psychological stressors.  Experiencing a psychological stressor 
is probably the most prominent source of activation.  Tasks that are 
uncontrollable and contain social-evaluative threat elements are the most 
effective in eliciting cortisol responses (e.g. Dickerson & Kemeny, 2004), for 
these reasons cortisol is commonly referred to as the stress response hormone.  
 
A physiological cascade links the hypothalamus, anterior pituitary gland and the 
adrenal cortex (see Figure 1.1).  Activation of this cascade is regulated by the 
nervous system, with production controlled directly by the brain.  Stimulation of 
the neurosecretory parvocellular neurons in the paraventricular nuclei (PVN) of 
the hypothalamus produce corticotrophin-releasing hormone (CRH).  CRH is 
transported to the anterior pituitary and the corticoptroph cells are stimulated to 
synthesis and release of adrenocorticotropin (ACTH) into the general circulation.  
ACTH circulates peripherally to arrive at the adrenal glands, which are situated 
above the kidneys.  The adrenal cortex produces various steroid hormones one 
of which is glucocorticoids.  Cortisol is the main glucocorticoid in humans, and is 
produced mostly by the zona fasciculate and at a lower rate by the inner zona 
reticularis.  
 
Stress-induced HPA axis activation is regulated by negative feedback inhibition, 
this enables an individual to adapt and recover from stress.  Cortisol regulates 
its own secretion through binding to receptor cells in the brain, which is unique 
to hormones whose secretion is regulated through the hypothalamus and 
pituitary.  Increased cortisol levels are detected by cortisol receptors in multiple 
brain regions including the hippocampus, hypothalamus and pituitary (illustrated 
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in Figure 1.1).  This results in the down-regulation of CRH and ACTH which in 
turn leads to less stimulation of the zona fasciculate of the adrenal cortex, and 
less cortisol secretion.  In healthy individuals this negative feedback inhibition 
facilitates an individual’s ability to adapt to and recover from stress.  It maintains 
cortisol levels within a particular and appropriate range.  
 
 
 
 
Figure 1.1 The hypothalamic-pituitary-adrenal (HPA) axis  
 
Illustrates the physiological cascade involved in the HPA axis in humans. 
Corticotrophin releasing hormone (CRH) is transported to the anterior pituitary 
via the hypothalamic-pituitary portal blood vessels. Adrenocorticotrophic 
hormone (ACTH) is released into the general circulation. The ‘+’ and ‘-‘ symbols 
indicate activation and inhibition respectively; cortisol exerts negative feedback 
as indicated to regulate the on-going cascade 
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1.4 Actions of cortisol 
 
Cortisol has a wide range of physiological effects on virtually all target tissues 
throughout the body.  It has many regulatory functions in the body for normal 
functioning but can also have deleterious effects at aberrant cortisol levels.  
One of the key roles of cortisol is facilitating the mobilization of energy 
resources.  Cortisol increases circulating glucose concentrations through 
promoting breakdown of protein stored in muscles.  This process is 
physiologically beneficial at adequate cortisol levels, but it has adverse effects 
of draining of the body’s protein stores at excessive cortisol levels (Genuth, 
1998).   
 
Cortisol regulates blood pressure, cardiovascular function, carbohydrate 
metabolism, and immune function.  Regulation of cardiovascular function 
includes enhancing vasoconstriction, maintaining normal blood pressure, fat 
depletion, and cardiac output (Sapolsky et al., 2000).  Cortisol has long been 
known for its role as immunosuppressive, in the last decade it is also 
recognised for its role in regulating the immune system, thus cortisol is essential 
in the balance of immune function (see Evans, Hucklebridge, & Clow, 2000). 
Cortisol also has profound effects on bone, by influencing calcium absorption. 
However, excessive cortisol can lead to a reduction in bone mass (e.g. 
osteoporosis), which is caused by enhancement of bone resorption and a range 
of inhibitory actions on bone formation resulting in thinning of capillary walls 
(Genuth, 1998).  Cortisol stimulates appetite and caloric intake.  Excessive 
cortisol, for example, in Cushing syndrome, leads to obesity in the form of 
abnormal distribution of fat in the abdomen, trunk and face.  Water and urine in 
the kidneys are maintained through the negative feedback actions of cortisol 
(Genuth, 1998).   
 
Glucocorticoids influence neural activity, mood and behaviour.  Both chronic 
hypercortisolism and chronic hypocortisolism observed in Cushing’s disease 
and Addison’s disease respectively present with negative psychological 
symptoms revealing the role of cortisol in affective processes (Porterfield, 2001).  
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Cortisol also regulates a variety of developmental events in the brain; high 
levels can have detrimental effects on brain development.  Cortisol has effects 
on cognitive performance, but this relationship is complex and unclear.  For 
example, administration of cortisol has been shown to enhance (e.g. Yehuda, 
Harvey, Buchsbaum, Tischler, & Schmeidler, 2007) and impair (Kirschbaum, 
Wolf, May, Wippich, & Hellhammer, 1996; Lee et al., 2007) cognitive 
performance, such as, memory.  Table 1.1 details the actions of cortisol, each 
of which are synchronised around the 24-hour dark/light cycle by its circadian 
pattern of secretion. 
 
Table 1.1 A summary of the actions of the hormone cortisol (adapted from 
Genuth, 1998) 
 
Actions of the hormone cortisol 
 Support of glucose availability drawing upon protein and fat reserves 
(gluconeogenesis) 
 Inhibition of inflammatory processes and modulation of immune responses 
 Modulation of emotional tone  
 Promotion of wakefulness 
 Maintenance of cardiac output; increased arteriolar tone; decreased endothelial 
permeability  
 Increased glomerular filtration and free water clearance 
 Regulation of muscle function; decreased muscle mass  
 Decreased bone formation; Increased bone reabsorption 
 
1.5 Circadian rhythm of cortisol  
 
The actions of cortisol are more than simple stress responsive; cortisol is 
essential for supporting normal physiological function during normal, non-stress 
situations.  Cortisol is one of the few hormones that is crucial for life (Baxter, 
Frohman, & Felig, 1995).  What makes cortisol particularly interesting and 
important for healthy functioning is its marked circadian rhythm.  The circadian 
pattern of cortisol was first described in a seminal study by Weitzman, 
Fukushima, Nogeire and colleagues (1971).  In six healthy participants, with 
well-defined sleep-wake cycles, four distinct temporal phases of adrenocortical 
activity was evident: (1) a phase of minimal cortisol secretory activity from four 
hours pre- and two hours post-sleep; (2) followed by a preliminary secretory 
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episode three to five hours into sleep; (3) the main secretory phase was 
observed during the final three hours of sleep and one hour post-awakening 
and (4) phase of sporadic waking secretory activity in the subsequent diurnal 
period until initiation of the next circadian cycle (Weitzman et al., 1971).  
Subsequent work confirmed the core elements of this rhythm (e.g. Linkowski et 
al., 1985).  
 
With regard to this circadian rhythm it is important to remember the pulsatile 
nature of cortisol secretion.  It is released in secretory episodes (called the 
ultradian rhythm) across the 24 hour cycle at a frequency of approximately once 
every one to two hours (see Liu, Kazer, & Rasmussen, 1987; Weitzman et al., 
1971).  Although these bursts of secretion are not usually apparent when 
measuring cortisol in blood or saliva, pulsatility could potentially influence 
variability in data.  An average secretory episode produces approximately 2.5 
nmol/l of salivary cortisol (Wust et al., 2000).  Changes in amplitude rather than 
frequency of these pulses predominantly account for differing cortisol 
concentrations across the circadian rhythm (Haus, 2007; Windle, Wood, 
Lightman, & Ingram, 1998).  As would be expected CRH and ACTH show 
similar ultradian and circadian pattern (e.g. Haus, 2007).  
 
Although the regulatory mechanisms underlying this circadian rhythm are not 
fully understood, it is thought to be responsible for regulating physiological 
function around the 24 hour sleep-wake or the light/dark cycle.  One of the most 
important triggers for patterns of cortisol secretion is the sleep/wake or 
light/dark cycle, information about which is relayed to the HPA axis via the body 
clock, a small region of the hypothalamus called the suprachiasmatic nucleus 
(SCN).  The SCN is located immediately above the optic chiasma and it 
receives information about light from the retina through the retinohypothalmic 
tract.  This in turn results in stimulation of the PVN of the hypothalamus to 
release CRH, resulting in activation of the HPA axis and secretion of cortisol. 
This regulates cortisol secretion during the day and inhibits secretion at night 
(Benarroch, 2011).  
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A non-HPA axis dependent pathway is also thought to be involved in the 
circadian regulation of cortisol secretion (Bornstein, Engeland, Ehrhart-
Bornstein, & Herman, 2008; Buijs, van Eden, Goncharuk, & Kalsbeek, 2003).  A 
direct neural pathway from the SCN to the adrenal cortex via the splanchnic 
nerve enhances adrenal ‘zona fasciculata’ sensitivity to ACTH.  This is thought 
to be associated with awakening, thereby maximising the rate of increase in 
cortisol secretion in the immediate post awakening period (see Clow, 
Hucklebridge, Stalder, Evans, & Thorn, 2010).  
 
In this way as well as being stress responsive, in healthy individuals cortisol 
exhibits a marked circadian rhythm characterised by peak levels following 
morning awakening (known as the cortisol awakening response: CAR) and 
declining levels thereafter, reaching lowest levels in early sleep (Edwards, Clow, 
Evans, & Hucklebridge, 2001).  This circadian rhythm has the role of providing 
the chemical signal to downstream physiological processes (that have no direct 
access to information about light from the SCN) about time of day and is 
essential for harmonious synchronisation across multiple physiological systems. 
The actions of cortisol listed in Table 1.1 are synchronised around the 24 hour 
light/dark cycle by its circadian pattern of secretion. 
 
Short-term stress activation of the HPA axis is adaptive and essential for 
supporting normal daily functioning in everyday life (Baxter et al., 1995). 
However, both high and low levels of cortisol as well as disrupted circadian 
rhythms are implicated in physical and psychological disorders.  For example, 
overall high levels are associated with major depression (Holsboer, 2000)  
whilst chronic fatigue syndrome is associated with lower overall cortisol levels 
(Crofford et al., 2004; Demitrack et al., 1991; Huber, Issa, Schik, & Wolf, 2006).  
Flattened cortisol circadian rhythms (either with abnormally high or low levels) 
are associated with a wide range of disorders, for example major depression 
(e.g.  Huber et al., 2006) and cancer prognosis (Abercrombie et al., 2004; 
Sephton, Sapolsky, Kraemer, & Spiegel, 2000).  Crucially, dysregulation of the 
HPA axis, other than that attributed to severe endocrine pathology is attributed 
to the cumulative effect of chronic stress, characterised by hyper- or hypo-
secretory patterns depending upon the timing, nature and duration of stress 
 10 
 
exposure.  In such circumstances the dual roles of cortisol as essential 
circadian ‘housekeeper’ and stress response hormone collide with the 
deleterious consequences for health. 
 
1.6 Positive Psychology  
 
The work of Martin Seligman, founder of the positive psychology movement 
brought the significance of positive characteristics and human flourishing to the 
focus of psychology.  The field of positive psychology is the study of positive 
emotions and character traits on well-being (Seligman & Csikszentmihalyi, 
2000; Seligman, Steen, Park, & Peterson, 2005).  This is an exciting new area 
of research; it attempts to understand, test, and enhance the potentially 
protective and beneficial effects of well-being on physical and psychological 
health.  Positive psychology represents a transition from focusing on the 
negative aspect of human functioning to thinking about the positive aspect of 
human functioning, for example, positive emotional states and the influence on 
behaviour and health.  
 
Research in the area of positive psychology is beginning to highlight the 
protective effects of well-being on health-related processes.  The following two 
studies provide striking examples of how positive characteristics, such as, 
happiness and positive emotions influence good health and longevity.  
Longitudinal analysis of a sample of Catholic nuns revealed that the positive 
emotional content of writings in young adulthood (average 22 years old) was 
associated with longevity during a 60-year period (Danner, Snowdon, & Friesen, 
2001).  In a recent study of American baseball players, smile intensity predicted 
longevity.  Smiles on photographs were used as a proxy for positive emotions 
and happiness.  Players with smiles were less likely to die than players with no 
smiles (Abel & Kruger, 2010).  Further, longitudinal studies demonstrate the 
impact of positive affective states and well-being on health.  In a review of 
prospective and empirical studies of older adults, positive affect was associated 
with lower mortality, reduced morbidity and pain, and better self-reported health 
(Pressman & Cohen, 2005).  In another study, well-being was associated with 
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substantially lower risk of future coronary heart disease, this effect remained 
significant when controlling for known influences such as demographic and 
medical factors (Kubzansky & Thurston, 2007).  In a recent review of 
prospective, observational and cohort studies trait and state well-being was 
associated with reduced mortality in healthy and disease population studies.  
Further, in studies that controlled for negative affect the protective effects of 
well-being were showed to be independent of negative affective states (Chida & 
Steptoe, 2008).  
 
Health behaviours and lifestyle may indirectly mediate the relationship between 
well-being and health.  Well-being may be associated with health-enhancing 
and protective behaviours, which in turn reduces the risk of long-term risk of 
illness.  There is compelling evidence that risky health behaviours, such as, 
smoking, lack of physical exercise and heavy alcohol consumption are 
associated with stress and negative emotions such as depression and anxiety 
(Biddle, Gorely, & Stensel, 2004; Kassel, Stroud, & Paronis, 2003; Regier et al., 
1990).  More recently, life satisfaction was associated with health enhancing 
behaviours such as, not smoking, healthy diet, using sun protection and 
physical exercise (Grant, Wardle, & Steptoe, 2009).  Well-being may have an 
effect on future health by directly influencing psychobiological processes, 
including promoting healthy cortisol rhythms, faster recovery from 
cardiovascular stress recovery, reduced inflammation, and resilience to 
infection (see Dockray & Steptoe, 2010 for a review).   
 
1.7 Structure of ill-being and well-being 
 
The field of positive psychology raises the question whether well-being is 
merely the opposite of ill-being or are well-being and ill-being separate and 
independent dimensions.  The former view assumes that well-being and ill-
being are opposite ends of a bipolar continuum and that knowledge about the 
causes, consequences and treatments of psychological maladjustment and 
disorders also informs understanding of well-being, this is commonly known as 
the ‘mirrored’ or ‘bipolarity’ hypothesis.  Typically, well-being was thought of as 
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merely the opposite of ill-being, those with high levels of ill-being would be 
expected to show low levels of well-being and vice versa.   
 
Previously, measures of well-being tended to focus upon the presence or 
absence of ill-being (e.g. negative symptoms such as stress, anxiety or 
depression).  However, more recently accumulating evidence suggests that 
well-being is more than the mere absence of ill-being.  While it is likely that well-
being will be low when ill-being is high, there is growing evidence that well-
being and ill-being tend to function relatively independently.  This is commonly 
known as the ‘independence’ hypothesis.  The idea that well-being and ill-being 
represent independent dimensions of human functioning will mean that our 
understanding of ill-being will not necessarily be reflected in the opposite way 
for well-being.  Testing the ‘mirrored’ or ‘bipolarity’ versus the ‘independence’ 
hypotheses deserve careful consideration in order to clarify the extent to which 
well-being is uniquely related to health and the physiological pathways involved.  
 
Accumulating evidence continues to favour the ‘independence’ hypothesis.  
Early work testing these hypotheses indicated that positive and negative affect 
were largely independent (Bradburn, 1969).  Further psychometric exploration 
of well-being and ill-being shows that the two domains are inversely correlated, 
but associations are weak, suggesting that positive affect is not simply the 
absence of negative feelings and experience, or vice versa.  Rather, some 
individuals show high levels of ill-being and well-being, whist others show low 
levels of ill-being but also lack well-being (Diener & Emmons, 1984; Diener, 
Smith, & Fujita, 1995; Keyes, 2002).  
 
Further support for the ‘independence’ hypothesis is evident from the distinct 
physiological correlates of well-being and ill-being.  It is a well-replicated finding 
that ill-being (e.g. depression, anxiety) is associated with increased cortisol and 
norepinephrine (Brown, Varghese, & McEwen, 2004; Hughes, Watkins, 
Blumenthal, Kuhn, & Sherwood, 2004), as well as increased cardiovascular risk 
(Ahlberg et al., 2002; Barefoot et al., 1998).  Although there is some evidence 
for links between well-being and physiology, few studies have examined this.  
Psychological well-being (e.g. purposeful life engagement) has been associated 
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with decreased cortisol levels, cardiovascular risk and inflammatory markers 
(Lindfors & Lundberg, 2002; Ryff, Singer, & Love, 2004).  Furthermore, most 
studies have assessed either ill-being or well-being in relation to physiological 
biomarkers, but not both. Ryff et al. (2006) investigated the physiological 
correlates of both well-being and ill-being in a sample of aging women.  Overall 
the findings from this study provided support for the ‘independence’ hypothesis.  
For the majority of neuroendocirine and cardiovascular markers that were 
associated with well-being they were not associated with ill-being (and vice 
versa). However, there was some evidence for the ‘mirrored’ or ‘bipolarity’ 
hypothesis, weight and glycosylated haemoglobin was negatively associated 
with both well-being and ill-being (Ryff et al., 2006).   
 
Furthermore, the two domains were associated differently with health variables.  
The absence of well-being was more predictive of seven year follow up mortality 
than the presence of ill-being (Huppert & Whittington, 2003; Watson, Clark, & 
Carey, 1988).  Compared with the presence of psychological symptoms or ill-
being, the absence of well-being was a stronger predictor of mortality 
(Whittington & Huppert, 1998).  Well-being was considered to be a better 
predictor of current of future health status, such as, mortality, mobility, stroke, 
and onset of disability than ill-being (Blazer & Hybels, 2004; Ostir, Markides, 
Black, & Goodwin, 2000; Ostir, Markides, Peek, & Goodwin, 2001).  Currently 
there is evidence for both hypotheses, given the evidence for the 
‘independence’ hypothesis it is important to investigate ill-being alongside well-
being in order to explore if well-being is uniquely related to physiology or 
psychosocial and health variables.  
 
1.8 Hedonic and eudemonic well-being  
 
The meaning and structure of well-being has puzzled the mind of philosophers 
for centuries.  It is important to understand what is meant by well-being in order 
to understand relationships between cortisol and well-being.  Within the well-
being literature, a distinction between hedonic and eudemonic well-being exists 
(Diener, Suh, Lucas, & Smith, 1999; Keyes, Shmotkin, & Ryff, 2002; Ryan & 
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Deci, 2001; Waterman, 1993).  The following sections define each term and 
discuss the on-going debate in the literature regarding the distinction between 
these two aspects.  
  
The hedonic approach is rooted in the ideas of human functioning being 
pleasurable, happy and satisfying and this dates back to the work of the Ancient 
Greeks (e.g. Epicurus), and philosophers such as Hobbes and Bentham (Ryan 
& Deci, 2001).  The scientific study of hedonic well-being is concerned with 
what makes experiences and life pleasant and unpleasant.  It falls under the 
umbrella term subjective well-being (SWB) and describes positive feelings such 
as happiness, pleasure and life satisfaction (Diener & Lucas, 1999).  It is 
typically defined in terms of the presence of positive affect, absence of negative 
affect and satisfaction with life (Diener et al., 1999; Kahneman, Diener, & 
Schwarz, 2003).  It is considered subjective because individuals make 
evaluations about themselves and the extent to which they experience a sense 
of wellness.  Assessing the extent to which feelings and experience are positive 
or negative involves an affective element.  However, making judgements of 
whether a life is satisfying involves a cognitive aspect, thus it is not strictly a 
hedonic aspect, but it is included in this approach amongst well-being 
researchers.   
 
Research on SWB has flourished; however, other researchers have argued that 
well-being is more than simply being positive and satisfied (e.g. happiness).  
Happiness does not necessarily mean psychological wellness (Ryan & Deci, 
2001).  The eudemonic perspective of well-being is based on the philosophy of 
Aristotle, who wrote about the realization of one’s true potential and living a life 
of contemplation and virtue (see Ryff, 1989).  Recent definitions of eudemonic 
well-being encompass the recognition of potentials in life and striving for a 
fulfilling and meaningful life (Ryan & Deci, 2001).  One model of psychological 
well-being that has integrated eudemonic concepts into large-scale population 
studies is the multidimensional model of psychological well-being (PWB).  PWB 
was based on the psychological resources required for flourishing throughout 
the lifespan (Ryff, 1989; Ryff & Keyes, 1995).  The PWB scales consists of six 
dimensions: individuals self-acceptance (feeling good whilst being aware of 
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limitations), positive relations with others (warm and trusting interpersonal 
relationships), environmental mastery (ability to shape own environment so as 
to meet personal needs and desires), autonomy (self-determination and 
authority), purpose in life (finding meaning in efforts and challenges) and 
personal growth (making the most of talents and capacities).  
 
Eudemonic well-being is criticised for its poor definition and measurement, this 
may be due to less focus on eudemonic well-being and this is evident in the 
relatively few psychological papers published explicitly on the topic.  Our 
understanding of hedonic or subjective well-being is clearer, therefore its 
definition and measurement is more rigorous (Waterman, Schwartz, & Conti, 
2008).  It is suggested that hedonic well-being is most likely the result of 
eudemonic pursuits of happiness (Ryan & Deci, 2001).  However, there is no 
clarity on the direction of this association; research is correlational so the causal 
direction is often assumed.  It may be likely that hedonic well-being causes 
eudemonic well-being.  Evidence for this comes from the meta-analysis 
providing  evidence that positive feelings play a role in people securing 
important life outcomes, for example, career success, or satisfying marriages 
(Lyubomirsky, King, & Diener, 2005).  It is important to acknowledge that 
hedonic well-being may be a causal role in eudemonia (but also vice versa).  
 
It is suggested that there are important differences between hedonic and 
eudemonic well-being (e.g. Ryan & Deci, 2001).  Researchers propose that 
these aspects are conceptually related but empirically distinct.  Factor analytical 
studies provide support for separate aspects of well-being.  In a national sample 
of Americans (N=3032, aged 25-74 years) SWB and PWB were highly 
correlated, however, the subjective and psychological components loaded 
separately onto distinct factors (Keyes et al., 2002).  Similar findings were 
subsequently replicated in students and adults from the UK.  Two factors of 
SWB and PWB were found and this was consistent across age, sex, age and 
ethnicity (Linley, Maltby, Wood, Osborne, & Hurling, 2009).  These studies 
suggest that SWB and PWB are two related but distinct dimensions.  Further 
support for this is evident from the associations with physiological pathways.  
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Eudemonic well-being was more strongly related with physiological correlates 
(Ryff et al., 2004).   
 
Currently, the positive psychology movement regard happiness in terms of both 
hedonic and eudemonic well-being.  Seligman proposes that happiness (well-
being) is achieved through a combination of a pleasant life (e.g. enjoyment and 
the savouring of positive feelings); a good life (e.g. engagement in everyday 
pastimes); and a meaningful life (meaning, belonging and purpose).  The 
pleasant life falls under SWB and the latter fall under PWB.  As such well-being 
in the studies in this thesis is defined as encompassing subjective (hedonic) 
and psychological (eudemonic) aspects of well-being. 
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Chapter 2 Introduction II 
 
Measurement of cortisol in saliva and hair  
 
 
2.1 Overview  
 
The purpose of this chapter is to discuss the measurement of cortisol secretion 
in saliva and hair samples.  The advantages and methodological issues of each 
measure are discussed.  The chapter begins with an overview of the 
advantages of salivary cortisol in relation to the more traditional methods of 
blood and urine.  Using salivary measures facilitates accurate investigation of 
the diurnal pattern of cortisol, under ambulatory conditions.  The diurnal pattern 
of cortisol secretion can be divided into two relatively discrete components: the 
cortisol awakening response (CAR) and the diurnal decline.  Typically, the CAR 
and diurnal decline are measured separately, and associations with 
psychosocial variables and health are explored. However, previous literature is 
limited by inconsistent and conflicting findings.  This may be due to participant 
non-adherence to the saliva sampling protocol, which results in misleading 
diurnal cortisol patterns, particularly for the CAR.  Measurement of cortisol in 
hair samples is a new area of research.  It provides a retrospective trait 
measure of cortisol secretion.  Sampling is relatively easy and quick and non-
adherence is not an issue, however, it is a blunt measure since no diurnal 
cortisol activity can be determined.  
 
2.2 Salivary Cortisol  
 
Cortisol is a steroid and as such can be measured in any body fluid because its 
chemical properties ensure it can pass through all membranes of the body 
without hindrance.  The clinical norm is to measure cortisol in blood, and 
sometimes urine.  More recently, cortisol has been measured in saliva, which 
has numerous advantages over blood and urine sampling.  Like plasma cortisol, 
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salivary cortisol provides a measure of cortisol within the last few minutes, 
whilst urinary cortisol provides a measure of cortisol secretion over hours (e.g. 
24 hrs).  In the blood, only 5-10% of cortisol is biologically active (‘free’) the rest 
is bound to large proteins (cortisol binding protein and albumin).  Consequently 
blood cortisol is usually measured as ‘total’ cortisol, comprising bound and 
unbound components.  The specific analysis of the free, biologically active 
cortisol element in blood is both time-consuming and expensive (Vining, 
McGinley, Maksvytis, & Ho, 1983).  In contrast salivary cortisol solely reflects 
the free component and so such measures are more meaningful in terms of 
cortisol activity.  The validity of salivary cortisol measures is evidenced by high 
correlations between salivary and circulating free cortisol, with most 
investigators reporting correlation coefficients of at least 0.90 (reviewed in 
Kirschbaum & Hellhammer, 1989, 1994).  
 
Saliva sampling has several additional advantages over determination of 
cortisol from blood and urine samples.  See Table 2.1 for a detailed summary of 
the strengths and considerations of using salivary measures of cortisol.  Unlike 
blood sampling, saliva sampling is convenient, non-invasive and does not need 
to be carried out by medically trained personnel.  The potential for repeated 
sampling allows close scrutiny of the dynamics of cortisol secretory activity or in 
ambulatory settings with participants going about their normal daily routines.  
Furthermore, salivary sampling method is non-stressful which is essential in any 
investigation of basal cortisol secretory activity.  As such, salivary cortisol is the 
ideal assessment for basal ambulatory studies. 
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Table 2.1 A summary of strengths and considerations when using salivary measures of cortisol 
 
Strengths Considerations  
Collection 
Saliva is not a Class II biohazard unless it is contaminated with blood.  
Saliva samples collected by participants – medically trained persons not 
required.  With assistance sampling in special populations (e.g. babies 
or children) is possible.   
Non-invasive procedure - sampling does not affect the cortisol levels 
(venepuncture can significantly increase cortisol). 
Sampling collection is relatively quick - approx. 1 min.   
Salivary flow rate does not affect salivary cortisol levels - standardising 
and recording time over which the saliva is collected is not required. 
Repeated sampling (e.g. every 15-30 min) enables assessment of 
dynamic cortisol profiles (e.g. over the day). 
Human saliva should be treated as potentially infectious 
material and normal microbiological safe handling 
procedures used at all times. 
Inclusion requires appropriate ethical approval. 
Some participants dislike the dry cotton swab in 
salivettes.  Saliva can also be collected by passive 
drool, which is approved with other analytes.  
  
Storage 
Stable at room temperature (approx. 2-4 weeks) - removes the need for 
immediate freezing.  Refrigeration/freezing recommended as soon as 
possible to prevent bacterial growth. 
Samples can be posted for assaying.  
Samples frozen at -20˚C can be stored for an extended period (i.e. 
years) and are not affected by thawing and re-freezing. 
Researchers collecting and storing saliva samples need 
to be aware of health and safety regulations e.g. in the 
UK the HTA regulates activities concerning the removal, 
storage, use and disposal of human tissue.  Saliva 
contains human cells so it is considered a tissue within 
the terms of the act (see HTA www.opsi.gov.uk) 
Assay 
Relatively easy to assay using a range of commercial assay providers.  
Required equipment is typically available in biological or medical 
laboratories.  Or samples can be posted to commercial laboratories that 
offer a full service (quotation, provision of labelled salivettes, packaging 
materials and full results).  It typically costs <£10 to assay each sample, 
depending on the size of the batch. 
The range of cortisol assays used across different 
laboratories means there are no standard absolute 
salivary cortisol values, making it difficult to compare 
findings across studies.  Important that all samples 
within a study are assayed in the same batch, using the 
same assay protocol so that values can be compared 
and integrated. 
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2.3 Salivary cortisol in ambulatory settings  
 
Salivary cortisol enables measurement of the basal circadian pattern of the 
hormone’s secretion in naturalistic settings and it is typically related with 
psychosocial and health variables, and more recently aggregated mood.  
Repeated saliva sampling enables measurement of the diurnal pattern of 
cortisol secretion under naturalistic settings, providing an account of real life 
exposure to stress and may be more relevant to long-term health outcomes.  
 
The diurnal cortisol pattern can be divided into two relatively discrete 
components the cortisol awakening response (CAR) and the diurnal cortisol 
profile across the day (see Figure 2.1).  Accordingly the following sections go on 
to discuss the measurement approach of the CAR and diurnal cortisol profile 
across the day as well as examine the methodological considerations for its 
measurement.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1  The diurnal pattern of cortisol secretion in healthy adults  
 
Plot illustrates the cortisol awakening response (CAR) and diurnal decline.  
Data derived from a composite of studies conducted at the laboratory at the 
University of Westminster and indicate the typical values across the day 
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2.3.1 The cortisol awakening response (CAR)  
 
The CAR is the 50-100% increase in cortisol levels following morning 
awakening, which typically peaks at 30-45 min post-awakening (see Figure 2.1).  
In the mid-1990s, Pruessner and colleagues were the first to bring it to the 
attention of social scientists by demonstrating a CAR in healthy participants 
(Pruessner, Kirschbaum, & Hellhammer, 1995).  The same group subsequently 
provided a more detailed account of the CAR showing the time course and 
intra-individual stability of the CAR over three consecutive days and three 
consecutive weeks in children, younger and older adults (Pruessner et al., 
1997).  Pruessner and co-workers originally considered the CAR to be “a 
reliable biological marker for the assessment of adrenocortical activity”, but the 
CAR is now considered a relatively distinct aspect of the circadian rhythm, 
initiated in response to morning awakening (Wilhelm, Born, Kudielka, Schlotz, & 
Wust, 2007).  Although activity of the HPA axis (and consequent secretion of 
ACTH) is an important factor across the 24 hr period, the CAR is somewhat 
independent of cortisol secretion over the rest of the day (see Clow et al., 2010). 
 
There has been considerable interest in the CAR and it promises to be a useful 
biomarker, perhaps more sensitive than the diurnal cortisol profile for a range of 
psychosocial and health outcomes (see Chida & Steptoe, 2009; Fries, 
Dettenborn, & Kirschbaum, 2009).  However, findings regarding associations 
with the CAR and psychosocial or health variables have frequently been 
inconsistent and require further clarification (Clow, Thorn, Evans, & 
Hucklebridge, 2004; Fries et al., 2009). Inconsistencies are likely to be caused 
by methodological differences, such as, inadequate control of the saliva 
sampling protocol and unaccounted situational and participant variables. 
 
When examining trait variables it is standard practice to measure the CAR on at 
least two consecutive weekdays.  However, others recommend up to six days 
for accurate determination of the trait CAR (Hellhammer et al., 2007).  This may 
be an excessive demand upon participants, to some extent negating the user-
friendliness of the ambulatory approach to salivary cortisol assessment.  In such 
cases, an awareness of possible confounding state variables may be preferable 
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to making routine such a demanding sampling protocol.  Such state variables 
include awakening time, and morning light levels, both of which have been 
shown to impact on the CAR (Edwards, Evans, Hucklebridge, & Clow, 2001; 
Scheer & Buijs, 1999; Thorn, Hucklebridge, Esgate, Evans, & Clow, 2004).  In 
addition, in healthy individuals the CAR is strongly influenced by state 
psychosocial variables such as, anticipation of significant workload or challenge 
during the day ahead, negative experiences during the previous day (e.g. 
Stalder, Hucklebridge, Evans, & Clow, 2009).  Table 2.2 details variables that 
impact upon the CAR and which should be considered when conducting basal 
ambulatory studies. 
 
Table 2.2 Variables to consider when conducting basal ambulatory studies 
 
Confounding 
variables  
 
Age  • Higher cortisol levels, attenuated CAR and attenuated 
diurnal decline are associated with age (Evans et al., 
2011; Ice, 2005). 
Gender  • Women have a greater CAR magnitude compared to 
males (Kirschbaum, Kudielka, Gaab, Schommer, & 
Hellhammer, 1999; Wright & Steptoe, 2005) and males 
peak earlier than females (Pruessner et al., 1997). 
Menstrual 
Cycle  
• Generally no difference in the CAR between menstrual 
cycle (Kudielka & Kirschbaum, 2003; Wolfram, 
Bellingrath, & Kudielka, 2011a) except ovulation – 
higher CAR magnitude and earlier CAR peak (Wolfram 
et al., 2011a) 
• Females on oral contraceptives were found to have 
lower mean cortisol in the CAR period (Pruessner et al., 
1997).  
Puberty 
Stage/hormonal 
status 
• Pubertal developmental changes are associated with 
increased daytime basal cortisol profiles and a steeper 
diurnal decline (Adam, 2006). Also, pre-menarche 
females show an earlier peak of the CAR (Oskis, 
Loveday, Hucklebridge, Thorn, & Clow, 2009). 
Alcohol 
consumption  
• Preliminary evidence that alcohol consumed the night 
before is associated with a decreased CAR the 
following morning (Stalder et al., 2009). More chronic 
consumption of alcohol is associated with an increased 
CAR (Adam, Hawkley, Kudielka, & Cacioppo, 2006; 
Badrick et al., 2008) and a reduced slope of cortisol 
decline (Badrick et al., 2008).   
table continued on next page  
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Smoking  • Cortisol levels over the day (2.5 hr to 12 hr post-
awakening) and the CAR are higher in smokers 
compared to non- or ex-smokers (Badrick, Kirschbaum, 
& Kumari, 2007).  
Medication  • Medication use should be recorded - numerous and 
ever-changing range of medications impact on salivary 
cortisol, see Granger et al. (2009) for the pathways 
involved.   
 
 
Determination of the CAR typically requires self-collection of saliva samples 
within the domestic setting at regular intervals post-awakening for 30-60 
minutes (e.g. 0, 15, 30, 45 and 60 min post-awakening).  Although some 
research indicates that unexpected awakening impacts the CAR (Born, Hansen, 
Marshall, Molle, & Fehm, 1999), studies have more generally shown that mode 
of awakening lacks influence (Pruessner et al., 1997; Wuest et al., 2000).  Thus, 
participants are generally instructed to awake in their usual way. CAR research 
has traditionally focused on the CAR magnitude which is the increase in cortisol 
in the first 45-60 minutes of awakening (Clow et al., 2004).  CAR magnitude 
should be measured as the mean increase [MnInc], or the near equivalent of 
area under the curve with respect to increase [AUCi] (see Figure 2.2 for 
formulae).   More simply it is possible to calculate the CAR as the difference 
between the awakening level and a single later ‘peak’ measure. Although most 
often used in large scale epidemiological-type studies this approach is not ideal 
as the actual peak may be missed.  This may be particularly problematic in 
studies of males and females.  Males typically peak at ~30 min post-awakening 
whereas females peak later at ~45 min post-awakening (Oskis et al., 2009; 
Pruessner et al., 1997).  Usually assessment of the CAR is limited to a 45 
minute post-awakening period, rather than an hour.  This is mostly for pragmatic 
reasons as requesting participants to refrain from normal morning activities for 
more than 45 minutes would be very demanding and likely limit participation.  
Accurate determination of the CAR crucially relies upon accurate collection of 
the first sample, immediately upon awakening.  
 
The composite measures AUCg (i.e. area under the post-awakening cortisol 
curve with reference to ground/zero) or, equivalently, mean levels of cortisol 
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secretion in the post-awakening period do not provide information about the 
dynamic of the cortisol increase.  Ideally when presenting CAR data, 
information about the value of the first sample and the dynamic increase 
(MnInc/AUCi) should both be provided.  The AUGg can then be deduced from 
these two measures. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2 Measurement of cortisol awakening response 
 
MnInc (mean increase) and AUCI (area under the curve relative to increase) 
provides an estimate of CAR magnitude. AUCg provides an estimate of total 
post-awakening cortisol secretion. Formulae: MnInc = (s2 + s3 + s4)/3 – s1; AUCI   
= s2 + s3 + [(s4 – s1)/2] - 2s1; AUCG  = s1 + s2 + s3 + [(s4 – s1) / 2]; or AUCI  = 
AUCG  - 3s1 (s1 collected immediately on awakening, s2 collected at 15 min, s3 at 
30 and s4 at 45 minutes post-awakening. These formulae all assume equal time 
intervals, arbitrarily denoted at unity, between all samples).  
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2.3.2 The diurnal decline of cortisol  
 
Cortisol secretion over the day is typically measured in terms of two key aspects: 
either the diurnal cortisol slope (typically a decline) or mean level over relevant 
sample points to provide a measure of overall cortisol secretion (mean diurnal 
cortisol), as shown in Figure 2.1.  A steeper cortisol decline has been 
consistently associated with better psychosocial and physical health outcomes 
(Adam & Gunnar, 2001; Adam et al., 2006; Cohen et al., 2006).  In line with 
best practice guidelines saliva sample points should always be synchronised to 
awakening time rather than clock time (Edwards, Clow, et al., 2001).  For 
measurement of the cortisol slope nearly all methods use an evening measure 
(prior to sleep or 12 hours after awakening).  However there is no consensus 
about the best morning time point from which to anchor the diurnal decline.  As 
the dynamic of change in cortisol is more marked in the morning compared to 
the evening this is an important issue and the choice of time can substantially 
affect the results obtained.  Various approaches have been adopted, for 
example, use of first awakening sample, the peak of the CAR or three hours 
following awakening.  As the CAR is thought to have some distinct regulatory 
input from diurnal cortisol secretion and the CAR is known not to correlate 
strongly with diurnal secretion (Edwards, Clow, et al., 2001), it is recommended 
to keep analysis of the CAR separate from analysis of the diurnal decline 
(Smyth, Hucklebridge, Thorn, Evans, & Clow, 2013).  Accordingly it is 
recommended that the diurnal decline is anchored with a morning sampling 
point outside of the CAR period, typically the diurnal decline is calculated as the 
change in secretion from 3 to 12 hours post-awakening (Smyth et al., 2013).  It 
is good practice to collect multiple samples across the day (e.g. at 3, 6, 9 and 
12 hours post awakening) and on two consecutive weekdays, which avoids 
distortion of data by random state factors (e.g. Thorn, Evans, Cannon, 
Hucklebridge, & Clow, 2011).  See Table 2.2 for a summary of considerations 
for confounding factors when measuring the diurnal cortisol profile across the 
day.  
 
Another common measure of daytime cortisol secretion is the ‘area under the 
daytime cortisol curve’.  This provides a measure of the average cortisol 
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secretory activity across the day and has been associated with early life stress 
(Nicolson, 2004).  Cortisol concentrations sampled throughout the day are 
averaged to give an overall measure of cortisol secretion.  Again there is no 
consensus about whether this measure should or should not include the 
immediate post-awakening period of cortisol secretion.  For the same reasons 
as outlined above it is suggested that the CAR period should be excluded from 
the assessment of the diurnal cortisol AUC (Smyth et al., 2013).  Estimates of 
average daily cortisol levels complement estimates of the diurnal decline.  This 
is necessary as a reduced slope may be associated with either hyper- or hypo-
cortisolemia, so reporting the slope or levels alone is not adequate, both 
estimates are required.  For studies which only include minimal sample points, 
bedtime cortisol concentrations are frequently the sole cortisol measure. Higher 
levels at this time can indicate a flatter diurnal cortisol slope over the day (e.g. 
Cohen et al., 2006; Pendry & Adam, 2007).  
 
2.4 Non-adherence to the saliva sampling protocol in 
ambulatory studies   
 
When studying the diurnal pattern of cortisol in the ambulatory setting, 
participants are left to their own devices to firstly remember to collect their saliva 
samples and secondly to collect them at the desired collection time. 
Researchers typically assume that participants adhere to the protocol, unless 
otherwise stated.  Due to the dynamic and brief nature of the CAR it is essential 
that participants adhere to the requested saliva sampling regime, inclusion of 
data derived from participants non-adherent to the protocol during the 
immediate post-awakening period is likely to explain the discrepancies in the 
CAR literature since it is likely that error in the timing of saliva sampling will 
impact upon accurate measurement of the CAR.  Cortisol measured over the 
day (e.g. diurnal decline and mean diurnal cortisol) may be less influenced by 
non-adherence to the protocol, since levels steadily decline over the day.  
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2.4.1 Monitoring non-adherence to the saliva sampling protocol  
 
Researchers typically rely on participant self-reports to identify whether 
participants have collected samples at the desired times.  The most typical of 
this is the diary method whereby participants report their awakening and saliva 
sampling times.  These are used to identify non-adherence to the protocol and 
delayed collection of samples can be excluded from the data analysis if 
necessary.  Using self-reports to monitor participant adherence to the protocol 
between 7% and 11% of participants reported a 10 minute delay in awakening 
and collection of sample one and this resulted in higher awakening samples 
and no rise from awakening to the 30 minute post-awakening sample compared 
to those that reported a delay of under 10 minute in sampling relative to 
awakening (Kunz-Ebrecht, Kirschbaum, Marmot, & Steptoe, 2004; Wright & 
Steptoe, 2005).  
 
The problem with the diary method is participant’s inaccurate self-reports. More 
objective measures of both awakening and sampling times estimated by 
electronic devices are recommended to monitor participant adherence to the 
saliva sampling protocol.  The next section discusses studies that have 
compared self-reported and electronically monitored adherence to the protocol 
and the impact of non-adherence on the CAR and diurnal cortisol profile.  
 
2.4.2  Assessment of saliva sampling times  
 
Collection of saliva samples can be monitored electronically using track caps 
(e.g. Medication Event Monitoring Caps etc).  These devices contain a bottle 
and a microelectronic cap, the cotton swabs or tubes used for saliva sampling 
are stored in the bottle and participants are instructed to open the bottle only 
when collecting the saliva sample.  Each opening of the cap records the time 
and date and this indicates the collection time of the saliva sample.  Such 
devices are typically used within medical settings to monitor patient adherence 
to medication regimens (Farmer, 1999; Schwed et al., 1999; Straka, Fish, 
Benson, & Suh, 1997).  Prevalence of non-adherence specific to the morning 
period was investigated in a large sample (N = 300) of adolescents.  Using track 
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caps, a significant number of participants that delayed saliva sampling were 
identified: 31% collected the awakening sample 10 minutes late, 37% collected 
the 30 minute post-awakening sample seven minutes early or late, and 40% 
collected the bedtime sample within ± 60 minutes (Halpern, Whitsel, Wagner, & 
Harris, 2012).   
 
In two studies self-reported and electronically monitored saliva sampling times 
were compared and this revealed the inaccuracy of participant self-reports.  In 
both studies, half of the participants were aware of the electronic estimates of 
sampling times.  In the first study, a group of community adults (average 30 
years old) collected saliva samples on one day in the morning (0 and 30 min 
post-awakening) and at spot samples over the day (11:00, 15:00, 20:00, 22:00 
hr). Participants unaware of electronic monitoring were inaccurate in reporting 
their sampling times, on average self-reports were over an hour (68 minutes) 
later than the electronic estimates (Kudielka, Broderick, & Kirschbaum, 2003).  
Considering that the non-adherence window was less strict for collecting the 
day samples (± 60 min) 25% of participants failed to collect the samples within 
this time frame.  Delays in saliva sampling specific to the morning period were 
shown to impact on the measurement of the CAR, a delay of over 10 minutes 
resulted in a lower rise in cortisol from awakening to 30 minutes post-awakening.  
Additionally the same group showed that as the delay in sampling collection 
increased so did the rise in cortisol.  Also, the authors suggested that the 
magnitude of the CAR influenced the diurnal cortisol profile, in that, participants 
that were non-adherent had a smaller slope in cortisol over the day (Kudielka et 
al., 2003).  In the second study females suffering from fibromyalgia and 
matched controls (average 50 years old) collected samples for a week; in the 
morning (0 and 30 min post-awakening) and over the day (16:00, 19:00, 22:00 
hrs or before sleep).  Unaware participants were less adherent; their self-
reported sampling times were consistent with the desired sampling times.  
Deviations in sampling times were most prevalent for the afternoon sample 
(16.00 h).  Sampling delay over 15 minutes during the CAR period resulted in a 
lower rise from awakening to 45 minutes post-awakening.  Deviations (± 60 min) 
in samples collected over the day resulted in a flatter slope (Broderick, Arnold, 
Kudielka, & Kirschbaum, 2004). 
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One study that examined the impact of non-adherence specifically on the 
diurnal cortisol profile over the day (8:00 -22:00) found that deviations in saliva 
sampling did not result in a flatter diurnal cortisol slope or differences in average 
cortisol levels (Jacobs et al., 2005).  The difference in results may be attributed 
to the measurement of the diurnal cortisol profile.  The latter study specifically 
measured the slope of cortisol over the day, whilst the two other studies 
included the CAR in the slope of cortisol.  The CAR was flatter due to delayed 
sampling and this will influence the slope of cortisol.  To gain a reliable estimate 
of the diurnal cortisol profile the CAR should be excluded (as discussed above).  
 
2.4.3 Assessment of awakening time  
 
The above studies highlight the inaccuracy of participant self-reported sampling 
times but do not identify the delay between awakening and collection of the first 
sample.  A measure of awakening time is needed for this, and it is particularly 
important for assessment of the CAR.  In the domestic setting, more objective 
measures include electroencephalography, polysomnography or wrist-worn 
actigraph.  Polysomnography records biophysiological changes that occur 
during sleep; it is regarded as the gold standard for determining awakening time.  
However, the latter, actigraphy can be used more easily within the domestic 
setting and allows estimation of awakening time with reference to increased 
activity associated with awakening.  Actigraphy have been validated against 
polysomnography (Lichstein et al., 2006) and are widely used in non-clinical 
and clinical studies (Lauderdale et al., 2006).  
 
In a study that explored genetic and environmental influences on basal cortisol, 
a subset of the sample had a negative CAR, for these participants electronic 
estimates of awakening time was available (59 out of 77).  In 80% of cases, 
electronically monitored awakening time was earlier than participant self-reports, 
on average 42 minutes (range 10 min – 2.15 hr) earlier, suggesting that the 
negative CAR was the result of delaying sampling after the electronic estimate 
of awakening.  To directly test this, CARs were compared between those with 
and without discrepancies between self-reported and electronically monitored 
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awakening time.  The negative CAR appeared to be the result of delayed 
sampling relative to the electronic estimate (Kupper et al., 2005).  
 
In several studies discrepancies between self-reports and electronic estimates 
of awakening times have been investigated and show that discrepancies 
between the two measures lead to a delay in collection of the first ‘awakening’ 
sample.  Dockray, Bhattacharyya, Molloy and Steptoe (2008) compared self-
reported and actigraph awakening times in patients with heart problems 
(average 61 years old).  The authors reported that discrepancies were relatively 
minimal; with only over five minute difference between self-reported and 
electronically determined awakening times in 30% of participants.  On average 
awakening times were earlier (average 6 min) than participant self-reports.  This 
discrepancy resulted in delays between awakening and collecting the first 
sample with electronic estimates detecting (average 12 min) longer delays than 
self-reports (average 6 min).  However, in older individuals (average 74 years 
old), using polysomnography, Okun et al. (2010) reported little difference (which 
was not significant) between self-reported and electronically monitored (average 
3 min difference) awakening times.  However, electronically determined 
awakening detected 18% more cases of delays between awakening and 
collection of the first sample (>15 min delay).  
 
In both of these studies delays between awakening and collection of sample 1 
resulted in erroneous CAR.  Dockray et al. (2008) found that participants who 
delayed over 15 minutes had a higher first sample and did not show a rise 
between 15 and 30 min, this is likely to be because cortisol in the delayed group 
(> 15 min) was decreasing at this point.  Likewise Okun et al. (2010) found that 
delays (> 15 min) resulted in a higher first ‘awakening’ sample and a smaller 
CAR magnitude compared to delays less than 15 minutes, indexed by the rise 
between awakening and 30 min post-awakening.  They also showed that as 
delay in collecting the first ‘awakening’ sample increased the rise in cortisol 
decreased, they report a window of less than 16 minutes acceptable for delays 
in the CAR period.  DeSantis, Adam, Mendelsohn and Doane (2010) 
investigated discrepancies in awakening times in adolescents (aged 17-19 
years).  Self-reported awakening times were relatively accurate, the majority of 
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participants (75%) reported their awakening time within five minutes of the 
actigraph estimate.  On average self-reported awakening was six minutes later 
than actigraph estimates.  A longer delay between awakening and collection of 
sample one was identified with electronic estimates compared to self-reports (7 
min versus 3 min respectively) and this was also the case for delay between 
awakening and collecting sample two (average 3 min delay).  Discrepancies 
between awakening times resulted in collecting the saliva samples later than 
the desired times.  Participants with discrepancies over 15 minutes between 
self-reported and electronically monitored awakening time had significantly 
lower CARs but only in participants with high neuroticism scores (DeSantis et 
al., 2010). 
 
Studies investigating the impact of non-adherence to the saliva sampling 
protocol on diurnal cortisol patterns have either monitored awakening times or 
sampling times electronically, but not both, and thus rely on demonstrably 
unreliable participant self-reports for the alternative variable.  To obtain a full 
estimate of non-adherence to the saliva sampling protocol estimate of collecting 
samples at the desired interval relative to awakening is not measurable by 
assessment of sampling or awakening times alone.  Thus, a combination of 
both awakening and sampling times are necessary in order to gain the most 
accurate estimate of sampling times relative to awakening.  Recently, a study 
monitored both awakening and sampling times electronically in a sample of 
young adults (average 27 years old) and middle-aged adults (average 59 years 
old) that completed sampling in a sleep laboratory and also in a student sample 
(average 25 years old) that completed sampling in their domestic setting 
(Griefahn & Robens, 2011).  Delays over 15 minutes resulted in a smaller CAR 
magnitude.  To determine if delays between 10 and 15 minutes were 
acceptable, the average CAR was plotted for each successive minute by which 
collection of sample one was delayed, delays under about 11.5 minutes were 
acceptable for measurement of the CAR.  
 
This non-adherence to the saliva sampling protocol raises concerns about the 
extent to which previous research has been in detecting reliable and valid 
relationships between the diurnal pattern of cortisol and psychosocial or health 
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variables.  Since researchers typically rely on self-reports it is very likely that 
samples considered non-adherent have been included in analyses, which in 
turn surely significantly reduces the ability to reveal existing relationship.  In this 
way, true relationships may not have been detected or incorrect relationships 
have been accepted.  
 
Strategies to increase adherence to the saliva sampling protocol are limited. 
Halpern et al. (2012) used incentives as a method of encouraging participants 
to collect saliva samples on time, however, providing incentives in the form of 
money failed to promote participant adherence to the post-awakening saliva 
sampling period.  Informing participants of electronic monitoring of their 
adherence to the protocol seems to be the most effective strategy in increasing 
their adherence to the protocol and accuracy in self-reports (Broderick et al., 
2004; Kudielka & Kirschbaum, 2003). 
 
The demands of the protocol may increase participant non-adherence.  For 
example delays in collecting saliva samples increased with the number of study 
days, but no differences were observed between week and weekend days 
(Broderick et al., 2004).  There is some evidence that awakening time 
influences the delay between awakening and collection of the first ‘awakening’ 
sample.  In middle-aged patients, delays between awakening and collection of 
the first sample was less in participants that awoke later, this may be explained 
by early risers being drowsier and thus less prompt in carrying out the sampling 
procedure (Dockray et al., 2008).  Consistent with this finding, in healthy 
adolescents poor assessment of awakening time was associated with 
subsequent sampling delay of the first ‘awakening’ sample (DeSantis et al., 
2010).  
 
Non-adherence does not appear to be due to participant factors, several studies 
have investigated the relationship between participant characteristics and non-
adherence to the saliva sampling protocol.  Delays in saliva sampling collection 
were not associated with age, gender or smoking status (Kudielka & 
Kirschbaum, 2003).  Health status did not influence adherence to the saliva 
sampling protocol, non-adherence did not differ between women suffering from 
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fibromyalgia and matched healthy controls (Broderick et al., 2004). Furthermore 
adherence to the sampling protocol was not associated with sociodemographic 
characteristics (Halpern et al., 2012), similarly  no relationship was found 
between inaccuracies in self-reported sampling times and demographic 
variables (Hall et al., 2011).  However a relationship between ethnicity and 
sampling delay was evident with African-Americans being more likely to delay 
sampling (Hall et al., 2011).  Psychosocial variables such as sleep quality, 
depression and perceived stress does not influence non-adherence (Okun et al., 
2010). 
 
2.5 Hair cortisol  
 
Given the limitation of non-adherence to the saliva sampling protocol, the 
measurement of a valid and easily obtainable measure of long-term cortisol 
secretion would constitute an important advancement to the field.  Table 2.3 
provides a summary of the strengths and considerations of measurement of 
cortisol in hair samples.  Over the last decade or so a new method of measuring 
cortisol in hair has been developed.  The key aspect of this measure is that hair 
grows on average 1cm per month, (Wennig, 2000), and is incorporated into the 
hair shaft (see Figure 2.3) equating to one months cortisol secretion growth rate 
of 1cm over one month.   
 
Several studies have demonstrated the validity of hair cortisol concentrations 
(HCC) as a marker of chronic cortisol production in humans.  Studies have 
demonstrated abnormal HCC in conditions known to be associated with 
increases and decreases in HPA activity.  Higher HCC was evident in 
conditions characterized with hyper-cortislism, for example, in pregnancy during 
the third trimester (D'Anna-Hernandez, Ross, Natvig, & Laudenslager, 2011; 
Kirschbaum, Tietze, Skoluda, & Dettenborn, 2009), endurance athletes 
(Skoluda, Dettenborn, Stalder, & Kirschbaum), alcoholics (Stalder, Kirschbaum, 
et al., 2010) and in patients with Cushing syndrome (Thomson et al., 2010).  
Higher HCC has also been demonstrated in other stress-related conditions in 
humans, for instance, in infants exposed to stressful hospital procedures 
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(Yamada et al., 2007), chronic pain patients (Van Uum et al., 2008) and 
unemployed individuals (Dettenborn, Tietze, Bruckner, & Kirschbaum, 2010).  
 
A multi-compartment model has been proposed in which there are general 
models of incorporation of drugs or hormones into hair (Henderson, 1993). 
Figure 2.3 provides an overview of these models (for a review, see Pragst & 
Balikova, 2006).  Cortisol incorporation through passive (or active) diffusion 
from blood into growing cells in the hair follicle is thought to be the primary 
mechanism (Cone, 1996).  An alternative incorporation pathway is through 
sweat or sebum secretion after formation of the hair shaft.  Incorporation of 
cortisol via these mechanisms reflects the “free” or unbound fraction of the 
steroid based on the free hormone hypothesis (Mendel, 1989).  Cortisol could 
be incorporated into hair through external contamination after formation of the 
hair shaft, for example, use of cortisol-containing creams passed onto the hair 
from hands when individuals touch his or her head (Thomson et al., 2010).  It 
may be possible that there are several pathways in which substances are 
incorporated into hair.  However, it is also possible that there are different 
incorporation pathways for different substances (e.g. drugs or hormones), which 
suggests that movement and stability may vary by the type of drug or hormone 
under investigation.  
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Figure 2.3 Assumed mechanisms of cortisol incorporation into hair and 
retrospective reflection of long-term cortisol secretion.  
 
Cortisol may be incorporated into hair via passive diffusion from blood (A), 
sweat (B) and/or sebum (C) as well as from external sources (D). In addition, it 
has been proposed that locally produced cortisol may also contribute to hair 
cortisol concentrations. Taken from (Stalder & Kirschbaum, 2012).  
 
 
The advantage of this method over other methods (e.g. saliva, blood and urine) 
is the unique feature of assessment of cortisol secretion over several months.  It 
provides a retrospective image of cortisol secretion, providing a window into the 
past, which will develop research on the effects of chronic exposure over longer 
periods of time and after an event.  A good example of the advantage of hair 
cortisol is the measurement of cortisol secretion over several months in patients 
after suffering from a heart attack.  HCC was significantly higher in patients who 
had suffered from an myocardial infarction compared with control patients 
(Pereg et al., 2011).   
 
The time period at which HCC can be reliably measured is currently debated.  
Some studies have reported a ‘wash-out’ effect, in which, HCC declines from 
proximal to more distal hair segments (e.g. Dettenborn, Muhtz, et al., 2012; 
Dettenborn et al., 2010; Kirschbaum et al., 2009; Stalder, Steudte, Alexander, 
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et al., 2012) while other did not find this.  Similarly, evidence regarding the 
associations between HCC to retrospectively reflect cortisol secretion over 
longer time periods is questioned.  Some have found that cortisol secretion 
closely resembled clinical conditions for more than a year (Manenschijn, van 
Kruysbergen, de Jong, Koper, & van Rossum, 2011; Thomson et al., 2010).  
Others however, have failed to find such associations, for example, HCC for 
detecting hyper-cortislism in the third trimester of pregnancy was only 
accurately reflected in hair sampled at three months but not six and nine 
months (Kirschbaum et al., 2009).  
 
Studies have demonstrated that HCC is a trait measure, with high intra-
individual stability in the absence of major life events (Stalder, Evans, 
Hucklebridge, & Clow, 2011). Also due to the retrospective nature of hair 
sampling and extended detection period it is relatively robust to a range of 
potential confounding influences, such as, natural hair colour, hair washing or 
dying, taking oral contraceptives, smoking status or general medication intake 
(Dettenborn, Tietze, Kirschbaum, & Stalder, 2012; Karlén, Ludvigsson, Frostell, 
Theodorsson, & Faresjö, 2011; Kirschbaum et al., 2009).  
 
The anatomy of growing hair is rather complex (for a review, see Alonso & 
Fuchs, 2006; Krause & Foitzik, 2006).  Hair growth originates from follicles 
located beneath the surface of the skin.  Hair follicles grow in repeated cycles 
composed of three phases, including anagen (active growth), catagen 
(transition or regression), and telogen (resting).  Hair follicles pass through each 
phase independently from neighbouring hair follicles.  A hair follicle is in the 
anagen phase for the longest time, on average between 2-6 years, the duration 
of which determines the hair length.  At any time, the majority of the scalp hairs 
(approx. 85-90%) are within anagen follicles.  The catagen phase signals the 
end of the growth period and the hair follicle is prepared for the resting period.  
This phase lasts for a few weeks, during which time the hair follicle converts to 
club hair (i.e. lower end of hair follicle attaches to the hair shaft).  During the 
resting phase, hair growth completely terminates, the hair follicle stays attached 
to the hair shaft until it sheds.  The cycle starts again and the new hair pushes 
out any dead hair left.  Although it is generally accepted that hair grows on 
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average 1-cm per month, this is an oversimplification and various factors 
account for the variation in hair growth.  For example, growth rate is slower in 
males (anagen phase in women is longer than men) and older individuals (see 
Harkey, 1993), and hair growth is faster in Asian hair compared to African and 
Caucasian hair with African being the slowest (Loussouarn, El Rawadi, & 
Genain, 2005).   
 
Some studies have shown that age and gender were not associated with HCC 
(Karlén et al., 2011; Kirschbaum et al., 2009).  However, more recently, HCC 
was higher in younger children and in older adults, also HCC was higher in men 
compared to women (Dettenborn, Tietze, et al., 2012).  This was the first large 
scale study that systematically investigated the possible confounding factors on 
HCC, while in previous studies these factors were investigated as secondary 
aims and samples were limited by small age range.  Another potential influential 
factor is body fat, studies have demonstrated positive associations between 
weight and HCC (Manenschijn, Koper, Lamberts, & van Rossum, 2011; 
Manenschijn, van Kruysbergen, et al., 2011; Stalder, Steudte, Alexander, et al., 
2012) but findings are mixed (Manenschijn, Koper, et al., 2011).  Stage of hair 
growth may increase variability; cortisol is not incorporated into the hair shaft 
during the resting phase.  Based on the research to date the potential factors 
that need to be considered in HCC studies are age, sex and BMI.  It is usually 
that these factors are controlled for by including a small age range or excluding 
overweight or obese individuals.  It is also important to consider the amount of 
times hair is washed (but only for more distal hair segments for the wash-out 
effect).  Table 2.3 provides a summary of the strengths and considerations of 
measurement of cortisol in hair samples.  
.  
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Table 2.3 Strengths and considerations of measurement of cortisol in hair samples 
 
Strengths  Considerations  
Collection 
Hair sample is non-invasive  
Only a small amount of hair (e.g. 10mg) is required, 
no visible mark is left, and it is well tolerated by 
participants 
Difficulty getting close to the scalp, especially with short hair 
(i.e. males).  
Cannot access all populations (i.e. balding, alopecia) 
Storage 
Hair does not decompose like other body 
fluids/tissues (Balíková, 2005) and is stable for yrs 
at room temperature - cortisol determined in ancient 
hair samples (e.g. mummies) (Webb et al., 2010) 
Samples should be wrapped in aluminum foil to maintain  
integrity and to avoid contamination and stored at room 
temperature 
Measure of cortisol secretion 
Retrospective calendar of cortisol secretion – 
provides a window to the past 
HCC is not affected by situational characteristics 
e.g. no effect of smoking status, medication 
intake/taking oral contraceptives on HCC 
(Dettenborn, Tietze, et al., 2012).  
 
Retrospective account of cortisol only valid for up to 6 months 
due to the ‘wash out effect’ (Dettenborn et al., 2010; 
Kirschbaum et al., 2010) 
Hair samples do not reflect the immediate or recent exposure 
of cortisol secretion – the hair follicle is embedded 
approximately 3-5 mm beneath the scalp 
No measure of acute changes in stress/diurnal pattern of 
cortisol 
Situational or confounding factors 
Hair characteristics or treatment do not influence 
HCC (Karlén et al., 2011; Kirschbaum et al., 2009). 
No problems of non-adherence - samples are 
collected by the researcher 
Possible confounding factors: age, gender, hair growth rate, 
body fat - record details and control in analyses if necessary 
Determination of cortisol 
Easily sent in the post to laboratory for analysis Still need to determine the most effective cortisol extraction 
method (methods of cortisol extraction differ between studies) 
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2.6 Aims and thesis summary  
 
The overarching aim of this programme of research was to explore associations 
between cortisol secretion and well-being, given that well-being may have an 
effect on future health by directly influencing cortisol secretion.  However, 
exploring these relationships under strict monitoring of adherence to protocol is 
crucial due to the impact of sampling delays on measurement of salivary cortisol.  
An overview of the studies and how they interlink is provided in Figure 2.4 and a 
brief outline of the aims of each study is given below.  A detailed rationale for 
each study is provided in experimental chapters. 
 
 
Figure 2.4 Flow diagram of the programme of research 
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Study I:  
 
The main aim of this study was to explore associations between the diurnal 
pattern of cortisol and subjective and psychological well-being independent of 
ill-being in healthy young individuals in the domestic setting.  Previous research 
demonstrates associations between lower cortisol patterns (e.g. lower cortisol in 
the post-awakening period and across the day) and higher levels of well-being 
independent of ill-being, particularly in middle-aged and older adults.  However, 
no study to date has investigated this specifically in a younger sample.  Non-
adherence to the saliva sampling protocol is a key issue in this type of research.  
It can lead to misleading CAR estimates, which may explain the inconsistencies 
in the literature regarding the relationship between the CAR and well-being/ill-
being.  Studies have generally relied on self-report methods of monitoring 
adherence to the saliva sampling protocol.  Some studies have used electronic 
estimates of awakening or saliva sampling times, but only one has utilised both. 
However, no study has accounted for non-adherence in the relationship 
between cortisol patterns and well-being using both track caps and actigraph.  
In this study participant adherence to protocol using both electronic estimates 
was monitored to examine the impact of non-adherence on cortisol patterns and 
to account for non-adherence in the relationship between cortisol patterns and 
well-being.  
 
Study II:  
 
The findings of Study I that moderate delay in saliva sampling lead to 
misleading CAR estimates provided the impetus for Study II.  The aim of this 
study was to investigate salivary cortisol secretion within the immediate post-
awakening period.  No study to date has measured salivary cortisol using 
repeated sampling (every 5 min) within the first 30 minutes following awakening.   
 
Study III: 
 
The aim of this study was to explore the relationship between hair cortisol and 
well-being/ill-being in young and older individuals.  Measurement of cortisol in 
hair provides an alternative method of examining relationships with well-
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being/ill-being.  Although salivary cortisol enables examination of the diurnal 
pattern of cortisol, it is limited by participant non-adherence to protocol, this is 
costly and time consuming to measure objectively using electronic estimates.  
Hair cortisol however, provides a retrospective trait measure of cortisol 
secretion.  This enabled studying associations between cortisol and well-
being/ill-being in a larger sample and comparison of young and old females 
without the issue of participant non-adherence 
 
In summary the overall aims of this research were:  
 
(1) To inform best practice methodology for the ever-increasing number of 
studies in this area of research 
 
- To monitor and examine the impact of non-adherence to the saliva sampling 
protocol in ambulatory studies.  
- Investigate the impact of moderate sampling delays on the CAR.  
 
(2) To expand significantly the collection of published data on the 
association between cortisol patterns and well-being in healthy participants 
using well-established methodology and strict monitoring of participant 
adherence to protocol.  
 
- Explore the relationship between diurnal patterns of salivary cortisol and well-
being independent of ill-being in young healthy females.   
- Explore the relationship between hair cortisol and well-being independent of ill-
being in healthy young and older females.  
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Chapter 3 General Methods 
 
 
3.1 Ethical Considerations  
 
The research presented in this thesis was carried out in line with the ethical 
guidelines for research with human participants set out by the British 
Psychological Society.  The guidelines set out by University of Westminster 
were also consulted.  Ethical approval for the studies presented in this thesis 
was obtained from the University of Westminster.  Ethical implications and the 
psychological consequences were considered for all aspects of the research 
studies.  Participants read the information sheet and provided informed consent 
(Appendix 1-4) and asked any necessary questions.  Every effort was made to 
create a relationship with mutual respect and confidence between the 
researcher and participant.  All participation was voluntary and participants were 
encouraged to participate only if they felt comfortable to meet the requests of 
the study protocol.  The nature of the three studies did not require deception or 
withholding of information, therefore, participants were fully informed of the 
study aims, rationale and procedure.  All reasonable steps were taken to ensure 
that participants understood the nature of the study; participants received both 
verbal and written information detailing the study and were given the opportunity 
to ask any questions.  All participants were provided with contact details of the 
researcher, to use if they wished to ask questions or express any concerns or 
issues during or following participation. 
 
All participants were healthy adults, with no impairments either in 
communication or understanding, enabling them to provide informed consent.  
Although the participants were sometimes students of the researcher, who was 
therefore in a position of potential influence, participants were not pressurised to 
participate or remain in the study.  To make participants feel at ease collecting 
saliva and providing hair samples they were given the opportunity to practice 
collecting a saliva sample or were either shown a picture of the hair sample 
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process or felt the amount of hair that would be cut.  
 
Participation in the studies did not increase participants’ exposure to risk or 
harm greater than or additional to those encountered in their normal daily 
routines.  Some participants reported discomfort with the saliva sampling 
protocol.  For example, some participants found the cotton swab (used for 
saliva sampling) distasteful.  However, participants were given a practice 
session to ensure they were comfortable collecting saliva samples.  Emotional 
discomfort could have potentially risen from completing the psychosocial 
measures pertaining to mental health.  However, participants were assured that 
they were under no obligation to disclose information that they did not wish.  
 
In all cases participants were made aware of their right to withdraw participation 
at any time, including withdrawing their data prior to publication, without 
explanation.  Participants were made aware that if they agreed to be contacted 
about future research they were under no obligation to participate in it.  
Participants were made aware that the information they provided would be 
confidential.  Data used for publication would be aggregated and no individual 
would be identifiable.  The researcher was responsible for the confidentiality of 
the information acquired.  All steps were taken in order to prevent the loss of 
data-security, participant names were separately coded rendering written and 
computerised records identifiable by only the researcher.  All hard-copy data 
generated from the research was stored in locked cabinets in secure offices in 
the Regent Street campus of the University of Westminster.  Consent forms and 
any other potentially identifiable information were kept in separate and secure 
cabinets.  Electronic data was stored in files on password-protected computers 
accessible only to the researcher.  Anonymous computer data files were 
viewable only by the supervisory team, all of whom were aware of confidentiality 
issues.  Participants consented to saliva and hair samples being tested for the 
hormone cortisol.  Hair samples were stored in secure cabinets in Regent Street 
campus and saliva samples were stored in the PSRG laboratory in the New 
Cavendish campus of the University of Westminster.  Storage and use of saliva 
samples were in line with the Human Tissue Act (HTA; 2004); samples stored 
were recorded on the HTA tracking form.  Both hair and cortisol samples were 
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labeled with participant code, and destroyed following analysis in line with the 
HTA. 
 
Responses to the psychosocial data were completed via online questionnaires.  
The online questionnaires were set up by systems designed to create 
questionnaires, these included Mircrosoft Office Frontpage and Qualtrics and 
were provided by the University of Westminster.  Participants accessed the 
questionnaires via a link, and were firstly presented with information sheets and 
were advised to save or print a copy for their records.  Before viewing the 
questionnaire they were required to provide consent; the system did not allow 
them to go to the next stage until this was provided.  Participants could only see 
the questionnaire items and select their responses, and were not able to see 
their responses once submitted.  To ensure that participants completed all 
questions and sections of the questionnaire, participants could not submit their 
responses until each item was assigned a response.  For each question there 
was an option to select ‘I do not wish to answer’ or ‘not applicable’ to enable 
participants to leave a question if they not wish to answer it.  
 
On completion of each study, participants were given the opportunity to discuss 
with the researcher their experiences of partaking in the study, during which 
participants were encouraged to give their feedback regarding their experience 
of partaking in the research.  This allowed the researcher to monitor any 
unforeseen negative outcomes or misconceptions.  Participants were informed 
that they could contact the investigator via email if they wished to be informed of 
the research findings. 
 
3.2 Participants and Researcher 
 
The programme of research was conducted in the UK, with a process of on-
going study design and recruitment from October 2010 to March 2013.  The 
author of the thesis (NS: white female aged 24-26) completed all aspects of 
each study including the study design, data collection, analysis of biological 
samples (apart from hair), and statistical analysis.  An MSc student completing 
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an internship with the PSRG at the University of Westminster (MB: white, 
female aged 26) assisted with data collection in study III. 
 
For the salivary cortisol studies pregnant females were excluded since changes 
in the HPA-axis take place during pregnancy, specifically, higher cortisol levels 
during the third trimester of pregnancy (Obel et al., 2005).  Participants were 
recruited on the basis that they were not taking prescribed medications and had 
not suffered from serious medical or psychiatric illnesses in the last two years.  
Participants providing hair samples were excluded if they were suffering from 
any condition of adrenocortical dysfunction or currently taking corticosteroid 
medication during the year before the study. 
 
Student volunteers were drawn from the psychology department at the 
University of Westminster via the research participation scheme (RPS).  This 
scheme is organised by the psychology department with the aim of engaging 
undergraduate psychology students in research, either as a participant or as an 
assistant for a period of three hours in their first year of study.  Students were 
under no obligation to participate in any research; alternatively they could write 
a short essay detailing the ethical considerations for conducting research.  
Recruitment of student participants for studies I and III were conducted in two 
stages.  The first stage involved completion of an online questionnaire, adverts 
were sent to students via email or the RPS website as well as leaflets posted 
around the psychology department (Appendix 5-6).  Interested students were 
instructed to follow a link to access the questionnaire, slips with the web link 
were provided for student’s convenience.  Wider recruitment was undertaken 
through word of mouth, as well as leaflets and articles posted in the psychology 
department and the university’s newspaper (Appendix 7).  Recruitment for 
participating in the second phases (e.g. saliva or hair sampling) was through 
invitation via email.   
 
Researchers within the psychology department and friends of the researcher 
familiar to the saliva sampling protocol volunteered to partake in study II.  They 
did not receive any financial incentives for their participation.  For study III, older 
female volunteers were recruited from among the University of the Third Age 
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and Women’s Institute.  Personal letters to individuals from University of the 
Third Age (of whom previously participated in research conducted by the PRSG) 
were sent inviting them to take part in a new study (Appendix 8-9).  Leaflets 
advertising the study were also sent to the University of the Third Age and 
Women’s Institute.  They were offered a small momentary token of a £10 high 
street voucher for expenses.  
 
3.3 Salivary Cortisol  
 
3.3.1 Saliva Sampling Protocol  
 
Salivary cortisol enables repeated sampling within participants’ domestic setting 
and measurement of the diurnal pattern of cortisol secretion.  Measurement of 
the CAR and diurnal decline requires repeated sampling in the post-awakening 
period and across the day (respectively).  Determination of the CAR typically 
requires repeated sampling at regular intervals during the post-awakening 
period as cortisol levels change rapidly during this period.  In study I sampling 
included the following time points 0, 15, 30 and 45 min post-awakening 
(samples 1-4), which are typically used  to capture the rise in cortisol (i.e. the 
CAR magnitude).  The diurnal cortisol profile was limited to two samples, 
collected at 3 and 12 hours post-awakening (samples 5-6), representing the 
change in cortisol from 3 to 12 hours post-awakening.  In study II, to capture the 
cortisol activity within the immediate post-awakening period, saliva samples 
were collected every 5 min for the first 30 min post-awakening (samples 1-7).   
 
Participants were instructed to awake in their usual way since mode of 
awakening does not influence the CAR (Pruessner et al., 1997; Wuest et al., 
2000).  The CAR and diurnal decline were measured on four study days to 
avoid distortion of data by state variables.  Study days included, two weekdays 
and two weekend days.  In study II, the saliva sampling protocol was quite 
intensive, to reduce the demand on participants, saliva sampling was limited to 
two weekdays.  
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Participants were asked to take nil-by-mouth (except water) and no smoking or 
brushing teeth during the CAR collection period and also for at least 30 min 
prior to saliva sampling over the reminder of the day to avoid HPA axis 
stimulation.  For example, smoking and caffeine have been associated with 
increased cortisol levels (Badrick et al., 2007; Lovallo et al., 2005).  For up to 
seven days, cortisol remains stable at room temperature (and for nine months 
at -20 degrees centigrade, Aardal & Holm, 1995).  Participants were, however, 
requested to store their samples in their home freezer or fridge as soon as 
possible after collection of saliva.  The use of salivettes (see below) allowed for 
hygienic storage of the samples in participants domestic freezer/fridge.  
Participants were provided with insulated bags in which to return their samples 
to the investigator upon which they were stored at -20°C in a laboratory freezer 
at the University of Westminster until they were assayed. 
 
Saliva samples were collected using the salivette sampling device, which is an 
optimal method for obtaining full saliva samples, manufactured and sold by 
Sarstedt© (Sarstedt Ltd, Leicester, England).  Figure 3.1 displays a diagram of 
a salivette adapted from the Sarstedt website (www.sarstedt.com).  The device 
contains a cotton swab placed within a suspended insert in a capped plastic 
tube.  Participants remove the swab from the suspended inserted tube and 
place it into their mouth and gently chew to stimulate saliva flow for a period of 
one to two minutes.  It usually takes approximately one minute to obtain up to 
0.5-1 ml of saliva.  Once saturated with saliva the swab is placed back in the 
suspended insert of the tube and firmly capped.  Saliva is released from the 
cotton swab by centrifuging the salivette and clear saliva is released into the 
centrifuge vessel via a hole in the suspended insert.  
 
 
 
 
 
 
 
 
 
Figure 3.1 The salivette saliva sampling device (Sarstedt Ltd) 
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Participants were encouraged to practice collecting a saliva sample using the 
salivette device to ensure that they were comfortable collecting samples.  
Participants were provided with a salivette for each sampling point per sampling 
day (with the cotton swabs removed, see below).  Salivettes were divided into 
ziploc bags for each sampling day and were labelled with participant code, 
sample tube, sampling day and sampling time.  The ziploc bags were labelled 
with participant code and sampling day.  To minimize collection mistakes the 
labels were colour-coded to symbolise the different collection times and days.  
As well as verbal instructions, detailed written instructions were provided 
regarding the sampling protocol and the correct use of the salivettes.  
 
3.3.2 Adherence to the saliva sampling protocol in the domestic 
setting  
 
Assessment of diurnal cortisol patterns in the domestic setting means that 
participants are left to their own devices to adhere to the protocol.  As 
mentioned in chapter 2, one of the main aims of this thesis was to take every 
possible measure to maximise participant adherence to the protocol and to put 
measures in place to control for potential violations.  Non-adherence to the 
protocol may arise from little or misunderstanding information about the 
research protocol and/or intentional non-adherence due to little motivation of the 
participant or underestimating the accuracy needed.  Some incidences of non-
adherence can be prevented through engaging the participant in the research 
protocol.   
 
Participants attended one-to-one research sessions with the researcher (NS) 
with the aim of providing clear instructions about every aspect of the protocol, 
and engaging participants in the protocol.  During the research session 
participants were briefed comprehensively; the whole procedure was explained 
in detail, using graphical illustrations of the protocol.  They received a study 
pack, which included all the necessary materials for saliva sampling and the 
electronic equipment used for monitoring awakening and sampling times.   
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To aid participants in carrying out the protocol in their domestic settings they 
were provided with study guidelines detailing every aspect of the study protocol 
(Appendix 10) and were also given the researchers contact information to use if 
they encountered any problems or concerns during the study.  Finally, 
participants were asked to relay the study protocol back to the researcher to 
ensure that they understood each aspect of the study.  It was emphasized that 
they should only participate if they felt confident and happy to adhere to the 
protocol.  To ensure that participants returned study materials participants could 
return them at times and places convenient for them.   
 
3.3.3 Monitoring adherence to the saliva sampling protocol  
 
3.3.3.1 Self-report measures  
 
Participants provided self-reported awakening and sampling times on each 
study day using diaries (Appendix 11-12).  After awakening and collection of 
sample 1, participants calculated their sampling times for the day relative to 
their awakening time.  They were also asked to record the time of actual 
collection of each saliva sample in order to identify any deviations from the 
desired sampling time.  During the one-to-one research session, participants 
were asked to practice calculating their salvia sampling collection times to 
ensure they understood how the sampling points related to their awakening 
times. 
 
For each sample, they were also asked to record any problems with sampling 
(e.g. failed to remain nil-by-mouth, smoking or brushing their teeth in the 30 min 
prior to saliva sampling).  In study I, participants  also rated their sleep quality 
on a five-point Likert scale, ranging from much better than usual to much worse 
than usual, how they awoke (e.g. alarm clock, somebody they asked to wake 
them, noises or spontaneously) and their ease of awakening on a five point 
Likert scale, ranging from very difficult to very easy on mornings of each study 
day.  
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3.3.3.2 Objective proxy of awakening and saliva sampling times  
 
It was argued in chapter 2 that participants’ self-reported awakening and saliva 
sampling times are inaccurate, comparison with electronic estimates show that 
awakening times are typically earlier and sampling times are typically later than 
self-reports.  Electronic estimates of awakening and sampling times provide a 
proxy of an objective measure, and together they provide real-saliva sampling 
times (i.e. sample collation time relative to awakening time).  
 
Sampling on awakening is crucial for accurate estimates of the CAR; delay in 
sampling on awakening will also delay subsequent sample points.  To assess 
awakening time, participants wore an activity device on their wrist (see Figure 
3.2) the night prior to each study day.  The actiwatch-score device (Actiwatch-
Score, Cambridge Neurotechnology, Cambridge, UK) is a piezoelectric motion 
sensor recording physical activity.  
 
 
 
 
 
 
 
 
 
 
Figure 3.2 The actiwatch-score device 
 
Awakening times were estimated using the actigraph software; it distinguished 
sleep and awakening periods by reduced and increased activity respectively.  
Figure 3.3 displays an example recording of awakening time from the actiwatch-
score software.  Actigraphy has been validated against the gold standard 
polysomnography (Lichstein et al., 2006) and is widely used in non-clinical and 
clinical studies (Lauderdale et al., 2006).  
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Figure 3.3 Actigraph analysis software  
(a) Actogram showing the awakening period (b) actigraph software used to 
determine the point of awakening 
  
 
Sampling times were determined by track caps (e.g. Medication Event 
Monitoring: MEM Caps), the cotton swabs normally in the salivettes and used 
for saliva sampling were stored in the track caps (Figure 3.4) — participants 
were instructed to open this device only at sampling times.  Following saliva 
collection, swabs were returned to the correctly labelled salivette for storage.  
Opening of each cap recorded the date and time and these timings were used 
as a proxy measure of participants’ saliva sampling times.  
 
 
 
 
 
 
  52 
 
 
 
 
 
 
 
 
Figure 3.4 Track cap device: Medication event monitoring (MEM) cap  
 
 
Both electronic devices were used to electronically determine actual saliva 
sampling collection times and determine non-adherent delays to sampling.  
Desired saliva sampling times of each sampling point were calculated for each 
participant based on his or her actigraph estimated awakening time (i.e. 0, 15, 
30 and 45 min, and 3, 12 hr post-awakening).  Actual sampling time was 
determined by subtraction of MEMs-determined sampling time from the desired 
sampling time. 
 
Participants were made aware of the importance of their adherence to the 
protocol in particular collecting samples at the desired times, and they were 
informed that the electronic devices would verify their awakening and sampling 
times.  This has previously been shown to increase adherence to the saliva 
sampling protocol (Broderick et al., 2004; Kudielka et al., 2003).  
 
3.3.3.3 Short Messaging Service (SMS) Protocol  
 
Practical advice was provided to participants on preparing for their upcoming 
study days (e.g. prepare and place study materials next to their bed the night 
prior to their study day to prevent delays in the mornings due to having to 
search for the materials).  As well as this reminders were used to ensure that 
participants remembered to carry out certain tasks.   
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Text messaging is a useful and welcomed method of communicating with 
participants.  It was crucial that participants remembered to wear the actiwatch-
score to bed the night prior to each study day, and during each sampling day.  
Repeated saliva sampling across the day can be difficult for participants to 
remember to collect the samples.  Text messages were used to remind 
participants to wear the actiwatch-score to bed and during the day, prepare 
study materials the evenings prior to each study day and to collect the day 
saliva samples (i.e. sample 5 & 6).  SMS-messages were easily and securely 
sent using a cost-effective automated text messaging service (TextAnywhere).  
Participants had access to a mobile phone and this was exploited in order to 
remind participants about upcoming study days.  Participants were sent a text 
message the evening prior to each study day reminding them to wear the 
actiwatch-score to bed and to place sampling packs next to their bed.  Text 
messages were used to remind participants to complete the morning diary.  
Participants were reminded to collect the 3 and 12 hr post-awakening samples 
by text messages.  Use of text messages are a cost-effective method of 
increasing adherence to a range of health behaviours and completion of diary 
entries (e.g. Anhoj & Moldrup, 2004), and have also been used in salivary 
cortisol studies to prompt participants to collect saliva samples  (Oskis et al., 
2009).  
 
3.3.4 Determination of cortisol in saliva samples  
 
Saliva samples were assayed by the author (NS) in the PSRG laboratory at the 
University of Westminster.  After saliva samples were thawed, clear saliva was 
released from the cotton swabs into the centrifuge vessel through centrifuging 
samples at 3500 rpm for 10 min.  Samples were assayed using the Cortisol 
Enzyme Linked Immuno-Sorbent Assay (ELISA) developed by Salimetrics LLC 
(USA).  All of the Salimetrics assay kits are commercially available.  This assay 
exploits immunological processes in the measurement of cortisol and is 
designed specifically to quantify the measurement of salivary cortisol.  The 
assay is highly sensitive to low values of cortisol, with detection of cortisol as 
low as 0.16 nmol/l.  Salimetrics report that the salivary cortisol assay correlates 
highly with those from a serum cortisol assay (r = 0.91, p < 0.0001, n = 47 
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samples, see www.salimetrics.com).  The amount of saliva required for the 
assay is just 25µl of saliva per test.  
 
The assay kit contains a microtitre plate with 96 wells coated with monoclonal 
antibodies to cortisol; cortisol standards, which represent known cortisol 
concentrations (values in nmol/l: 82.77, 27.59, 9.19, 3.06, 1.02, 0.33). The 
standards and unknowns (saliva samples from participants) were pipetted into 
the wells in the microtitre plate, and an enzyme conjugate (cortisol labelled with 
horseradish peroxidase) was added. The test principle is that cortisol in 
standards and unknowns compete with the enzyme conjugate for antibody 
binding sites in the wells on the microtitre plate.  Following incubation for one 
hour unbound components are washed away using a phosphate buffered 
solution containing detergents.  Bound cortisol peroxidase is measured by 
reaction with tetramethylbenzidine (TMB) solution, which produces a blue colour 
following 30 min incubation in the dark.  The reaction is terminated by added 
sulphuric acid, which is a stop solution producing a change in the colour (blue to 
yellow).  Within 10 min of adding the stop solution the optical density was read 
on plate reader with a 450nm filter.  The amount of cortisol peroxidase present 
is inversely proportional to the amount of cortisol present, which visually follows 
that the more yellow the solution in each well, the less cortisol.  
 
The researcher carefully followed the procedure provided by Salimetrics for all 
the salivary cortisol assays performed.  In addition to this samples from one 
participant were assayed on the same day and each sample was assayed in 
duplicate.  On the rare occasion that the percentage variation between the 
duplicate samples was greater than 10% the sample was re-assayed on 
another plate.  In this way intra-assay variation was less than 10% for all studies.  
Other known concentrations of cortisol, the high and low controls, (27.6 nmol/l 
and 2.76 nmol/l, respectively) were treated like unknowns and used to 
determine inter-assay variability, which was below 10% for all studies.  On 
average both intra and inter assay coefficients of variation were comfortably 
below 10%. 
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3.4 Hair Cortisol  
 
3.4.1 Hair sampling protocol  
 
Hair samples were cut with clean fine scissors as close as possible to the scalp 
from the vertex posterior of the head.  This area has the least variation (e.g. 
16%) as compared to other areas (e.g. 31%) (Sauve, Koren, Walsh, 
Tokmakejian, & Van Uum, 2007).  Further, it has the largest percentage of 
follicles in the anagen phase (85%) and the fastest growth rate of up to 1.12 
mm per day (Harkey, 1993).  The hair follicle is not included in the analysis as 
they have previously been shown to produce cortisol responses to corticotropin-
releasing hormone stimulation (Ito et al., 2005).  Before cutting the hair 
participants were given the opportunity to feel or look at the amount of hair to be 
cut.  The number of hair strands obtained varied in accordance with 
participant’s permission to cut more or less hair.  Hair samples were wrapped in 
aluminium foil and stored in a dry and dark place.  Figure 3.5 shows the process 
of collecting hair samples.  It is generally accepted that hair grows on average 
1cm per month (Wennig, 2000), therefore the most proximal 1cm of hair 
represents the previous month’s cortisol exposure.  Based on this, a 3cm 
segment of hair nearest to the scalp was examined.  This sample was assumed 
to represent the cumulative cortisol secretion over the previous three months.  
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Figure 3.5 Hair sampling process 
 
 
3.4.2 Determination of cortisol in hair  
 
In the laboratory, hair strands were lined up and the first 3 cm scalp near hair 
strands were cut.  Samples were analysed at the Technical University in 
Dresden.  The wash procedure followed the laboratory protocol in (Kirschbaum 
et al., 2009).  The hair segment was washed with 2.5 ml of isopropanol and 
gently mixed on an overhead rotator for 3 min.  The wash cycle was repeated 
twice and samples were left to dry for at least 12 hr.  The extraction of cortisol 
followed the laboratory protocol in (Stalder, Steudte, Miller, et al., 2012).  After 
weighing, 10mg of whole, non-pulverised hair were transferred into 2 ml cryo 
vial (Eppendorf, Hamburg, Germany) 1.800 ml of pure methanol was added and 
the virals were slowly rotated over 18h at 45° C for steroid extraction.  Samples 
were spun in a microcentrifuge (at 10.000 rpm) for 2 min.  Next, 1 ml of the 
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clear supernatant were transferred into a new 2 ml cryo vial and the alcohol was 
left to evaporate at 60°C under a constant stream of nitrogen until the sample is 
completely dry (takes approximately 20 min).  Finally, samples were 
reconstituted; 0.4 of phosphate buffer was added (CAL A, IBL-Hamburg, 
Germany) and to mix the viral it was vortexed for 15 sec. For cortisol 
determination, 20 microliters from the vials were removed and assayed with a 
commercially available immunoassay with chemiluminescence detection (CLIA, 
IBL-Hamburg, Germany).  
 
3.5 Ecological momentary assessment method 
 
In line with the Ecological Momentary Assessment (EMA) method (Stone & 
Shiffman, 1994) positive and negative mood was rated across the day.  The 
EMA method enables assessment of mood in participants’ natural setting and 
during their normal routines enabling assessment in changes in mood within 
and between days.  
 
Between 10.00 and 21.00 hr participants rated their mood at five random points.  
They rated the extent to which they were experiencing positive and negative 
mood states.  On a five point Likert scale, ranging from (1) ‘not at all’ to (5) ‘very 
much’.  Participants rated the extent to which they felt happy, pleased, stressed, 
down, frustrated, goal-directed, busy and in control.  This method has been 
used previously in salivary cortisol studies (e.g. Steptoe, Gibson, Hamer, & 
Wardle, 2007; Steptoe, O'Donnell, Badrick, Kumari, & Marmot, 2008). 
 
3.5.1 Electronic recording of EMA mood ratings  
 
To ensure mood ratings were completed in real-time and not retrospectively, the 
mood ratings were recorded using an electronic device - the actiwatch-score.  
Prior to the study days, the researcher (NS) programmed the device to beep at 
five random times on each of the study days.  Participants were told that the 
watch would provide a series of letters representing each of the mood 
adjectives and they were instructed to use the watch to rate their mood.  To aid 
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participants in completion of the mood ratings, participants were provided with a 
mini key ring attached to the watch detailing the letter code for the mood 
adjectives (e.g. P = pleased, H = happy, S = stressed, D = down, F = frustrated, 
G = goal-directed, B = busy, C = in control).  If participants missed the beep on 
the watch, they were asked to record the date and time and their mood ratings 
on paper. 
 
During the one-to-one research sessions, participants were shown how to enter 
their mood ratings using the actiwatch-score device and were asked to practice 
this with the researcher to ensure they were comfortable using it on their own.  
They also received written instructions for using the device detailed in the study 
guidelines.   
 
3.6 Measures: demographic, hair, and psychosocial variables 
 
3.6.1 Demographic Variables  
 
Demographic questions (Appendix 13) included age, sex, ethnicity, relationship 
status, smoking status, subjective health and perceived social status.  Smoking 
status was assessed on a five-point Likert scale (current, occasional, ex-
smoker, never smoked) and subjective health status was assessed on a single 
item scale ranging from poor (1) to excellent (5).  The ladder measure 
(Goodman et al., 2001) was used to measure participants’ perceived social 
status.  This involved participants placing themselves on a ten-step ladder, 
which represented where individuals stood in society.  The upper end 
represented individuals that are the best off (individuals with the most money, 
most education and the best jobs), and the lower end represented individuals 
who are the worst off (individuals with the least money, least education and the 
worst jobs or no job).  Participants marked the step they felt represented their 
social standing. 
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3.6.2 Hair characteristics  
 
Hair characteristic questions (Appendix 14) included participants natural hair 
colour, type of hair (i.e. curly, straight or wavy), number of washes per week, 
hair treatments (e.g. colours, perms etc), and use of hair products (including 
hair stimulators).  
 
3.6.3 Subjective Happiness Scale  
 
The Subjective Happiness Scale (SHS; Appendix 15) was designed to measure 
global subjective happiness; it determines if an individual is happy or unhappy 
based on the individual’s perspective (Lyubomirsky & Lepper, 1999).  For two 
items, respondents characterise themselves using absolute ratings (e.g. in 
general, I consider myself (1) not a very happy person to (7) a very happy 
person).  The remaining items were rated relative to other peers, participants 
rate the extent to which brief descriptions of individuals happiness and 
unhappiness apply to them on a seven point scale ranging from (1) not at all to 
(7) a great deal.  Scores are obtained by reversing the negatively worded item 
(item 4) and averaging responses to the four items.  Possible scores range from 
1 to 7, higher scores indicate greater happiness.  
 
The authors of the scale tested its psychometric properties in fourteen studies 
compromising of US students and community samples.  The studies make up a 
large (N=2,732) demographically diverse sample.  In four of these studies 
internal consistency (α = 0.70 to 0.94 M=0.86) and adequate test-retest 
reliability (r = .90 for four weeks) was demonstrated.  In another study the one 
factor structure was demonstrated, the four items loaded strongly onto one 
factor.  In longitudinal studies, good test-retest reliability was demonstrated, 
time period ranging from three weeks to one year (rs ranging from .55 to .90, 
average r = .72).  In three college student samples and a retired adult sample, 
the SHS correlated highly with other happiness and well-being measures (rs 
ranging from 52 to .72, average r = .62).  The SHS also correlated moderately 
with several dispositional constructs that are theoretically and empirically 
related to happiness, for example optimism, positive or negative emotionality, 
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extraversion and neuroticism (rs ranging from.36 to 0.60, average r = 0.51), 
demonstrating convergent validity (Lyubomirsky & Lepper, 1999).  
 
3.6.4 Positive and Negative Affect Schedule  
 
The Positive and Negative Affect Schedule (PANAS; Appendix 16), is a 20-item 
scale that assesses positive affect (10 items) and negative affect (10 items).  
Feelings of alertness, activation, enthusiasm and, more generally, pleasurable 
engagement with the environment is typical of high positive affect whilst 
lethargy and sadness are typical of low positive affect.  Feelings of anger, 
tension, distress, and more generally, unpleasant engagement with the 
environment is typical of high negative affect and absence of such feelings is 
typical of low negative affect (Watson et al., 1988).  Participants rated the extent 
to which they felt each emotion on a five-point Likert scale ranging from (1) very 
slightly to (5) extremely.  The PANAS can be presented in different time frames, 
and does not affect the psychometric properties (Watson et al., 1988).  Scores 
for the positive and negative scale are calculated by summing the separate 
scores on the two dimensions.  For each dimension scores range between 10 
and 50.  
 
The scale exhibits good psychometric properties.  Watson et al. (1988) reported 
Cronbach’s alpha coefficients for various time frames (α = .86-.90 for positive 
affect and .84-.87 for negative affect).  The scale exhibited good test-retest 
reliability over an eight week period (α = .47 to .68 for positive affect and .39 
to .71 for negative affect).  The authors also reported evidence for the validity of 
the PANAS, it was highly correlated in the expected direction for each 
dimension with general distress and dysfunction, depression, and state anxiety 
are more.  Further Crawford and Henry (2004)demonstrated that PA and NA 
are two distinct dimensions, but are moderately negatively correlated in a large 
general adult sample.  
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3.6.5 Satisfaction with Life Scale  
 
The Satisfaction with Life Scale (SWLS; Appendix 17) is a short five-item tool 
measuring individual’s global cognitive judgements of their satisfaction with life 
(Diener, Emmons, Larsen, & Griffin, 1985).  Items are designed to measure 
respondents overall judgments of their life.  Judgments are based on the 
individual’s own standards of evaluation.  Although they are not designed to 
assess satisfaction of individual’s life domains (e.g. health, finances, or 
relationships) respondents can integrate their satisfaction with such domains in 
formulating their responses.  All items are positively stated (e.g. in most ways 
my life is close to my ideal), focusing on the positive or pleasant (and not the 
negative) side of individual’s emotions.  Respondents rate the extent to which 
they agree with each statement on a seven-point Likert scale ranging from 
strongly disagree (1) to strongly agree (7).  Possible scores range from 5 to 35, 
with higher scores indicating greater life satisfaction.  
 
The authors demonstrated good psychometric properties of the scale in US 
student and elderly samples (Diener et al., 1985).  In the student sample the 
scale exhibited good test-retest reliability (α = .87 for two months) and factor 
analysis indicated one factor, which accounted for 66% of the variance.  The 
scale correlated moderately in the expected direction with other measures of 
subjective well-being, such as happiness and positive affect, and 
psychopathology, such as neuroticism.  Correlations indicate that individuals 
satisfied with their lives are generally experiencing well-being and free from 
psychopathology.  In the elderly sample the scale exhibited good internal 
consistency, it correlated moderately with interviews and other measures 
assessing an individual’s life satisfaction (rs ranging from .43 to .46), item total 
correlations were moderate (rs ranging from .61 to .81).  Other studies have 
demonstrated good psychometric properties for this scale (see Pavot & Diener, 
1993).  
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3.6.6 Meaning in Life Scale  
 
The Meaning in Life scale (MIL; Appendix 18) is a 10-item tool assessing two 
dimensions of meaning in life (Steger, Frazier, Oishi, & Kaler, 2006).  It included 
two sub scales, including the presence of meaning (MLQ-P) and search for 
meaning (MLQ-S) in life.  The MLQ-P consists of five-items assessing the level 
of meaning or purpose in one’s life (e.g. I understand my life’s meaning).  The 
MLQ-S consists of five-items assessing the extent to which respondents seek to 
find meaning and understanding in one’s life (e.g. I am searching for a 
meaningful life).  Respondents rate the extent to which each statement 
describes themselves on a seven-point Likert scale ranging from absolutely 
untrue (1) to absolutely true (7).  One item (item 9) is negatively worded and 
reversed scored prior to summing items on each sub-scale.  Scores for each 
subscale range from 7 to 35, higher scores indicate greater meaning in life for 
the presence subscale and greater searching for a meaningful life for the search 
subscale.  
 
Steger et al. (2006) tested the psychometric properties of the scale in an 
undergraduate student sample.  Exploratory factor analysis showed a two factor 
structure in two independent studies, the first taps into having meaning or 
purpose in life, measuring the subjective judgments of a meaningful life.  The 
second taps into the search for meaning in life, measuring drive and orientation 
toward finding a life with meaning.  Good internal consistency was exhibited for 
both subscales (αs range from .86 to .88).  Convergent validity was 
demonstrated through the presence subscale moderately positively correlating 
with other measures of well-being (e.g. life satisfaction) and negatively with 
measures of ill-being (e.g. depression) (rs ranging from .61-.74) and the search 
sub-scale being unrelated to the well-being measures but positively with the ill-
being measures.  Discriminant validity was demonstrated for both sub-scales 
being distinct from conceptually different measures.  Steger et al. (2006) 
provides evidence for the independence of the presence and search 
components.  Further evidence is provided and shows that searching for a 
meaningful life can be particularly positive when the search being sought is for 
deeper meaning from an already meaningful life.  
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3.6.7 Ryff’s Scales of Well-being  
 
Ryffs’ scales of psychological well-being (RPWB; Appendix 19) is a 
multidimensional measure assessing the psychological aspect of wellbeing 
(Ryff, 1989).  It assesses many aspects of well-being, which include self-
acceptance; establishing good relations with others; a sense of autonomous 
thinking and acting; the ability to manage complex environments in line with 
personal needs and values; pursuing meaningful goals and a sense of purpose 
in life; continued growth and development as a person.  These dimensions are 
theory driven and the development of the dimensions is outlined in Ryff et al. 
(1989).  The original RPWB consists of 84 items; each dimension consists of 14 
items.  The studies presented in this thesis used the mid-length version, 
consisting of 54 items (9 per dimension).  Respondents rate the extent to which 
they agree with statements on a six-point (1-6) Likert scales ranging from 
strongly disagree to strongly agree.  Responses are summed for each of the six 
dimensions (about half of the items are negatively word, items are reverse 
scored), possible scores range between 6 and 64.  A score for each dimension 
is obtained; a high score indicates that an individual has mastered that area of 
his or her life.  A low score indicates that the individual struggles to feel 
comfortable with that area of his or her life.  Table 3.1 provides further 
information of the characteristics of a high or low score for the six dimensions.  
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Table 3.1 Definitions of theory-guided dimension of well-being with example 
items for each dimension 
 
Self-acceptance: 
Refers to the positive evaluations an individual makes about his or her self and 
past life (e.g. I like most aspects of my personality).  High scorer possesses a 
positive attitude toward the self; acknowledges and accepts multiple aspects of 
self, including good and bad qualities; feels positive about past life.  Low scorer 
feels dissatisfied with self; is disappointed with what has occurred with past life; is 
troubled about certain personal qualities; wishes to be different than what he or 
she is. 
Positive relations with other: 
Refers to an individual having good quality relationships with others (e.g. most 
people see me as loving and affectionate).  High scorer has warm, satisfying, 
trusting relationships with others; is concerned about the welfare of others; 
capable of strong empathy, affection, and intimacy; understands give and take of 
human relationships.  Low scorer has few close, trusting relationships with 
others; finds it difficult to be warm, open, and concerned about others; is isolated 
and frustrated in interpersonal relationships; not willing to make compromises to 
sustain important ties with others. 
Autonomy: 
Refers to an individual; with a sense of self-determination (e.g. I have confidence 
in my opinions even if they are contrary to the general consensus).  High scorer 
is self-determining and independent; able to resist social pressures to think and 
act in certain ways; regulates behavior from within; evaluates self by personal 
standards.  Low scorer is concerned about the expectations and evaluations of 
others; relies on judgments of others to make important decisions; conforms to 
social pressures to think and act in certain ways. 
Environmental Mastery: 
Refers to an individual mastering and controlling his or her environment (e.g. I 
am quite good in managing the many responsibilities of my daily life).  High 
scorer has a sense of mastery and competence in managing the environment; 
controls complex array of external activities; makes effective use of surrounding 
opportunities; able to choose or create contexts suitable to personal needs and 
values.  Low scorer has difficulty managing everyday affairs; feels unable to 
change or improve surrounding context; is unaware of surrounding opportunities; 
lacks sense of control over external world. 
Purpose in life: 
Refers to an individual’s goals in life and belief in his or her life having purpose 
and meaning (e.g. some people wander aimlessly through life, but I am not one 
of them).  High scorer has goals in life and a sense of directedness; feels there is 
meaning to present and past life; holds beliefs that give life purpose; has aims 
and objectives for living.  Low scorer lacks a sense of meaning in life; has few 
goals or aims, lacks sense of direction; does not see purpose of past life; has no 
outlook or beliefs that give life meaning. 
Personal growth: 
Refers to an individual’s sense of continued development and growth in his or her 
life (e.g. I think it is important to have new experiences that challenge how you 
think about yourself and the world).  High scorer has a feeling of continued 
development; sees self as growing and expanding; is open to new experiences; 
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has sense of realizing his or her potential; sees improvement in self and behavior 
over time; is changing in ways that reflect more self-knowledge and 
effectiveness.  Low scorer has a sense of personal stagnation; lacks sense of 
improvement or expansion over time; feels bored and uninterested with life; feels 
unable to develop new attitudes or behaviors. 
Table adapted from (Ryff, 1989, p. 1072).  
 
Despite the extensive use and interest in the theoretical structure of the RPWB 
scale and the evidence of a six-factor structure through factor analytical studies 
carried out by Ryff and colleagues (Phillapa, Clarke, Carol, & Wheaton, 2001; 
Ryff & Keyes, 1995) the psychometric properties of the full scale has been 
questioned. In a sample of females in a UK cohort (n = 1179) the factorial 
validity and structure of the scale (42-item version) were tested.  Two of the 
dimensions (autonomy and positive relations with others) failed to explain the 
general well-being factor, suggesting that psychological well-being may not 
consist of these dimensions (Abbott et al., 2006).  The authors suggested that a 
more parsimonious model is needed if the six dimensions are to be retained.  
Thus, due to the questioning of these two dimensions they were excluded from 
the studies presented in this thesis.  
 
3.6.8 Perceived Stress Scale   
 
The Perceived Stress Scale (PSS: Appendix 20) is a measure of generalised 
perceptions of stress; it is designed to measure the degree to which situations 
in an individual’s life are perceived as stressful (Cohen, Kamarck, & 
Mermelstein, 1983).  It is designed for use with community samples with at least 
a high school education.  The authors state that the items are quite general in 
nature and thus relatively free of content specific to any sub population group.  
The items tap into the unpredictability, uncontrollability and how overloaded an 
individual’s life is and some items ask about individuals current level of stress in 
their life.  The full scale PSS, comprises of 14 items referring to individuals 
thoughts and feelings of events that occurred over the last month.  Seven items 
are positively worded (e.g. “In the last month, how often have you felt that you 
were effectively coping with important changes occurring in your life”) and 
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seven are negatively worded (e.g. “In the last month, how often have you been 
upset because of something that happened unexpectedly”).  Responses are 
made on a five point (0-4) Likert scale (never, almost never, sometimes, fairly 
often, very often).  Scores are obtained by reverse scoring the items on the 
seven positive items and then summing across all 14 items.  Possible scores 
range from 0 to 56, with a high score indicating higher perceived stress.  The 
PSS is not considered to be a diagnostic instrument, thus, no specific 
categories are proposed by the authors for “high”, “medium” or “low” stress 
scores.  
 
The authors tested the psychometric properties of the scale in two student and 
one community sample (Cohen et al., 1983).  The scale exhibited good internal 
consistency (rs ranging from .84 to .86).  Good test-retest reliability over short 
time intervals (over 2 days r = .85, after 6 weeks r = .55).  It correlates highly 
with indices of depressive symptomatology (rs ranging from .65 to .76) and 
moderately with number of life events (rs ranging from .17-.35).  The PSS is 
reported to be a better predictor of health outcomes (e.g. physical 
symptomatology rs ranging from .52 to .65 and social anxiety rs ranging 
from .37 and .48) than measures of life events since the focus is on appraisal of 
events rather than simply number of events.  In clinical samples the scale 
exhibited two components; perceived distress and perceived coping (Hewitt, 
Flett, & Mosher, 1992).  The factor structure has not been tested in non-clinical 
samples (Hewitt et al., 1992). The authors propose that the PSS can be viewed 
as a tool assessing a state that identifies people at risk of a clinical psychiatric 
disorder.  
 
Shorter versions of the scale are also available, the 10-item version (PSS-10) 
consists of four positively worded items and six negatively worded items (Cole, 
1999).  The four positively worded items are reverse coded and items are 
summed across all the items, possible scores range between 0 and 45.  The 
four-item version (PSS-4) consists of four items (items 2, 4, 5 and 10 from the 
PSS-10).  Two items (items 4 & 5) are positively stated and reversed scored 
prior to summing across items, possible scores range from 0 and 16.  Both 
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versions use the same scale as the full version; a higher score indicates higher 
perceived stress.  
 
The PSS-10 exhibited a better factor structure and internal reliability than the 
PSS-14 and correlations between the PSS-10 and other measures of stress 
were evident showing construct validity.  The PSS-4 exhibited less reliability but 
its factor structure and predictive validity were good.  Thus, authors recommend 
use of the PSS-10 and use of PSS-4 for situations that require brief measures 
of stress perceptions.  Studies in this thesis used the 10-item and 4-item 
versions.  
 
3.6.9 Centre for Epidemologic Studies Depression Scale  
 
The Centre for Epidemologic Studies Depression Scale (CES-D; Appendix 21) 
developed by Radloff (1977) measures levels of depressive symptoms in the 
general population.  It is a self-report tool measuring the frequency of 
depressive feelings and behaviours.  The items are based on symptoms 
associated with a clinical diagnosis of depression.  It consists of 20 items 
compromising six scales reflecting depressed mood, feelings of guilt and 
worthlessness, feelings of helplessness and hopelessness, psychomotor 
retardation, loss of appetite and sleep disturbance.  Respondents are presented 
with statements about the way they may have felt or behaved in the last week.  
Statements are worded positively (e.g. I felt as good as other people) and 
negatively (e.g. I felt that everything was an effort).  Respondents rate the 
frequency they experienced each statement on a four-point Likert scale (0 = 
rarely or none of the time to 3 = most or all of the time).  The positively worded 
items (items 4, 8, 12, 16) are reversed-coded prior to summing the score on 
each item to obtain a total score.  Possible scores range from 0 to 60 with 
higher scores indicating greater presence of depression symptomatology, a 
score set at 16 is the cut-off point for high depressive symptoms (Radloff, 1977) 
but others suggest a higher cut off point to be used (Boyd, Weissman, 
Thompson, & Myers, 1982; Zich, Attkisson, & Greenfield, 1990). 
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Radloff (1977) demonstrated good psychometric properties of the CES-D in 
American healthy adults and clinical samples.  The high inter-item and item-
scale correlations were weaker in the general population than the clinical 
sample.  Internal consistency was high in the general population (α = .84 to .85) 
and higher for the patient sample (α = .85 to 92).  Test-retest reliability was 
highest for shorter intervals of 2 to 8 weeks (r = .51 to .67), and weaker for 
longer intervals of 3 to 12 months (r = .32 to .54).  The CES-D discriminates 
between clinical and general samples; scores were significantly higher in the 
clinical sample compared to the CES-D average scores of the general 
population samples.  The scale correlated highly with other depression 
measures, indicating concurrent validity and correlated weakly with measures 
measuring different constructs (e.g. aggression, social functioning).  The strong 
correlations between the CES-D and life events demonstrated the measures 
sensitivity to current mood state.  The CES-D has been demonstrated to assess 
symptoms of depression across different racial, gender, education level, and 
age samples (Knight, Williams, McGee, & Olaman, 1997; Radloff, 1977; 
Roberts, Vernon, & Rhoades, 1989).  Also good factorial validity has been 
demonstrated for the scale, correlations with the CES-D items were higher for 
the scales total score than with related but distinct constructs, for example, with 
self-esteem, and state or trait anxiety (Orme, Reis, & Herz, 1986). 
 
3.6.10 The Depression Anxiety Stress Scales  
 
The Depression Anxiety and Stress Scales (DASS; Appendix 22) was designed 
to measure three related negative emotional states of depression, anxiety and 
stress (Lovibond & Lovibond, 1995).  The original scale consists of 42 items; 
each of the three dimensions consists of 14 items.  The depression dimension 
measures dysphoria, hopelessness, devaluation of life, self-deprecation, lack of 
interest/involvement, anhedonia, and inertia (e.g. I felt that life was 
meaningless).  The anxiety dimension measures autonomic arousal, skeletal 
muscle effects, situational anxiety, and subjective experience of anxious affect 
(e.g. I felt scared without any good reason).  The stress dimension is sensitive 
to levels of chronic non-specific arousal, assessing difficulty relaxing, nervous 
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arousal, and being easily upset/agitated, irritable/over-reactive and impatient 
(e.g. I found myself getting agitated).  Table 3.2. provides further information of 
the characteristics of a high score for the dimensions. 
 
On a 4-point Likert scale (0-4) respondents rate the severity or frequency to rate 
the extent to which they have experienced (did not apply to me, applied to me to 
some degree, or some of the time, applied to me to a considerable degree, or a 
good part of time, applied to me very much, or most of the time) each statement.  
Scores are obtained for Depression, Anxiety and Stress are calculated by 
summing the scores for the relevant items.  A shorter form of the scale is 
available, this is the 21-item version and seven items make up each dimension 
(stress = 1,6,8,11,12,14,18; depression = 3,5,10,13,16,17,21; anxiety = 
2,4,7,9,15,19,20).  To obtain the score, responses are summed for the relevant 
items and multiplied, possible scores for each dimension range from 0-42.  A 
higher score for each dimension indicates higher negative emotional states.  
Table 3.2 details the characteristics of a high score on the three dimensions.  
 
Large population studies of clinical and non-clinical studies have demonstrated 
good psychometric properties for the 42-item version (Brown, Chorpita, 
Korotitsch, & Barlow, 1997; Lovibond & Lovibond, 1995).  For example, in a 
non-clinical sample, factor analysis showed three factors representing 
depression, anxiety and stress.  The DASS discriminated between the three 
dimensions but they are still moderately correlated with each other, the stress 
scale exhibited higher correlations with the anxiety compared to the depression 
scale.  Convergent validity was demonstrated with high correlations between 
the DASS dimensions and similar measures.  Further support for the 42-item 
and 21-item versions was demonstrated (Antony, Bieling, Cox, Enns, & 
Swinson, 1998), the 21-item version exhibited a better factor structure and 
smaller inter-factor correlations than the 42-item version.  The 20-item was used 
in the research for this thesis.   
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Table 3.2 Characteristics of a high score on the DASS depression, anxiety 
and stress dimensions.  
Depression 
• Self-disparaging 
• Dispirited, gloomy, blue 
• Convinced that life has no meaning or value 
• Pessimistic about the future 
• Unable to experience enjoyment or satisfaction 
• Unable to become interested or involved slow, lacking in initiative 
Anxiety 
• Apprehensive, panicky 
• Trembling, shaking 
• Aware of dryness of the mouth, breathing difficulties, pounding of the 
heart, sweatiness of the palms 
• Worried about performance and possible loss of control 
Stress 
• Over-aroused, tense 
• Unable to relax 
• Touchy, easily upset 
• Irritable 
• Easily startled 
• Nervy, jumpy, fidgety intolerant of interruption or delay 
Table taken from http://www2.psy.unsw.edu.au/dass/over.htm 
 
3.7 Approach to statistical analysis  
 
The assumption of normality is required for use of parametric statistical tests, 
such tests are more powerful than their counterpart (non-parametric) tests in 
which the normality assumption is not made.  Cortisol data are often positively 
skewed (e.g. Edwards, Evans, et al., 2001), and an appropriate transformation 
is required to yield normally distributed data.  In all the studies presented here 
the raw cortisol data was positively skewed.  To normalise sample distributions 
for inferential analyses, square root or log transformations were performed.   
 
Measurement of the diurnal pattern of salivary cortisol included six cortisol 
measures to examine the CAR (measured in saliva samples collected at and 
sampled at 0, 15, 30 and 45 min post-awakening) and the decline in 
concentrations thereafter (samples collected at 3 and 12 hrs post-awakening).  
Analyses for the CAR and the diurnal cortisol profile were separate.  Composite 
cortisol measures were computed for each participant for each study day.  The 
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CAR magnitude was computed as the mean increase of cortisol from the first 
sample (MnInc: Mean [S2,S3,S4] – S1).  In addition to measures of the CAR, 
starting levels of cortisol at S1 was used as an outcome measure. Two 
composite measures for the diurnal cortisol profile were calculated.  An 
estimation of the decline in cortisol concentrations over the day was obtained by 
subtracting sample 6 from sample 5 (diurnal decline).  Accompanied with the 
decline measure is the mean diurnal cortisol calculated as the mean of sample 
5 and 6 (i.e. S5 + S6 / 2).  
 
Typically statistical approaches to cortisol data are conducted with correlation, 
regression or analysis of variance (ANOVA).  Such methods are limited in 
dealing with data patterns involving multiple repeated measures and often 
unbalanced data sets, leading often to needless exclusion of participants with 
missing data points from the analysis.  Flexible and increasingly used 
alternatives are mixed regression modelling approaches which permits multi-
level analysis of data.  Such strategies are deemed most appropriate for 
designs incorporating multiple repeated measures over time with fixed and 
random parameters (Blackwell, de Leon, & Miller, 2006) and enable modelling 
of dynamic aspects of the diurnal cortisol cycle (Adam & Kumari, 2009).  Such 
methods do away with crude artificial correction for sphericity violation 
associated with conventional general linear method ‘solutions’ to the problem of 
repeated measures.  They permit full and simultaneous consideration of both 
within- and between-participant associations, adjusting for missing data 
(assuming it is ‘randomly’ missing) so participants are not necessarily excluded 
from analysis simply because some repeated-measures data are missing. 
Mixed regression modelling was used in all studies in this thesis when dealing 
with multiple repeated measures.  
 
In repeated-measures units of measurement are nested within individuals. 
Mixed regression modelling was used for study I-II.  The data contained a two-
level hierarchical structure - Level 1 represented measures over four days 
which were nested within participants (level 2) The mood ratings in study 1 were 
a time-covarying covariate of the outcome (i.e. mood fluctuates over the four 
study days).  Centering of such data makes the data completely within-persons, 
  72 
as it eliminates the between person differences in mood on the outcome (i.e. 
cortisol patterns).  Scores on each study day are expressed as a value above or 
below each participant’s mean score across study days, shifting the zero point 
of the data to a more meaningful reference.  The nested design of this study I (4 
days of data nested within each participant) allowed use of mixed regression 
modelling to test whether the within-person relationship between well-being or 
ill-being and diurnal patterns of cortisol secretion varies as a function of 
between-person characteristics.  Although hair cortisol did not contain repeated 
measurement, using the mixed regression modelling allowed for easier 
investigation of the interaction effects between well-being/ill-being and age on 
hair cortisol. 
 
Other analyses performed were ANOVAs, t-tests or Chi-square tests to 
examine differences in demographic, situational and psychosocial variables 
between groups of interest (e.g. well-being groups).  Pearson’s tests of 
correlation were conducted to explore simple zero-order relationships between 
cortisol measures, psychosocial variables and mood data.  For all correlations, 
scattergrams were produced to check that any significant associations were 
valid and not unduly influenced by outliers etc.  All given values of p are two-
tailed. All statistical analyses were performed using SPSS.  
  
  73 
Chapter 4 Study I: Experiment I  
 
Impact of non-adherence to the saliva sampling 
protocol on the diurnal pattern of cortisol  
 
 
4.1 Introduction  
 
Determination of the CAR and diurnal decline typically requires self-collection of 
saliva samples within the domestic setting.  For the CAR, samples are collected 
at regular intervals during the post-awakening period, between 30 and 60 
minutes (e.g. 0, 15, 30, 45 and 60 min post-awakening), the peak of secretion 
characteristically occurs between 30 and 45 minutes post-awakening (Oskis et 
al., 2009; Pruessner et al., 1997).  For the diurnal cortisol profile, samples 
collected across the day are synchronised to awakening (e.g. 3, 6, 9 and 12 hr 
post-awakening).  
 
Studies measuring the diurnal pattern of cortisol in the domestic setting usually 
rely upon unsupervised participant adherence to saliva sampling protocols.  
More objective measures include electronic monitoring of sampling and 
awakening times using track caps and actigraph (respectively), and these have 
been shown to be more accurate than participant self-reports.  Participant’s self-
reported saliva sampling times are typically earlier than the track caps, which 
suggests that participants report their sampling times in line with the 
researchers desired sampling time (Broderick et al., 2004; Kudielka et al., 2003).  
Actigraph estimates of awakening time are typically earlier than participant self-
reports.  The discrepancies in awakening time leads to a delay in collecting the 
first awakening saliva sample (DeSantis et al., 2010; Dockray et al., 2008; 
Kupper et al., 2005) which is crucial for measurement of the CAR.  Informing 
participants of electronic monitoring of sampling times can be an effective 
strategy to maximising participant motivation in collecting saliva samples at the 
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desired times and accuracy for reporting sampling times (Broderick et al., 2004; 
Kudielka et al., 2003).  Earlier awakening and poor assessment of awakening is 
associated with greater delay between awakening and collection of the 
‘awakening’ sample, this may be due to sleep inertia in the immediate post-
awakening period and highlights the problems of self-assessment of awakening 
time.  Non-adherence to the saliva sampling protocol does not appear to be 
associated with participant characteristics such as demographic or psychosocial 
characteristics suggesting that sampling delay is a random factor.   
 
The dynamic and brief nature of the CAR makes it likely that errors in the timing 
of saliva sampling will impact upon its accurate measurement. The immediate 
post-awakening period (i.e. the CAR period) is associated with the presence of 
sleep inertia which is a state of reduced cognitive and motor performance (Tassi 
& Muzet, 2000) and is likely to increase the difficulty of adhering to protocol 
requested timings, even in well-intentioned participants. Until recently, 
quantification of the CAR has almost exclusively focused upon its magnitude 
(e.g. mean increase [MnInc] measures, or the near equivalent of areas under 
the curve with respect to increase [AUCi].  More economically, some have taken 
simple differences between awakening level and a single later measure, 
(typically at 30 min).  However the timing of the CAR peak is also an important 
variable.  For example, it has been shown to be related to gender, with males 
peaking earlier than females (Pruessner et al., 1997); menstrual cycle, with 
females in the ovulation phase peaking later (Wolfram et al., 2011a); hormonal 
status, with pre-menarche females peaking earlier than menarche females 
(Oskis et al., 2009); and individuals with better cognitive function peaking earlier 
(Evans, Hucklebridge, Loveday, & Clow, 2012).  This often overlooked CAR 
characteristic is likely to be increasingly studied and adds to the CAR’s value as 
a biomarker.  Although in recent years participant non-adherence to protocol 
has received increasing attention with respect to CAR magnitude, there has 
been no investigation of this issue with respect to the timing of the CAR peak, 
and even with respect to CAR magnitude there have been no comparative 
studies of delayed sampling on the different commonly used quantifications 
mentioned above.   
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Sampling delay in the post-awakening period results in attenuated CAR 
magnitude.  For instance, studies that have estimated awakening time by 
actigraph or polysomnography have reported that delays over 15 minutes lead 
to higher awakening samples and flatter CARs of smaller magnitude (DeSantis 
et al., 2010; Dockray et al., 2008; Okun et al., 2010).  These studies did not 
electronically monitor sampling times, but more recently awakening sampling 
times were electronically monitored and delays of 11.5 minutes resulted in 
attenuated CAR (Griefahn & Robens, 2011).  
 
Pooling the evidence, it seems to be broadly accepted that non-adherence of 
more than 15 minutes leads to under-estimation of CAR magnitude, for instance, 
apparently higher first samples and reduced CARs.  By default these studies 
imply that sampling delays of up to 10-15 minutes are ‘safe’ and acceptable in 
this line of research.  However, studies have not directly tested the impact of 
virtually no delay compared to moderate delays (i.e. < 10-15 min) on 
measurement of the CAR and this needs to be directly investigated.  It is a 
convenient finding that delays less than 10-15 min do not affect the CAR 
magnitude since it simplifies the data collection process, in that delays of this 
nature can be included in analyses meaning that less data is wasted; however, 
it is theoretically challenging.  It is understood that the moment of awakening 
initiates the CAR (see Clow et al., 2010; Wilhelm et al., 2007) and it is assumed 
that the rise in cortisol secretion is linear from awakening to 15-30 min later.  If 
this is the case, then moderate delays (< 10-15 min) would result in attenuated 
CAR magnitude since the ‘awakening’ sample would be higher compared to 
those that collected their awakening sample without any delays, thus, there 
would be less of a rise from awakening since a proportion of the CAR will have 
happened before sampling and not visible to researcher and therefore show an 
attenuated CAR magnitude.  The conundrum may be resolved, however, if 
there is a time lag of 5-15 minutes between awakening and increased cortisol 
concentrations in saliva.  This would mitigate any reduction in the CAR 
magnitude due to such moderate sampling delays.  However an implication of 
this scenario may be that CAR magnitude is over-estimated and the timing of 
the CAR peak would occur earlier than if the first sample was actually collected 
at the moment of awakening.  In view of a burgeoning literature addressing 
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associations between the CAR and psychosocial and health domains, what is or 
is not ‘tolerable’ measurement error is something in need of urgent investigation. 
 
Previous studies have investigated if sampling delay influences measurement of 
the diurnal cortisol profile, but in these studies saliva samples were collected 
according to clock time and not awakening time.  One study showed that 
sampling delay did not influence the diurnal cortisol profile (Jacobs et al., 2005).  
On the other hand, two other studies showed that sampling delay resulted in a 
flatter diurnal decline, however in these studies the diurnal decline was 
anchored from the CAR, which was attenuated from sampling delay in the post-
awakening period.  Due to the steady decline in cortisol over the day it is likely 
to be less influenced by sampling delay when anchored outside the CAR period.   
 
4.1.1 Aims  
 
In the current study participant adherence to the saliva sampling protocol was 
electronically monitored.  Awakening times were verified by actigraphy and 
saliva sampling times were verified by track caps, participants were made 
aware that the electronic estimates would be used to verify their self-reported 
awakening and sampling times.  The study sought to investigate the impact of 
previously thought tolerable delays of up to 15 min on the CAR magnitude and 
timing of the CAR peak.  Further, it was also possible to investigate if non-
adherence to saliva sampling across the day impacted on the diurnal cortisol 
profile.  The specific aims and objectives of the current study are displayed 
below (see Table 4.1).  
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Table 4.1 Specific aims and objectives  
 
Aims Objectives 
Monitor adherence to the saliva 
sampling protocol  
Electronically monitor awakening and 
saliva sampling times using actigraph 
and track caps, along with 
participants self-reports  
Investigate the prevalence and type 
of non-adherence to the saliva 
sampling period  
Determine sampling delay relative to 
awakening time  
Compare sampling delay determined 
by electronic estimates and 
participants self-reports  
Investigate the impact of moderate 
delays on measurement of the CAR 
Compare the CAR magnitude on 
days in which saliva sampling relative 
to awakening was delayed with days 
when delay was minimal.  
Investigate the impact of sampling 
delay relative to awakening on the 
timing of the CAR peak on delayed 
and minimal delay days.  
Investigate the impact of non-
adherence to measurement of the 
diurnal cortisol profile  
Compare the diurnal cortisol profile 
on non-adherent days and adherent 
days  
 
4.1.2 Hypotheses 
 
Although participants were aware of electronic estimates of adherence to the 
saliva sampling protocol, it was hypothesised that participants would delay 
sampling.  It was also hypothesised that sampling delay would be attributable to 
delay between awakening and collection of the first (‘awakening’) sample and 
participants self-reported sampling times would be in line with the electronic 
devices.  Further, it was hypothesised that there would be differences in the 
CAR magnitude on non-adherent and adherent study days; specifically 
moderate non-adherence (delays of 5-15 min between awakening and 
commencement of saliva sampling) in comparison to adherent days (defined as 
less than five min delay) would be associated with an over-estimated CAR 
magnitude.  
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4.2 Method  
 
4.2.1 Participants  
 
Fifty female psychology students (21.0±4.4 years) were recruited on the basis 
that they were healthy, not taking prescribed medication or suffering from any 
medical or psychiatric illness (ascertained by self-report).  The majority of 
participants were White (60%) or Asian (27%).  Subjective social status was 
self-assessed with the 1-10 ‘ladder’ measure (Goodman et al., 2001) and on 
average was 5.6±1.4.  The majority of participants did not smoke (63%) or were 
occasional smokers (16%).  Participants received no financial incentive to take 
part in the study but did receive course credits.  For one participant, samples on 
one of the study days were outside the range of the cortisol assay detection 
range and a further four participants did not return their samples for two of the 
study days.  All five were excluded from the analyses.  The University of 
Westminster ethics committee approved the protocol.  All participants provided 
signed informed consent. 
 
4.2.2 Materials 
 
Participants were provided with a study pack which included full standardised 
written instructions, a saliva sampling kit containing four colour-coded Ziploc 
bags labelled day 1-4, each containing six colour-coded Salivettes (saliva 
sampling devices, Sarstedt Ltd., Leicester, England), labelled tube 1-6 with their 
cotton swabs removed (see below).  Participants were provided with a record 
sheet to record their awakening and saliva sampling times.  Participants were 
also provided with electronic devices, which monitored their awakening times 
(wrist-worn actiwatch-score device) and saliva sampling times (MEM Cap), 
which contained the swabs from the salivettes.   
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4.2.3 Procedure   
 
Participants individually attended a research study induction session at the 
University of Westminster with the lead researcher (NS).  During this session 
(duration 15-25 min) participants provided informed consent, received full verbal 
and written instructions on procedures, and practised the techniques for 
collecting and recording times of saliva samples.  Participants were informed 
about the need to adhere to the strict sampling regime relative to awakening 
time and were informed that the electronic devices would be used to check on 
the accuracy of their saliva sampling.  Prior to each study day, participants were 
reminded to prepare for the study day (e.g. place samples next to their bed and 
wear the actiwatch-score device to bed) via automated text messages. 
Participants were instructed to collect saliva samples immediately on awakening 
(S1) and 15 (S2), 30 (S3), and 45 (S4) min and 3 (S5) and 12 (S6) hr later.  
Participants were instructed to awake in their usual way and this was either 
spontaneous or by an alarm clock.  During the saliva collection period 
participants were instructed to refrain from smoking, brushing their teeth, 
exercising and take nil by mouth except water.  Samples were initially stored in 
a domestic freezer until they were returned to the laboratory to be stored at -
20ºC until assayed.  Participants were asked to fill in a record sheet on each 
day entering their awakening times, their protocol-required saliva sampling 
times based on their awakening time that day, and their actual saliva sampling 
times.  To remind participants to collect the saliva samples throughout the day, 
text messages were sent near to their sampling times.  The study materials and 
the saliva samples were returned to the researcher at the end of the study. 
 
4.2.4 Electronic monitoring of adherence to saliva sampling 
protocol   
 
As well as the usual self-report diary method of recording awaking and sampling 
collection times, electronic devices were used to monitor awakening and saliva 
sampling times electronically.  To assess awakening, participants wore an 
activity device (Actiwatch-Score, Cambridge Neurotechnology, Cambridge, UK) 
on their wrist; this is a piezoelectric motion sensor recording physical activity.  
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Awakening times were estimated using the actiwatch-score software that 
distinguishes sleep and awakening periods by reduced and increased activity 
respectively.  To monitor saliva sampling collection times the cotton swabs 
removed from the salivettes and used for saliva sampling were stored in the 
MEM cap — participants were instructed to open this device only at sampling 
times.  Following saliva collection, swabs were returned to the correctly labelled 
salivette for storage.  Openings of the MEM cap were a proxy for the collection 
timing of the saliva samples.  Both electronic devices were used to 
electronically monitor actual saliva sampling collection times and determine 
non-adherent delays to sampling: desired saliva sampling times were calculated 
for each participant based on the actigraph estimated awakening time (i.e. 0, 15, 
30 and 45 min and 3 and 12 hr post-awakening) and actual sampling was 
determined by subtraction of MEMs-determined sampling times from time of 
awakening for each saliva sample.  
 
4.2.5 Cortisol assessment and assay  
 
Cortisol assays were carried out at the University of Westminster.  Samples 
were thawed and centrifuged for 10 minutes at 3,500 rpm.  Cortisol 
concentrations were determined by Enzyme Linked Immuno-Sorbent Assay 
developed by Salimetrics LLC (USA).  The lower limit of sensitivity is <0.01638 
nmol/l.  The standard range in assay is 0.513 – 8.468 nmol/l. Correlation of 
assay with serum: r (47) = 0.91, p <0.0001.  Intra and inter-assay variations 
were both below 10%. 
 
4.2.6 Statistical analysis  
 
Cortisol concentrations ranged between .004 and 55 nmol/l and values were 
moderately positively skewed.  To normalise sample distributions for inferential 
analyses, square root transformations were performed.  
 
Electronic estimates of saliva sampling times relative to awakening (derived 
from actigraph estimated awakening and MEMs-determined sampling times) 
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were determined for each participant on each day.  Days with delays over 15 
minutes were excluded from analyses as the purpose of the study was to 
assess the impact of shorter more moderate periods of sampling delay.  Saliva 
sampling in the CAR period was categorised as essentially ‘adherent’ when the 
delay on that day between awakening and provision of first saliva sample was 
less than 5 minutes.  ‘Non-adherent’ days were categorised as those having a 
delay between 5-15 minutes over this period.  The effects of delay condition on 
the CAR were investigated in respect of four outcome measures.  The first was 
the mean increase of cortisol from the first sample (MnInc: Mean [S2,S3,S4] – 
S1), which, together with its near equivalent of Area Under the Curve with 
respect to increase from S1 (AUCi) constitutes the typical composite measure 
of CAR magnitude in studies which collect multiple post-awakening saliva 
sample points.  The three other CAR outcome measures were the increases in 
cortisol level from S1 to each subsequent sample points i.e. S2-S1, S3-S1, and 
S4-S1. These three measures are the defining components of the composite 
MnInc measure.  It should be noted that the S3-S1 component (assuming 
accurate timing) represents the simple rise in cortisol in the first 30 minutes 
following awakening, and has often been used in larger studies where only two 
samples are collected to assess the CAR. In addition to measures of the CAR, 
differences in starting levels of cortisol at S1 were examined as a function of 
delay.  The possible effects of delay on tendency to earlier peaking was 
investigated by polynomial trend analysis for all sample points with the 
expectation that quadratic coefficients, indicating a slowing or reversal of 
cortisol increase over time, would be greater in the delayed condition.  
 
Days in which samples 5 and 6 were collected one hour earlier than desired 
sampling time were excluded from analysis since there was only a small 
number (S5 = 4 days, S6 = 2 days) of days.  Saliva sampling across the day 
was categorised as essentially adherent if samples 5 and 6 were collected 
within one hour of the desired time (i.e. ± 59 min).  Non-adherent days were 
categorized as samples collected over one hour of the desired time (> 60 min). 
The effects of delay condition on the diurnal cortisol period were investigated in 
respect of two outcome measures.  The first was the diurnal decline measured 
as the slope from 3 to 12 hrs post-awakening (diurnal decline: 3 hr – 12 hr) and 
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average cortisol secretory over the day (mean of cortisol at 3 and 12 hrs post-
awakening: S5 + S6/ 2)  
 
The effects of delay conditions on CAR and diurnal cortisol outcome measures 
were investigated using mixed regression modelling.  The question asked of the 
data was whether participants’ CARs on days on which they delayed collecting 
the first sample as defined above were significantly different from their CARs on 
days with non-existent or minimal (< 5 min) delay.  Secondly the question asked 
of the data was whether participants’ diurnal cortisol activity on days in which 
they delayed collecting samples, as defined above, were significantly different 
from their diurnal cortisol activity on days categorised as adherent.  The mixed 
regression dimension used in modelling CAR or diurnal cortisol outcome 
measures included participant identity (subject variable) and order of study day 
(repeated effect) as random effects and delay condition and intercept as fixed 
effects parameters.  A simple auto-regressive (AR1) co-variance structure was 
specified for the repeated measures effect of study days.  The assumption of an 
AR1 co-variance structure for the repeated measures in the mixed regression 
models was supported as optimal in all cases except for the CAR component of 
S4-S1, where a compound-symmetry (CS) assumption provided a marginally 
better fit.  However differences between Schwarz’s Bayesian Criterion (BIC) 
were trivial (<2) as were estimates of fixed effects parameters, thus for 
simplicity AR1 solutions are presented in all cases.  More complex models were 
initially run for all dependent variables to check that any emerging within-
subjects effects of delay were not confounded with any effects of the covariate 
of clock time of awakening and there were no interactions with day of study, 
which might have suggested delay effects were significantly restricted to a sub-
set of the overall data.  In all cases, no significant additional main or interactive 
effects emerged, and results from final models involving the single predictor of 
delay are presented. 
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4.3 Results  
 
4.3.1 General descriptives for delay data  
 
All delay data were highly positively skewed due to a small tail of outlying long 
delays.  Median, mode, and inter-quartile range most appropriately summarize 
the data.  Median delay between awakening and collecting the first sample (S1) 
was 4 min, mode was 2 min, and inter-quartile range 2-9 min.  MEMs 
monitoring of saliva sampling times revealed that thereafter participants 
collected saliva samples (S2-S4) very closely in accordance with protocol, 
around a median and modal average of 15 min for each interval (i.e. precisely 
the protocol requirement), and an inter-quartile range of 15-17 min between S1 
and S2 samples, 14-16 min between S2 and S3 samples, and 15-16 min 
between S3 and S4.  Non-adherence in the CAR period was thus largely 
attributable to inaccurate assessment of awakening time.  Saliva samples 
collected across the day (i.e. S5 and S6) deviated from the desired sampling 
time in the form of collecting saliva samples earlier or later.  The general 
desciptives for this type of non-adherence to collecting samples 5-6 are 
presented in Table 4.2 and show that generally participants collected these 
samples close to the desired sampling times.  
 
Table 4.2 General descriptives for non-adherence for the saliva sampling 
protocol over the day 
 
Saliva sample   Median 
(min) 
Mode  
(min) 
Sample 5 (3 hr post-awakening) 
Delayed   0:10 0:02 
Early  -0:14 -0:01 
Sample 6 (12 hr post-awakening) 
Delayed   0:14 0:00 
Early  -0:03 -0:01 
 
 
There were no differences between participants’ MEMs-determined sampling 
times and participants’ self-reports.  The high degree of adherence in respect of 
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intervals between samples is consistent with expectation for participants who 
are informed that their timings are being objectively checked. 
 
4.3.2 Impact of non-adherence on the CAR  
 
Full data including actigraph estimates of awakening times, MEMs estimates of 
sampling-times, and four post-awakening cortisol values were available for 149 
days.  Analyses were undertaken only on days in which the delay between 
awakening and collection of S1 was less than 15 min.  Furthermore, in order to 
ensure maximum accuracy of the analyzed data-base, days in which samples 
2-4 were collected 7.5 min earlier or later than the required 15 min sampling 
intervals were excluded; in other words all included sample points were closer 
to their protocol required time than an earlier or later point.  These further 
restrictions resulted in a final data-base of 115 days, comprising 65 days with 
essentially accurate (delay < 5 min.) data, and 50 days where delay was 
between 5 and 15 min.  
 
Data within adherent and non-adherent categories was not significantly skewed 
and Table 4.3 displays the mean electronically estimated delay for adherent, 
and non-adherent days for the CAR period.  Self-reported awakening time is 
also shown; it was significantly later than actigraph estimated awakening time 
for both delay conditions.   
 
Table 4.3 Mean (±SD) delay between actigraph awakening, collection of the 
1st (‘awakening’) sample, and self-reported awakening for delay 
groups 
 
 Difference in Time 
Mean (SD) Min:S 
Delay Conditions  Actigraph awakening  
& S1 collection  
Actigraph & self-
reported awakening 
<5 min (N=65 days) 01:47 (01:24)* 02:55 (05:28)* 
5-15 min (N=50 days)  
08:26 (02:48)* 
 
07:55 (03:34)*  
*p <.001. N.B. degree of difference between unsynchronised self-report times and 
synchronised actigraph values for different delay groups are meaningful, absolute 
differences are not. 
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Moderate delay of 5-15 min in providing the first awakening sample was 
associated with a significantly greater CAR as measured by MnInc compared to 
adherent data (< 5 min delay).  When MnInc was decomposed into its 
component parts, the same significant effects were evident when CAR was 
defined as cortisol rise between S1 and S2 and S1 and S3 but not between S1 
and S4.  Table 4.4 shows the mean (SEM) difference between the delayed and 
adherent data for each CAR measure.  
 
 
Table 4.4 Mean (±SEM) difference in CAR magnitude between delayed and 
adherent data and statistics 
 
CAR 
measure  
Difference in CAR 
magnitude between 
delayed and adherent 
data  
Adherent 
data   
Non-
adherent 
data   
Statistics  
 Mean (±SEM)                          Mean  
MnInc  2.27 (1.05) 2.93 5.20 F = 4.68; df = 
1,109.21; p = .033 
S2-S1 2.16 (0.99) 1.71 3.87 F= 4.76; df = 
1,111.52;  
p = .031 
S3-S1 3.17 (1.39) 2.87 6.04 F = 5.18; df = 
1,108.68; p = .025 
S4-S1 1.59 (1.20) 4.07 5.66 F = 1.74; df= 1.94.23;  
p =.191 
 
 
Analysis of levels of S1 cortisol showed very similar starting-point values of 6.78 
and 6.02 nmols/l for non-delayed and delayed conditions respectively which in 
line with expectation were not significantly different (F = 1.45; df = 1,109; p 
= .230).  Also in line with expectation, on average cortisol peaked earlier (S3) in 
the delayed condition than in the non-delay condition (S4).  Polynomial trend 
analysis was used to examine this in more detail.  Typically and on average, as 
we have discussed, cortisol rises to its peak at somewhere between 30 min and 
45 min after awakening.  Thus, over a period of at least 45 min following 
awakening, data is typically characterised by a large linear rise component but 
also a (usually) smaller quadratic (curvilinear) component reflecting negative 
acceleration towards a peak and any post-peak decline.  In the delayed 
condition, significant linear and quadratic trends were evident (F = 45.57, df = 
  86 
1,123.42, p < .001, and F = 8.599, df = 1,123.42, p = .004 respectively).  By 
contrast, in the adherent non-delay data, a significant linear trend was evident 
(F = 33.08, df = 1,185.85, p = .020) but the quadratic trend failed to reach 
conventional significance (F = 3.43, df = 1, 185.85, p = .066).   
 
Figure 4.1 shows the real time pattern of cortisol secretion plotted at eight min 
intervals using values calculated from the data file using electronically derived 
assessments of awakening and sampling time.  An eight min sample interval 
was utilised to illustrate vividly the impact of the average sampling delay (8 min) 
of the delayed condition in this study.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1 Real-time patterns of cortisol secretion  
 
The solid black line shows the real-time pattern of cortisol secretion, plotted at 8 
minute intervals.  The dotted grey line illustrates the impact of a delay of 8 
minutes between awakening and collection of S1: the line has been shifted 8 
minutes to the left 
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4.3.3 Impact of non-adherence on the diurnal cortisol period  
 
For S5 and S6 full electronically determined sampling times (determined by 
actigraph awakening time & MEMs estimates of sampling times) were available 
for 141 days.  It was investigated if cortisol values differed on days in which 
samples were delayed compared to adherent days (e.g. ± 59 min).  For S5, 15 
days were categorised as delayed.  Cortisol levels at 3 hour post-awakening (i.e. 
S5) did not significantly differ on delayed and adherent days (F = 2.098, df = 1, 
118.780, p = .150).  For S6, 12 days were categorised as delayed.  Cortisol 
levels at 12 hour post-awakening (i.e. S6) were not significantly different form 
delayed days compared to adherent days (F = .256, df = 1, 121.335, p = .613). 
 
Next the impact of sampling delay was explored for the diurnal decline and 
mean diurnal cortisol.  Days were categorized as adherent if both samples were 
collected within 1 hour (± 59 min) of the desired time (N = 98).  Days 
categorized as non-adherent if either sample were collected one hour later than 
the desired sample time (N = 26).  Again days in which samples were collected 
over one hour earlier than the desired sample time were excluded (N = 4 days).  
Sampling delay had no effect on the diurnal decline (F = 1.927, df = 1, 117.918, 
p = .168) or mean diurnal cortisol (F = .456, df = 1, 113.807, p = .501).  
 
4.4 Discussion  
 
This study has shown for the first time that moderate delays between 
awakening and collection of the first saliva sample (between 5-15 min, average 
8±3 min delay) that were previously thought ‘tolerable’ resulted in estimation of 
greater CAR magnitude and earlier CAR peaks.  This level of non-adherence 
could not be detected using self-reports of time of awakening since such self-
reports were on average 8±11 min later than actigraph estimates.  These 
findings have implications for theory and best practice in accurate determination 
of the CAR.  Sampling delay across the day did not affect measurement of 
diurnal decline or mean diurnal cortisol.  This is the first study to examine the 
impact of sampling delay on measurement of the diurnal cortisol profile when 
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saliva samples are synchronised to awakening time, and the diurnal cortisol 
profile is anchored outside the CAR period.  
 
The healthy young female participants were aware that their adherence to 
protocol was being monitored electronically, and their self-reported saliva 
sampling times were in line with the MEM Cap times and broadly collected at 
the desired 15 minute time intervals for the CAR period.  On the majority of 
days samples collected during the day (S5 & S6) were close to the desired 
sampling time.  This is in line with previous studies showing that informing 
participants that saliva sampling times were being electronically monitored 
increases their adherence to the protocol (Broderick et al., 2004; Kudielka et al., 
2003).  However, as noted, participants’ self-reported awakening times were 
significantly later than actigraph estimates, resulting in a delay between 
awakening and collection of the first sample.  Collection of subsequent samples 
(samples 2-4) were synchronised to the first sample.  Although it was not 
directly tested in this study, the initial delay between awakening and collection 
of sample 1 was likely to be related to co-incident sleep inertia.  This is a state 
of reduced cognitive and motor performance following awakening (Tassi & 
Muzet, 2000). This is likely to increase the difficulty of adhering to protocol 
requested timings, even in well-intentioned participants.  Thus, these findings 
emphasis the need for electronic measures of awakening in CAR research as 
self-reported estimates at this time are not sufficiently reliable.  
 
The average delay between actigraph estimated awakening time and collection 
of the first sample on the non-adherent days was on average 8±3 minutes.  
Sampling delay was around 10 minutes for collection of S5 and S6.  These 
sampling delays could not be explained by participant characteristics, as the 
participants could be either adherent or non-adherent on different study days.  
Neither were differences between CAR profiles nor diurnal cortisol profiles on 
adherent and non-adherent study days associated with particular study days or 
day differences in awakening time.  These findings are consistent with previous 
reports of no relationship between psychosocial factors and saliva sampling 
delay (e.g. Hall et al., 2011; Okun et al., 2010). 
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The novel findings in this study are that relatively minimal sampling delays of 
8±3 minutes were associated with greater CAR magnitude when data was 
analysed either using the MnInc from 0-45 min or the frequently used change in 
cortisol concentration from sample one to 30 min post-awakening.  The same 
minimal level of non-adherence in this sample was also associated with an 
apparent average CAR peak at 30 min post-awakening compared to the more 
typical female peak at 45 min post-awakening (Oskis et al., 2009).  These 
findings raise a query over the validity of post-awakening sampling delays 
previously assumed to be acceptable, at least in women.  However, it cannot be 
assumed that these findings extend to males since timing of peak is typically 
earlier (Pruessner et al., 1997).  
 
Consequently the CAR apparently peaks earlier than if the first sample was 
actually collected at the moment of awakening.  As the timing of the CAR peak 
has been linked to measures of gender, work overload, hormonal status and 
cognitive function (Evans et al., 2012; Kudielka & Kirschbaum, 2003; Oskis et 
al., 2009; Pruessner et al., 1997; Schulz, Kirschbaum, Pruessner, & 
Hellhammer, 1998; Wolfram, Bellingrath, & Kudielka, 2011b) this finding has 
implications for theory and practice and definitely merits further investigation.  
Even if such associations with timings of CAR peaks were to prove robust to 
control for accuracy of awakening time, there might still be a need for re-
assessment of parameter estimates of such effects.  A similar point could be 
made in regard to the provision of accurate incidence estimates of so-called 
‘negative CARs’ in normal populations when timing of samples is carefully 
assessed.  In the present study, a little less than a quarter of days showed no 
evidence of a post-awakening rise, and this proportion was comparable in both 
delay and non-delay conditions, suggesting that biases caused by delay 
influence the magnitude and timing of a CAR if it occurs, but not whether it 
occurs or not.  
 
As expected the measurement of diurnal cortisol activity across the day was not 
influenced by sampling delay.  This contrasts with previous studies showing that 
sampling delay results in a flatter decline (Broderick et al., 2004; Kudielka et al., 
2003), but in these studies the decline in cortisol was anchored from the CAR, 
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which was attenuated due to sampling delay in the morning period.  The current 
findings are however consistent with Jacobs et al. (2005) who also found no 
influence of delay on diurnal decline of cortisol.  
 
This study adds to the body of literature that highlights the necessity of 
electronic monitoring of participant adherence to requested saliva sampling 
protocols in CAR research: even moderate non-adherence impacts on the 
measurement of the CAR.  Adoption of these electronic devices provides a 
more accurate measure of the timing of saliva sampling than self-report in a 
domestic setting.  In this study, using a combination of these devices enabled 
detailed real-time analyses of the impact of non-adherence previously not 
investigated, for instance between 5-15 minutes delay between awakening and 
collection of S1.  Previous studies that have monitored adherence (either 
electronically or by self-report) have focused upon the impact of delays greater 
than 10-15 min post-awakening.  The data presented here shows that accurate 
determination of the CAR (at least in females) requires more attention to detail 
to participant adherence than previously thought necessary.  Although the 
implications of this study are inconvenient in terms of the practicalities for 
accurate estimation of the CAR within the domestic setting it may shed light on 
why there is so much inconsistent evidence for the association between the 
CAR and a range of psychosocial and health variables.  
 
In conclusion moderate non-adherence (average delays of 8±3 min between 
awakening and collection of sample one) has been shown to impact on the 
accurate measurement of the CAR magnitude and peak time in a healthy young 
female sample.  Future research that seeks to use the CAR magnitude and 
timing of the CAR peak as a biomarker should take careful electronic measures 
of adherence to protocol in all respects.  Accurate knowledge of sampling delay 
could be used as a covariate in determination of the CAR, ensuring that data is 
not wasted but adjusted accordingly (e.g. mapping cortisol samples to real 
timings).  Collecting saliva samples in the domestic setting during the 
challenging post-awakening period, when participants are likely to be in a state 
of sleep inertia, substantially increases the risk that misleading results will arise.  
Conveniently, non-adherence to the sampling protocol across the day did not 
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impact on measurement of the diurnal cortisol measures when measured at 3 to 
12 hr post-awakening.   
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Chapter 5 Study II 
 
A 10 min time lag between awakening and rise in 
cortisol levels  
 
 
 
5.1 Introduction  
 
Wilhelm et al. (2007) compared pre- and post-awakening measurements of 
cortisol and ACTH in both blood and saliva.  They revealed significantly steeper 
increases in cortisol and ACTH after awakening reflecting processes specific to 
the sleep/wake transition, indicating conclusively that the increased secretory 
activity of these hormones after morning awakening is, in part, caused by the 
process of awakening itself.  In other words the CAR is a genuine response to 
awakening.  In this study, as with other studies, the CAR is represented as a 
linear response to awakening.  However, blood and saliva were sampled at 15 
minute intervals and the period immediately following awakening was not 
scrutinised. 
 
Findings from Study I (Experiment I) are suggestive of a time lag in salivary 
cortisol secretion between awakening and the start of increased cortisol 
secretion, which characterises the CAR.  In other words awakening sets off a 
chain of events, which leads to, increased cortisol secretion, which takes 5-15 
minutes to manifest as increased cortisol concentrations in saliva.  This 
proposed time lag would explain the finding that awakening cortisol levels were 
not different between the adherent and moderately non-adherent day data in 
Study I (Experiment I).  A moderate delay (i.e. 5-15 min) in collection of S1 
would lead to the assumed ‘awakening’ sample being collected during the time 
lag period when cortisol levels are relatively stable (i.e. no dynamic increase 
during this time).  The over-estimated CAR magnitude found in Study I 
(Experiment I) would be a consequence of the real-time CAR-assessment 
period being shifted just sufficiently along the time axis to maximise the average 
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level of cortisol measured in subsequent samples relative to the first sample but 
not being shifted sufficiently for that average to be influenced unduly by 
significantly lower post-peak values (unlike for longer delays > 15 min).  The 
peak of cortisol secretion would occur up to 15 minutes earlier than if the first 
sample was actually collected at the moment of awakening, which explains why 
the timing of the peak is earlier.  
 
In summary, studies typically investigate the CAR in saliva samples collected at 
15 minute intervals with the assumption that cortisol rises linearly between 
sample points; however to the knowledge of the author this assumption has not 
been investigated directly.  Smaller intervals between post-awakening saliva 
samples are required to explore directly whether there is a predicted time lag 
between awakening and the post-awakening rise in cortisol secretion.  
 
5.1.1 Aims  
 
In order to understand the findings of Study I (Experiment I) that moderate 
delays impact on the CAR, the current study explored directly whether there 
was a predicted time lag between awakening and the post-awakening rise in 
salivary cortisol secretion in an intensive study utilising five min intervals 
between post-awakening samples.  The specific aims and objectives of the 
current study are displayed below (see Table 5.1).  
 
Table 5.1 Specific aims and objectives  
 
Aims Objectives 
Monitor adherence to the 
saliva sampling protocol  
Electronically monitor awakening and saliva 
sampling times using actigraph and track caps, 
along with participants self-reports  
Determine sampling delay relative to awakening 
time  
Investigate cortisol 
secretion in the 
immediate period 
following awakening   
Investigate cortisol secretion in five minute 
intervals for the first 30 minutes following 
awakening   
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5.1.2 Hypotheses  
 
In light of the findings of Study I (Experiment I), it was hypothesised that cortisol 
in saliva would not increase linearly from awakening and that a 10-15 minute 
time lag between awakening and significant increase in cortisol levels would be 
observed thereafter. 
 
5.2 Method  
 
5.2.1 Participants  
 
Ten male and female participants (M = 32, SD = 13.6 years) were recruited on 
the basis that they were familiar with the saliva sampling protocol.  All were 
laboratory research personnel; they were healthy, not on medication or 
pregnant.  Participants did not receive any incentives to take part in the study.  
Three participants collected saliva samples on one study day only, the 
remainder collected samples on two days.  
 
5.2.2 Procedure  
 
Participants were instructed to collect saliva samples on awakening and every 
five minutes for the first 30 minutes post-awakening.  As well as the self-report 
method, awakening and saliva sampling times were monitored electronically by 
actigraph and MEM caps respectively.  As in Study I, the same materials were 
provided and participants received the same instructions for saliva sampling.  
Cortisol concentrations were determined by Enzyme Linked Immuno-Sorbent 
Assay (see chapter 3 for details).  
 
5.2.3 Statistical analysis  
 
Cortisol concentrations ranged between 2.29 and 25.65 nmol/l and values were 
moderately positively skewed.  To normalise sample distributions square root 
transformations were performed.  Real sampling times was determined from 
electronically determined saliva sampling times relative to electronically 
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determined awakening time.  Sample timings were mostly highly accurate but 
four of 17 days of data available showed some small delay (06:45±02:13 min) 
and were excluded.  The mixed regression dimension used in final models of 
the data included participant identity as random subject variable, fixed effects 
parameters of sample point and study day, and intercept as both fixed and 
random parameters.  The dependent variable was cortisol concentration.  
 
5.3 Results  
 
Initial analysis of all data revealed a typical CAR profile of substantial linear 
increase in cortisol over the 30 minute post-awakening period (F = 114.35; df = 
1, 78.98; p < .001).  Given sampling was confined to the first 30 minutes where 
few participants are likely to have peaked, the quadratic term just eluded 
significance (F = 3.69; df = 1, 78.98; p = .058).  In addition, cortisol levels were 
significantly lower on the second day of the study (F = 26.08; df = 1,82.02;         
p < .001).  There was however no significant interaction term. 
 
Given the significant main effect of study day across all sample points, it was 
modelled as an additional fixed parameter in comparisons of differences 
between cortisol immediately post-awakening (S1) and points thereafter.  
Cortisol level at awakening was compared sequentially with each subsequent 
sample (5, 10, 15, 20 etc. min post-awakening) to investigate the point at which 
cortisol levels rose significantly.  In line with expectation, there were no 
significant increases in cortisol levels before the 15 minute point following 
awakening.  Thereafter, cortisol levels were significantly higher than at 
awakening.  Table 5.2 displays the mean (±SEM) differences from awakening 
and inferential statistics for all sampling points, while Figure 5.1 provides a plot 
of estimated marginal means for the whole sampling period, which clearly 
shows the distinct latency of the CAR for the first 10 minutes of the period. 
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Table 5.2 Estimated marginal means for sample points 0 to 30 min post-
awakening sampling points 
 
Cortisol   sampling 
points 
Difference between 
Means (nmols/l) 
(±SEM. = 1.02) 
F Statistic, p value 
0 - 5 min -0.12 F = 0.01, p = .932 
0 - 10 min 0.81 F = 2.13, p = .164 
0 - 15 min 2.02 F = 5.92, p = .028 
0 - 20 min 3.02 F = 13.65, p = .002 
0 - 25 min 5.02 F = 44.41, p < .001 
0 - 30 min 6.28 F = 32.71, p < .001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1 Time lag in cortisol secretion following awakening Cortisol 
samples 0 to 30 minutes post-awakening  
*p < .05 *** p < .001 (S1 to subsequent sample specified axis) 
 
 
 
 
 
 
  * 
***   
*** 
*** 
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5.4 Discussion  
 
In this study the time lag hypothesis was tested in a small but intensive study of 
laboratory research personnel that were monitored for adherence and 
volunteered to collect saliva samples at five minute intervals for the first 30 
minutes post-awakening.  As predicted there was no significant change in 
cortisol from awakening until the 15 minutes post-awakening point.  This 
provides further support to the theoretical explanation for the observed effects in 
Study I (Experiment I). 
 
There are also theoretical implications in regard to understanding the underlying 
physiology of the CAR, something which has possibly been somewhat 
neglected in the collective effort to establish reliable psychosocial correlates.  
While it is widely understood that secretion of cortisol is pulsatile, the 
assumption of linear continuity between saliva sampling points, referred to 
earlier, has doubtless relied on the further assumption that individuals’ pulsatile 
profiles should average out to support the assumption of linearity in aggregated 
data.  An aspect of the findings presented here is that they suggest individual 
patterns of secretion may not vary randomly immediately after awakening but 
are synchronised by the processes of awakening (a tipping point) initiating a 
similar process in all participants that results in a more or less uniform increase 
in cortisol secretion some 10 minutes later.  This synchrony would be lost later 
in the day with individual variation in the time lag between bursts of cortisol 
secretion (i.e. the ultradian rhythm).  So the data presented here is consistent 
with the evidence that awakening per se is the trigger for the CAR (Wilhelm et 
al., 2007). 
 
The time lag in this study may be explained by the patterns of secretion of 
ACTH and cortisol in the post-awakening period.  ACTH is the required 
secretogue for cortisol.  In males an interval between release of ACTH and 
cortisol following awakening has been demonstrated (Wilhelm et al., 2007).  On 
average ACTH peaked 15 minutes after awakening whereas cortisol peaked at 
30 minutes after awakening, although in this study samples were collected at 15 
minute intervals only, so it could be that peaks of cortisol and ACTH were 
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earlier or later than observed.  Furthermore, cortisol secretion has been 
demonstrated to begin at about 10 minutes after initiation of ACTH secretion in 
a case study employing blood sampling every 5 minutes from 01:00 to 09:00 
hours (Gallagher et al., 1973).  Awakening is stimulatory to ACTH and the time 
lag then could be due to the complex sequential conversion of cholesterol to 
cortisol, in which ACTH stimulation is only the first step. 
 
Results should be interpreted cautiously; one of the limitations of this study is 
the small sample size.  Future research should test the time lag in a larger 
sample, this would enable testing of individual differences in cortisol secretory 
activity in the first 15 minutes following awakening.  The finding of a time lag 
would have methodological implications for CAR research.  Great care should 
be taken with the determination of awakening time as per the findings of Study I 
(Experiment I).  Awakening is the trigger to the CAR and must be determined in 
an accurate way (i.e. electronic estimations rather than self-report). 
 
In conclusion, as predicted a time lag between awakening and initiation of 
increased cortisol secretory activity was observed for the first time.  The 
previous assumption that cortisol increased in a linear manner was not 
supported by the findings of this study.  This finding explains the findings of 
Study I (Experiment I) that moderate delays in collection of the awakening 
sample result in over-estimated CAR magnitude in the first 45 minutes and 
earlier peak. This ‘time lag’ could be explained in terms of the ultradian pulsatile 
pattern of HPA activity and the conversion of cholesterol to cortisol following 
stimulation of ACTH at the adrenal cortex. 
 
  
  99 
Chapter 6 Study I: Experiment II  
 
Diurnal patterns of cortisol; relationships with 
trait and state well-being in young healthy 
females 
 
 
6.1 Introduction  
 
There is accumulating evidence suggesting the beneficial effects of well-being 
on future health outcomes (Pressman & Cohen, 2005) even after controlling for 
known covariates (Chida & Steptoe, 2008; Kubzansky & Thurston, 2007).  
There are several possible pathways through which well-being may confer 
favourable health outcomes (for a review, see Dockray & Steptoe, 2010).  One 
possible pathway is via the neuroendocrine system.  Both the CAR and diurnal 
cortisol profile have been associated with well-being.  However, the literature is 
limited by inconsistent findings, particularly for the CAR.  Variation in findings 
may be due to differences in the dimension of well-being measured (i.e. 
subjective or psychological, state or trait), the time of day of cortisol 
measurement, aspect of the circadian rhythm measured, and age or gender of 
the sample.  Further non-adherence to the saliva sampling protocol is 
problematic for CAR studies and may contribute to the mixed findings present in 
the literature. 
 
The subjective aspect of well-being is typically investigated in relation to cortisol.  
Lower levels of positive affect and less variation of positive affect in the 
afternoon was associated with higher evening cortisol in older adults (Simpson 
et al., 2008).  In middle-aged adults (N = 227, average 45-59 years old) lower 
cortisol over the day (measured at 2 hr intervals between 08:00-23:30) was 
related with higher aggregated happiness ratings.  The happiest individuals 
exhibited 32-34% less cortisol on work and leisure days after controlling for 
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psychological distress and other known covariates (Steptoe, Wardle, & Marmot, 
2005).  These results were replicated in a three year follow-up of the same 
individuals (Steptoe & Wardle, 2005).  The effect of well-being being 
independent of ill-being demonstrates the unique relationship between well-
being and cortisol.  Others however have failed to find associations between 
well-being and diurnal cortisol patterns.  In healthy young females (N = 556, M = 
27, 18-61 years) aggregated positive affect was not related with lower cortisol 
output over the day, but aggregated negative affect was related with higher 
cortisol (Jacobs et al., 2007).  The differences in findings between the studies 
may be the age of the participants (i.e. young vs middle-aged).  It is possible 
that the association between cortisol and well-being vary with age; differences 
in cortisol output over the day in relation to well-being may evolve with 
increasing age.  
 
Recently more recognition has been given to the psychological aspect of well-
being; evidence suggests that it may be more strongly related to cortisol.  In an 
older female sample, subjective well-being (measured by the PANAS) was not 
associated with cortisol over the day but higher levels of psychological well-
being (e.g. personal growth and purpose in life) was associated with lower 
cortisol (Ryff et al., 2004).  This finding suggests that both aspects of well-being 
should be measured in relation to cortisol.  This effect was more pronounced for 
those over 75 years of age (Ryff et al., 2004), which supports the notion that 
such relationships may vary across the lifespan.  In the same study ill-being (e.g. 
anxiety, anger) was not associated with cortisol secretion over the day (Ryff et 
al., 2006).  This provides support for the ‘independence view’ of ill-being and 
well-being and warrants the need for investigating well-being and ill-being at 
least in relation to cortisol secretion. 
 
Cortisol has a marked circadian rhythm and it is best practice to measure 
cortisol secretion according to awakening time and not clock time (Edwards, 
Clow, et al., 2001).  Further, the CAR and diurnal decline should be investigated 
separately since the CAR involves different regulatory processes (Clow et al., 
2004).  Associations between well-being and the CAR or diurnal cortisol profile 
vary across studies.  In 72 middle-aged males (M = 34, SD = 9 years) higher 
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aggregated positive affect was related with lower cortisol in the first 60 minutes 
following awakening and a smaller CAR magnitude, after controlling for 
negative affect, age, and BMI.  However, no relationship with cortisol measures 
and the PANAS were observed (Steptoe et al., 2007).  The lack of association 
with the PANAS suggests that aggregated ratings of positive affect may be 
more strongly related with well-being.  Positive affect measured by the PANAS 
shows a distinctive circadian rhythm, positive affect on awakening is low and 
increases during the morning reaching peak levels during the afternoon and 
gradually declining in the evening (e.g. Simpson et al., 2008).  The EMA method 
captures changes in mood over the day, which may be a more robust measure 
of capturing mood and thus more strongly related with cortisol patterns.  The 
same group failed to replicate the CAR findings in a sample of older adults (N = 
2873, 50-74 years), aggregated positive affect was not related with the CAR 
magnitude but was associated with cortisol output over the day (Steptoe et al., 
2008).  Likewise, Lai et al. (2005) did not find the CAR to be associated with 
positive affect in a sample of 80 young Chinese adults (average 27 years old), 
but higher levels of positive affect was related with lower cortisol over the day 
(assessed at spot time points).  
 
Only one of the studies above electronically monitored saliva sampling times 
and this was for samples collected across the day which has not been shown to 
influence measurement of the diurnal cortisol profile (Jacobs et al., 2007).  The 
other studies relied on participant self-reported adherence to the saliva 
sampling protocol, which is largely inaccurate and results in researchers failing 
to identify delays in sampling, which is particularly problematic for accurate 
measurement of the CAR (see chapter 4).  In a smaller intensive study of 50 
healthy older adults (average 74 years olds) sampling times were electronically 
monitored using track caps.  A combination of ill-being and well-being was 
associated with lower cortisol in the first 45 minutes of awakening.  Individuals 
exhibiting the ‘best’ levels of well-being (e.g. a combination of high levels of 
well-being and low levels of ill-being) exhibited less cortisol in the first 45 
minutes of awakening.  But no associations were found with the CAR (MnInc) or 
diurnal decline (3-12 hr post-awakening).  The combination of well-being and ill-
being suggests that they have to co-exist to have an impact on well-being, 
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therefore supporting the view that both well-being and ill-being need to be 
measured in relation to cortisol secretion (Evans et al., 2007).  However, this 
study did not electronically monitor awakening times, and as revealed from 
Study I (Experiment I) electronic estimates of awakening time are essential to 
identify moderate delays in the post-awakening period which impact on CAR 
measurement.  
 
In a meta-analysis inconsistent relationships between the CAR and 
psychosocial variables were evident.  For instance, ill-being (e.g. depression, 
stress) was associated with an increased and decreased CAR.  Positive 
psychological traits (such as well-being, happiness, optimism, vitality, 
lively/energetic feelings, self-esteem, and self-efficacy) were associated with a 
reduced CAR, which is consistent with positive characteristics having biological 
correlates that are the opposite of negative affective responses (for a review, 
see Chida & Steptoe, 2009).  However, to further complicate the issue the CAR 
is suggested to be an adaptive response that helps individuals to meet 
anticipated demands of the day ahead (Adam et al., 2006).  Evidence to support 
this comes from larger CARs evident in healthy individuals (Kudielka & 
Kirschbaum, 2003) and a larger CAR on work compared to week days (Kunz-
Ebrecht et al., 2004; Schlotz, Hellhammer, Schulz, & Stone, 2004).  Further the 
CAR was associated with study-day anticipations of the level of obligations; 
days anticipated to be busier were associated with an elevated CAR (Stalder, 
Evans, Hucklebridge, & Clow, 2010; Stalder et al., 2011).  Thus it is difficult to 
predict the direction of the association between the CAR and well-being.  
 
Gender differences may exist in the associations between cortisol and well-
being, in healthy adults (N = 334, age M = 29, 18-54 years) males with low 
aggregated positive affect exhibited a high flat cortisol rhythm, and females with 
high aggregated positive affect exhibited a low flat cortisol rhythm.  In males no 
decline in cortisol over the afternoon was observed, whilst for females, cortisol 
in the morning was low and remained low over the day (Polk, Cohen, Doyle, 
Skoner, & Kirschbaum, 2005).  Furthermore, the CAR magnitude and cortisol 
peak differ for males and females; women exhibited larger CARs (Kunz-Ebrecht 
et al., 2004; Wright & Steptoe, 2005) and peak later (Oskis et al., 2009; 
  103 
Pruessner et al., 1997).  
 
The notion of age difference in the relationship between well-being and ill-being 
is already apparent in the studies discussed above.  Evidence that the circadian 
rhythm of cortisol becomes disrupted in older age (Sapolsky, 1999), as well as 
higher cortisol levels, attenuated CAR and attenuated diurnal decline are 
associated with older age (Evans et al., 2011; Ice, 2005) further supports this 
notion.  Additionally, mood changes are observed with older age; negative 
mood is generally shown to decrease with age and increases in the very old 
(e.g. Kessler & Staudinger, 2009).  Findings for positive mood are less clear, 
studies show a decrease or increase in positive mood with old age (e.g. 
Mackinnon et al., 1999; e.g. Mroczek & Kolarz, 1998) or no change (e.g. 
Carstensen, Pasupathi, Mayr, & Nesselroade, 2000).   
 
Few studies have investigated associations between well-being and cortisol 
specifically in younger individuals.  In young adults (19-26 years old) depression 
was related with higher cortisol levels (Van Honk et al., 2003).  Studies 
specifically investigating the CAR or diurnal cortisol profile have been on 
samples of mixed ages or middle-aged and older individuals.  To the knowledge 
of the author, no study has directly explored well-being in relation to the CAR 
and the diurnal cortisol profile in younger individuals only (i.e. age 20-30 years).  
There is growing interest in how stress affects the HPA axis across the life span 
(Lupien, McEwen, Gunnar, & Heim, 2009) and thus it is important to understand 
if the effects of well-being on favourable health are only relevant among the 
aging population or if they extend to younger adulthood.  An understanding of 
this is important in developing effective interventions aimed at preventing and 
treating chronic stress or disease.   
 
6.1.1 Aims  
 
The aims of this study were to examine the structure of the trait well-being and 
ill-being measures using factor analysis, to investigate the components from the 
factor analysis in relation to diurnal cortisol patterns, and to explore associations 
between the diurnal pattern of cortisol (CAR and diurnal decline) and trait/state 
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well-being independently of ill-being in young healthy females.  A further aim 
was to monitor participant adherence to protocol electronically enabling 
identification of non-adherent samples, which could be removed, or statistically 
controlled in analyses examining patterns of cortisol and well-being.  The 
specific aims and objectives of the current study are displayed below (see Table 
6.1).  
 
Table 6.1 Specific aims and objectives  
 
Aims Objectives 
Explore the structure of trait ill-being 
and subjective/psychological well-
being  
Conduct factor analysis to explore the 
structure of the trait ill-being and 
subjective/psychological well-being 
measures  
Categorise state well-being and ill-
being based on the mood ratings 
Explore relationships between the 
daily mood ratings 
Account for non-adherence to the 
saliva sampling protocol in 
associations between diurnal cortisol 
patterns and well-being/ill-being  
Control for electronically determined 
(e.g. actigraph and track caps 
timings) non-adherence in analyses 
exploring associations between 
diurnal cortisol patterns and well-
being/ill-being 
Explore relationships between diurnal 
cortisol patterns and trait/state well-
being independent of ill-being  
Measure the CAR and diurnal decline 
across four days 
Explore associations between diurnal 
cortisol patterns and wellbeing and ill-
being  
For any significant effects of well-
being on diurnal cortisol patterns 
control for ill-being   
 
6.1.2 Hypotheses  
 
It was hypothesized that there would be a relationship between well-being and 
the CAR across the four study days, however, given the mixed findings for 
associations between psychosocial variables and the CAR the direction of the 
relationship was not specified.  It was predicted that there would be a positive 
association between the diurnal decline and well-being; people with higher well-
being would have a steeper slope from the three to twelve hours post-
awakening across the four days.  Further, the mean diurnal cortisol was 
predicted to be negatively associated with well-being; mean cortisol from three 
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to twelve hours post-awakening across the four days would be lower in those 
with higher levels of well-being.  It was also hypothesised that well-being would 
be uniquely related with cortisol; associations between cortisol patterns would 
be independent of ill-being.   
 
6.2 Method  
 
Recruitment of participants was in two phases; phase I involved completion of 
an online questionnaire of well-being and ill-being measures.  Based on 
participants’ scores, participants were recruited to take part in the second phase, 
which involved the salivary sampling and mood ratings over four days.  
 
6.2.1 Participants  
 
Male and female students were recruited from the psychology department (N = 
240) at the University of Westminster.  Participants were on average 21 (SD = 
4.6, range 18-50) years old.  On average participants rated their perceived 
social status in the middle of the ladder (5.3 ± 1.6).  The majority was White 
(43%) or Asian (32%).  Participants completed an online questionnaire 
consisting of demographic questions and measures of trait well-being and ill-
being.  
 
6.2.2 Psychosocial Measures  
 
A full description of the demographic questions and psychosocial measures 
used in this study is provided in chapter 3, as a reminder to the reader an 
overview of the measures is provided here.  Demographic questions included 
age, sex, ethnicity, and marital status.  Participants also reported their smoking 
status (e.g. current, occasional, ex-smoker, never smoked), health status  (e.g. 
1 = poor, 5 = excellent), and subjective social status using the ‘ladder’ measure 
(Goodman et al., 2001).  Hedonic well-being was assessed using the 4-item 
subjective happiness scale (SHS), the 5-item satisfaction with life scale (SWLS) 
and positive affect (PA) from the positive and negative affect schedule (PANAS).  
Higher scores indicated greater happiness,  life satisfaction and positive affect 
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respectively.  Psychological well-being was measured using the meaning in life 
scale, which consists of meaning in life (MIL-P; higher scores indicated greater 
meaning in life) and searching for a meaningful life (MIL-S; higher scores 
indicated greater searching for a meaningful life); and Ryff scales of 
psychological well-being (RPWB), only four dimensions were used (EM = 
environmental mastery, PIL = purpose in life, PG = personal growth, SA = self-
acceptance), higher scores indicated greater psychological well-being.  Ill-being, 
was measured using the 10-item perceived stress scale (PSS), the 20-item 
centre for epidemiologic studies depression scale (CES-D), and negative affect 
(NA) from the positive and negative affect schedule (PANAS).  Higher scores 
indicated greater perceived stress, depression and negative affect respectively.  
 
6.2.3 Statistical analysis  
 
All measures were scored in accordance with the recommended guidelines (see 
chapter 3 for details).  Mean scores (based on individual responses to individual 
measures) were computed for missing responses.  Factor analysis was 
conducted to explore the structure of the well-being and ill-being measures.  
The measures of well-being and ill-being were analysed by means of principle 
component analysis, with varimax rotation.  The various indicators of 
factorability indicated good factorability and the residuals indicated a good 
solution.  For example, the KMO and Bartletts test was significant (statistic 
= .901, p < .001) indicating that there was a good amount of variance within the 
data explained by the factors.  The anti-image covariance values were small, 
which is indicative of good factor structure and the correlations showed that the 
KMO statistic for each variable included in factor analysis were all above .8 
indicating that it was not necessary to drop any of the measures.  Identification 
of participants exhibiting high or low well-being were based on scores on the 
well-being component.  
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6.3 Results: Phase I  
 
6.3.1 General descriptives for demographic, health and 
psychosocial variables  
 
The majority of participants were female (N = 197, 82%).  All of the measures 
exhibited good reliability statistics (see Table 6.2).  Pearson’s correlations 
among the well-being and ill-being indicators correlated in the expected 
direction (see Table 6.3).  The SHS, PA, SWLS, MIL-P EM, PG, PIL were 
positively correlated with each other.  The NA, PSS and CES-D were positively 
correlated with each other.  
 
Table 6.2 Reliability & descriptive statistics for psychosocial measures 
 
Scale  α Mean (±SD)  Min-max  
SHS  .822 4.90 (1.17) 1-7 
SWLS  .839 21.32 (6.49)  5-35 
PA  .802 33.05 (7.78) 11-48 
NA  .770 21.66 (7.63) 10-46 
CES-D .898 17.28 (10.69) 2-52 
MIL-P  .871 24.39 (6.51)  6-35 
MIL-S  .892 21.37 (7.89) 5-35 
PSS  .853 19.06 (6.61) 3-34 
EM  .807 36.20 (7.45) 13-53 
PG  .719 41.39 (6.23) 29-54 
PIL  .693  38.96 (6.28) 22-52 
SA  .852 36.59 (8.49) 10-54 
SHS = subjective happiness scale; PA = positive affect; SWLS = satisfaction with life 
scale; MIL-P = meaning in life – presence; MIL-S= meaning in life – search; EM = 
environmental mastery; PG = personal growth; PIL = purpose in life; SA = self-
acceptance; NA = negative affect; PSS = perceived stress scale; CES-D = centre for 
epidemologic studies depression scale. 
 
The well-being measures correlated negatively with the ill-being measures 
except for the searching for a meaningful life measure, which was not related 
with MIL-P, PA, or PA (see Table 6.3).
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Table 6.3 Pearson’s correlations for the well-being and ill-being indicators 
 
 PA SWLS MIL-P MIL-S EM PG PIL SA NA PSS CES-D 
SHS  .532*** .601*** .469*** -.155** .588*** .359*** .466*** .628*** -.374*** -.508*** -.578*** 
PA  - .478*** .381*** -.024 .524*** .405*** .514*** .504*** -.226*** -.429*** -.477*** 
SWLS  - .528*** -.180*** 657*** .358*** .551*** .741*** -.362*** -.540*** -.540*** 
MIL -P    - -.229 .490*** .325*** .572*** .564*** -.208*** -.300*** -.356*** 
MIL-S     - -.218*** -.058 -.160** -.204*** .240*** .255*** .274*** 
EM      - .538*** .650*** .727*** -.483*** -.701*** -.619*** 
PG       - .681*** .514*** -.269*** -.466*** -.395*** 
PIL        - .714*** -.393*** -.543*** -.601*** 
SA        - -.431*** -.621*** -.659*** 
NA          - .601*** .711*** 
PSS          - .718*** 
*** p < .0001, **p < .01 SHS = subjective happiness scale; PA = positive affect; SWLS = satisfaction with life scale; MIL-P = meaning in life – 
presence; MIL-S= meaning in life – search; EM = environmental mastery; PG = personal growth; PIL = purpose in life; SA = self-acceptance ; 
NA = negative affect; PSS = perceived stress scale; CES-D = centre for epidemologic studies depression scale
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6.3.2 Structure of well-being and ill-being indicators  
 
The associations between the well-being and ill-being measures suggested 
shared variance among them.  To explicitly test the structure of the well-being 
and ill-being measures exploratory factor analysis was conducted.  Principal 
component analysis revealed two components with an eigenvalue greater than 
1.0 for the well-being and ill-being measures.  The scree plot also indicated two 
components (see Figure 6.1). The two components accounted for 62% of total 
variance explained by the solution to the factor analysis, component 1 
accounted for 41% and component 2 accounted for 21%.  The component 
matrix (Table 6.4) shows the component loadings prior to rotation.  It shows that 
the majority of measures correlated with component 1.  The MIL-S correlated 
more strongly with component 2.   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1 Scree plot showing two eigenvalues (> 1) 
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The rotated component matrix (Table 6.4) shows the factor loadings after 
rotation.  It shows the unique relationship between each component and each 
measure, relationships exclude overlap between components.  SHS, PA, MLQ-
P, SWLS, EM, PG, PIL and SA are related with component 1.  NA, depression, 
MLQ-S and PSS are related with component 2 
 
Table 6.4 Factor analysis of well-being and ill-being measures  
 
 
 
 
Note. Presented is the component matrix showing the correlations between 
components 1 and 2 before rotation and the rotated component matrix correlation 
between component 1 and 2 after rotation. SWB = subjective well-being; PWB = 
psychological well-being; IB = ill-being; SHS = subjective happiness scale; PA = 
positive affect; SWLS = satisfaction with life scale; MIL-P = meaning in life – presence; 
MIL-S= meaning in life – search; EM = environmental mastery; PG = personal growth; 
PIL = purpose in life; SA = self-acceptance; NA = negative affect; PSS = perceived 
stress scale; CES-D = centre for epidemologic studies depression scale. 
 
 
Figure 6.2 shows the component plot in rotated space.  Component 1 can be 
seen as representing hedonic and eudemonic well-being and component 2 
represents ill-being.  A positive value indicates a high score and a negative 
value indicates a low score on the components.  To identify participants 
experiencing high and low levels of well-being, scores on the well-being 
component were divided.  Participants whose scores fell into the upper quartile 
(top 25% of scores) were categorized as high well-being.  Participants whose 
scores fell into the lower quartile (bottom 25% scores) were categorized as low 
well-being.  
 Component Matrix Rotated component  
matrix 
Measure Components 
 1 2 1 2 
SHS  .741 .088 .679 -.309 
SWLS  .781 .124 .732 -.299 
PA  .652 .338 .732 .049 
NA  -.615 .575 -.229 .810 
CES-D -.817 .336 -.525 .711 
MIL-P .627 .290 .687 .077 
MIL-S -.287 .564 .046 .631 
PSS  -.788 .301 -.518 .665 
EM .858 .017 .743 -.430 
PG .631 .286 .688 .082 
PIL .812 .217 .807 -.235 
SA .872 .107 .802 .360 
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Figure 6.2 Component plot in rotated space 
 
6.4 Method – Phase 2  
 
The participants and saliva sampling protocol for this study are the same as 
described in Study I: Experiment 1 (see chapter 4).  To remind the reader an 
overview will be provided.  
 
6.4.1 Participants  
 
Fifty female students that participated in phase 1 of the study were invited to 
take part in the second phase.  First they were selected based on the well-being 
category they fell into (i.e. high or low well-being group) in phase 1.  The high 
and low well-being participants were selected so cortisol profiles could be 
compared between participants exhibiting high and low well-being with the aim 
of increasing statistical power in a modest sized sample.  Participants were also 
recruited on the basis that were not taking any prescribed medication or had 
suffered from any medical or psychiatric illness in the last two years.  
Participants received no financial incentive to take part in the study but did 
receive course credits.  For one participant, samples on one of the study days 
  112 
were outside the range of the cortisol assay detection range and a further four 
participants did not return their samples for two of the study days.  One 
individual was older than the age of interest.  All six participants were excluded 
from the analyses.  The University of Westminster ethics committee approved 
the protocol.  All participants provided written informed consent. 
 
6.4.2 Materials  
 
The study pack included study instructions, a saliva sampling kit (24 labelled 
salivettes), electronic devices used to record awakening and mood ratings, 
(actiwatch-score) and sampling times (MEM caps including the 24 cotton swabs 
for saliva sampling).  The actiwatch-score was used to collect participants’ 
mood ratings.  The device was pre-programmed prior to the study to prompt 
participants to rate their mood at random times on each of the four days.  
 
6.4.3 Procedure  
 
Participants individually attended a research study induction session at the 
University of Westminster with the lead researcher (NS).  During this session 
(duration 15-25 min) participants provided informed consent, received full verbal 
and unwritten instructions on procedures, practiced the techniques for collecting 
and recording times of saliva samples and practiced using the score function of 
the actiwatch-score.  Participants were strongly encouraged to adhere to the 
saliva sampling protocol and were informed that their awakening and sampling 
times were being monitored electronically.  The evening prior to the study days, 
participants were reminded of the upcoming study days via text messages. 
Participants were instructed to collect six saliva samples (samples 1-6: 0, 15, 30 
and 45 min, and 3 and 12 hr post-awakening).  Participants were instructed to 
awake in their usual way.  During the saliva collection period participants were 
instructed to remain nil-by-mouth (except water).  Samples were initially stored 
in a domestic freezer until they were returned to the laboratory to be stored at -
20ºC until assayed.  Participants were asked to complete the study diary on 
each day to recode awakening and sampling times.  Text messages were sent 
to participants to remind them to collect samples 5-6.  In line with the EMA 
method (Stone & Shiffman, 1994), throughout the day, participants rated their 
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mood at five random times.  Participants were prompted to rate their mood via 
the wrist-worn actiwatch-score device.  Participants rated on a scale of not at all 
(1) to very much (5), the extent to which they were feeling pleased, pleased, 
happy, stressed, down, frustrated, goal-directed, busy, and in control.  The 
study materials and the saliva samples were returned to the researcher at the 
end of the study. 
 
6.4.4 Cortisol assessment and assay  
 
Cortisol assay was the same as in Study I: Experiment I (see chapter 4), 
determined by Enzyme Linked Immuno-Sorbent Assay.  
 
6.4.5 Statistical analyses  
 
Cortisol concentrations ranged between .004 and 55 nmol/l and values were 
moderately positively skewed.  To normalise sample distributions for inferential 
analyses, square root transformations were performed.  
 
The composite measures of cortisol were calculated for the CAR and diurnal 
cortisol cycle.  CAR magnitude was calculated as the mean increase of cortisol 
from the first sample (MnInc: Mean [S2,S3,S4] – S1).  In addition to the CAR 
magnitude, starting levels of cortisol at awakening (S1) was used as an 
outcome measure.  The diurnal cortisol measures included the diurnal decline, 
the mean difference from S5 to S6 and accompanied with the mean levels over 
the day, the diurnal mean cortisol (S3 + S6 / 2).  Actual timing of sample 
collection was based on electronic estimates of saliva sampling times relative to 
awakening (derived from actigraph estimated awakening and MEMs-determined 
sampling times) this was determined for each participant on each day.  All days 
in which delay in sampling in the CAR period exceeded 15 minutes were 
excluded for analyses involving the CAR or S1.  Sample delay in the CAR 
period (e.g. adherent <5 min, non-adherent 5-15 min) as specified in chapter 4 
was used as a covariate in analyses involving the CAR and S1.  Days in which 
samples 5 and 6 were collected earlier than 1 hr were excluded from analyses 
involving the diurnal cortisol cycle.  
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Pearson’s correlations were conducted for the positive and negative mood 
ratings, and based on the direction of these associations mood ratings were 
combined to obtain a measure of state well-being and ill-being.  The well-being 
or ill-being data were collapsed to obtain a day-level measure.  State well-being 
and ill-being were person-centered.  The difference between an individual’s day 
score and mean score over four days was calculated (e.g. mean WB – well-
being on day 1, day 2, day 3 or day 4).  Trait well-being and ill-being 
components (from phase 1) were grand-mean centered so that an individual’s 
well-being or ill-being score reflected individual’s deviation from the sample 
mean (e.g. WB participant – WB mean). 
 
The relationships between well-being or ill-being and cortisol measures were 
investigated using mixed regression modelling.  First the relationship between 
state well-being and ill-being and cortisol rhythm was investigated.  The 
question asked of the data was how does a woman’s cortisol rhythm change in 
responses to fluctuations of her own usual pattern of well-being or ill-being.  
Next the relationships between trait well-being or ill-being and cortisol rhythm 
were investigated.  The question asked of the data was how does each 
participant’s cortisol rhythm change in responses to fluctuations in their own 
pattern of well-being or ill-being compared to the sample mean.  The mixed 
regression dimension used in modelling cortisol outcome measures included 
participant identity (subject variable), and order of study day (repeated effect), 
and well-being or ill-being indicators (state or trait) and intercept as fixed effects 
parameters.  A simple auto-regressive (AR1) co-variance structure was 
specified for the repeated measures effect of study days.  The assumption of an 
AR1 co-variance structure for the repeated measures in the mixed regression 
models was supported as optimal in all cases.  More complex models were 
initially run for all dependent variables to check that any emerging within-
subjects effects of well-being or ill-being indicators were not confounded with 
any effects of the covariate of clock time of awakening and there were no 
interactions with day of study, which might have suggested well-being or ill-
being effects were significantly restricted to a sub-set of the overall data.  In all 
cases, no significant additional main or interactive effects emerged.  
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6.5 Results – phase 2  
 
6.5.1 Participant characteristics for high and low well-being 
participants  
 
Participants included in the analyses consisted of 24 high and 20 low well-being 
females.  Given that participants were selected on the basis of their trait well-
being score, as expected, trait well-being differed among the high and low well-
being groups (F (1, 43) = 129.827, p < .001), with the high well-being group 
exhibiting higher levels of well-being (see Figure 6.3).  Significant differences in 
trait ill-being (F (1, 43) = 17.302, p < .001) between the well-being groups were 
also observed, with the high well-being group exhibiting lower levels of ill-being 
(see Figure 6.4).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3 Differences in trait well-being between high and low well-being 
groups  *p < .001 
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Figure 6.4 Differences in trait well-being between high and low well-being 
groups  *p < .001 
 
 
 
Table 6.5 presents the descriptives for the high and low well-being groups.  
Group comparisons on demographic and health variables were made.  There 
were significant differences in perceived social status among the well-being 
groups, with the high well-being group perceiving higher social status.  
Significant differences emerged in self-reported health status, with the low well-
being group reporting poorer health.  The majority of individuals were non-
smokers (N = 27, 61%) and there were no significant differences between 
smoking statuses among the well-being groups.  
 
Table 6.5 Mean (±SD) demographics between the well-being groups  
 
  WB Group a  
M (SD)  
 
 High  Low  Group 
differences  
Age (yrs) 21.5 (3.1)   19.4 (2.8)  F  = 2.739 
SES 6.0 (1.3)  5.1 (0.8)  F = 5.496* 
Health status  2.2 (0.79)  3.9 (0.9)  F = 29.621** 
Smoker   N (%) 6 (18 %)  8 (21 %) X2 = 3.626  
*p < .05, **p < .001; a Well-being groups based on the trait well-being and ill-being 
components presented in phase 1 of this study.  
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6.5.2 General descriptives for state well-being and ill-being data   
 
The participant’s daily ratings of positive and negative mood made up the state 
well-being and ill-being variables.  The mood data were based on a potential 
880 observations.  The majority of participants completed the full five mood 
ratings on each study day.  Table 6.6 shows the percentages of completed 
mood ratings for each study day.  
 
Table 6.6 Mood ratings N (%) completed by participants on each study day  
 
   Mood 
ratings  
   
   N (%)    
Study Day  0  1 2 3 4 5 
1  0  2 (4.5) 2 (4.5) 5 (11.4) 12 (27.3) 23 (52.3) 
2  3 (6.8) 2 (4.5) 3 (6.8) 5 (11.4)  10 (22.7) 21 (47.7) 
3 2 (4.5) 2 (4.5)  6 (13.6) 6 (13.6) 6 (13.6) 22 (50.0) 
4  0  2 (4.5) 5 (11.4) 4 (9.1) 11 (25.0) 22 (50.0) 
Study day: 1 = Tuesday; 2 = Wednesday; 3 = Saturday; 4 = Sunday  
 
 
Pearson correlations were conducted between the positive and negative mood 
ratings (see Table 6.7) to explore associations between the mood ratings and in 
turn categorise mood ratings into state well-being or ill-being.  The positive 
mood items (happiness, pleased and goal-directed) were positively related with 
each other.  The negative mood ratings (out of control, frustrated, stressed, and 
down) correlated in the expected direction.  However, not all of the positive and 
negative mood ratings correlated with each other.  For example feeling stressed 
was not correlated with feeling pleased or goal directed.  Feeling frustrated was 
not correlated with feeling goal directed.  All the other mood ratings correlated 
with each other in the expected direction.  Based on the direction of these 
correlations state well-being and ill-being scores were computed.  State well-
being consisted of the positive mood ratings, including happiness, pleased and 
goal directed.  State ill-being consisted of the negative mood ratings, including 
stressed, down, frustrated and out of control. 
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Table 6.7 Pearson correlations between the mood ratings 
 
 Pleased  Goal 
Directed  
Out of 
Control  
Frustrated  Stressed  Down  Busy  
Happy   .821** .536** -.659** -.495** -.451** -.605** .446* 
Pleased   .395* -.561** -.328* -.220 -.290* .415* 
Goal 
Directed  
  -.618** -.240 -.253 -.440** .496** 
Out of 
Control  
   .670** .466** .560** -.216 
Frustrated      .767* .755** .089 
Stressed       .738* .132 
Down        -.176 
**p < .0001, *p < .05 
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Mixed regression modelling was used to investigate if the well-being groups 
exhibited different levels of state well-being and ill-being.  As expected state 
well-being differed among the high and low well-being groups (F = 7.795, df = 1, 
68.991, p = .007) (see Figure 6.5).  The high well-being group exhibited lower 
levels of state ill-being over the four days compared to the low well-being group 
(F = 24.320, df = 1, 66.3, p < .001) (see Figure 6.6).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.5 Differences in state well-being between the well-being groups  
*p < .001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.6 Differences in state ill-being between the well-being groups  
*p < .001 
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6.5.3 The CAR: associations with well-being and ill-being   
 
Figure 6.7 shows the mean diurnal cortisol pattern for all participants over the 
four days.  There were no differences in the expected (mean) CAR or 
awakening cortisol levels over the four study days, on weekend or week days, 
or condition (e.g. 1st day Tuesday or Saturday).  For results of this analysis see 
Appendix 23, Table 1.  Demographic and health variables were not associated 
with the CAR or awakening cortisol levels (see Table 6.8).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.7 Mean (+SEM) cortisol levels across four days. The diurnal pattern 
of cortisol (samples collected < 15 min delay)  
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Table 6.8 Demographic and health variables and the CAR (MnInc) and 
awakening cortisol levels  
 
   MnInc  S1 (SQRT)  
  Fixed effect Coefficient 
(SE) 
p  Coefficient 
(SE) 
p 
  Intercept  3.712 (1.203) <.003 2.375 (0.236)  <.001 
  Non-smoker  1.993 (1.228) .112 0.1533 (0.259) .557 
  Intercept  6.953 (2.971) .049 2.557 (0.592) <.001 
  SES  -0.337 (0.508)  .510 -0.136 (0.102) .895 
  Intercept  4.024 (1.678) .021 2.829 (0.332) <.001 
  Health 
status  
0.424 (0.527) .424 -0.119 (0.103) .252 
MnInc = mean increase; S1 SQRT = awakening cortisol levels  
 
Results of the analysis exploring the relationship between the well-being and ill-
being indicators and the CAR and awakening levels are presented in Table 6.9.  
The expected (mean) CAR for the overall sample on average state well-being 
days was 3.785, which was significantly different from zero.  The estimated 
value of 1.417 represents how the CAR varied in response to deviations from a 
women’s average level of state well-being.  As a woman’s state well-being was 
above the mean of their well-being for the four days their CAR was higher, but 
this was not significant suggesting no association between the CAR and 
fluctuations in a person’s state well-being.  The expected (mean) awakening 
cortisol level for the overall sample on average state well-being days was 2.536, 
which was significantly different from zero.  The estimated value of 0.219 
represents how awakening cortisol levels varied in response to deviations from 
a women’s average level of state well-being.  As a woman’s state well-being 
was higher than their mean wellbeing over the four days their awakening 
cortisol levels were on average higher, however, this was not significant 
suggesting no association between awakening levels and fluctuations in a the 
women’s state well-being.  The expected (mean) CAR for the overall sample on 
average state ill-being days was 5.175, which was significantly different from 
zero.  The estimated value of -1.038 represents how the CAR varied in 
response to deviations from a woman’s average level of state ill-being.  As a 
woman’s daily ill-being was lower than their mean ill-being over the four days 
their CAR was reduced, but this was not significant suggesting no association 
between the CAR and fluctuations in a person’s state ill-being.  The expected 
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(mean) awakening cortisol level for the overall sample on average state ill-being 
days is 2.483, which is significantly different from zero.  The estimated value of  
-0.153 represents how awakening cortisol levels vary in response to deviations 
from a woman’s average level of state ill-being.  As a woman’s daily ill-being 
decreases from their mean ill-being over the four days their awakening cortisol 
levels was lower, but this was not significant suggesting no association between 
awakening levels and fluctuations in a person’s state ill-being in the sample as 
a whole.  The associations of trait well-being and ill-being with the CAR and 
awakening levels were also investigated.  Neither trait well-being nor ill-being 
was associated with the CAR or awakening cortisol levels (see Table 6.9).  
 
Table 6.9 The CAR and awakening levels associations with well-being or ill-
being indicators  
 
 MnInc  S1 (SQRT)  
Fixed effect  Coefficient 
(±SEM) 
p  Coefficient 
(±SEM) 
p  
  Intercept  5.174 (0.826) <.001 2.483 (0.149)  <.001 
  State WB  1.417 (1.379)  .307 0.250 (0.206)  .229 
  Intercept 5.175 (0.828)  <.001 2.483 (0.149)  <.001 
  State IB -1.038 (1.098)  .347 -0.153 (0.168)  .365 
  Intercept 5.203 (0.838)  <.001 2.480 (0.149)  <.001 
  Trait WB -0.426 (0.473)  .929 -0.063 (0.091) .491 
  Intercept 5.192 (0.839)  <.001 2.475 (0.149)  <.001 
  Trait IB 0.149 (0.614)  .810 0.093 (0.116)  .432 
S1 SQRT = awakening cortisol levels 
 
6.5.4 The diurnal cortisol cycle: associations with well-being/ill-
being  
 
Figure 6.7 shows the mean diurnal decline for all women over the four days. 
There were no differences in the expected (mean) diurnal decline or average 
cortisol levels over the four study days, on weekend or week days, or condition 
(e.g. 1st day Tuesday or Saturday).  For results of this analysis see Appendix 23, 
Table 2.  Demographic or health variables were not associated with the diurnal 
decline or average cortisol levels (see Table 6.10).   
 
Table 6.10 Demographic and health variables and the diurnal decline and 
average cortisol levels  
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Results of the analysis exploring the relationship between well-being and ill-
being and the diurnal decline or average cortisol levels are presented in Table 
6.11.  The expected (mean) diurnal decline cortisol measures or average 
cortisol levels were not associated with fluctuations in participants’ state well-
being or ill-being.  Nor was the diurnal decline or average cortisol levels 
associated with a person’s deviation in trait well-being or ill-being from the 
sample mean.  
 
 
Table 6.11 The diurnal cortisol cycle and associations with well-being or ill-
being indicators  
 
 
Next both well-being and ill-being indicators were included in the model to 
investigate if relationships were present with well-being and the diurnal decline 
or mean diurnal cortisol while controlling for ill-being (and vice versa).  No main 
effects emerged.  Further no consistent significant interaction effects between 
 Diurnal decline   Mean diurnal 
cortisol  
 
Fixed effect Coefficient 
(±SEM) 
p  Coefficient 
(±SEM) 
p  
  Intercept  3.869 (0.624) <.001 5.019 (0.586) <.001 
  Non-smoker  0.585 (0.797) .466 0.346 (0.747) .645 
  Intercept  6.129 (1.583)  <.001 6.436 (1.675)  <.001 
  SES  -0.367 (0.277) .190 -0.234 (0.293) .430 
  Intercept  4.142 (1.007)  <.001 6.535 (0.927) <.001 
  Health status  0.030 (0.322)  .245 -0.452 (0.296) .134 
 Diurnal decline   Mean diurnal 
cortisol  
 
Fixed effect Coefficient 
(±SEM) 
p  Coefficient 
(±SEM) 
p  
  Intercept 4.265 (0.389) <.001 5.186(0.373) <.001 
  State WB -0.707 (0.390) .419 -0.747 (0.576) .198 
  Intercept 4.265 (0.385) <.001 5.182 (0.382) <.001 
  State IB 0.672 (0.793) .398 0.954 (0.515)  .066 
  Intercept 4.227 (0.387) <.001 5.233 (0.364) <.001 
  Trait WB -0.197 (0.307) .523 0.089 (0.288) .760 
  Intercept  4.228 (0.389) <.001 5.232 (0.364) <.001 
  Trait IB 0.100 (0.385) .797 -0.060 (0.360) .868 
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well-being and ill-being indicators on the diurnal decline or average cortisol 
levels emerged.  Since delay in collecting S5 and S6 did not influence estimate 
of diurnal decline or average cortisol measures they were not included in the 
model.  To ensure that sampling delay did not influence the results sampling 
delay for collection of S5 and S6 were entered in the model but results were 
unchanged.  Further, situational variables (e.g. awakening time, study day) 
were also entered into the model but results were unchanged.  
 
6.6 Discussion  
 
The main aim of this study was to investigate the relationship between the 
diurnal pattern of cortisol (the CAR and diurnal decline) and trait/state well-
being independent of ill-being in a young healthy female sample.  Well-being 
and ill-being was measured in two ways; firstly, a trait measure of ill-being and 
well-being was assessed using validated questionnaire measures.  According to 
the factor analysis, ill-being and well-being were separate dimensions, and the 
subjective and psychological aspects of well-being were considered one 
dimension.  Based on the well-being or ill-being component scores, participants 
categorised as high or low well-being completed the next phase of the study.  
Over four days in line with the EMA method positive and negative mood was 
assessed to provide a measure of state well-being and ill-being.  On these days 
the CAR and diurnal cortisol profile were also assessed.  To circumvent issues 
of non-adherence to the saliva sampling protocol, both awakening and sampling 
times were electronically monitored.  Long delays in sampling in the CAR period 
(i.e. > 15 min) were excluded from analyses with the CAR.  Moderate delays 
during the CAR period (i.e. 5-15 min) were controlled in analyses involving the 
CAR.  Non-adherence for the diurnal decline was not an issue in this sample; 
however, to ensure accuracy, deviations in sampling (± 60 min) were excluded 
from analyses involving the diurnal decline or mean diurnal cortisol.  In these 
healthy young females categorised as high or low well-being, trait/state 
measures of well-being/ill-being were not associated with diurnal patterns of 
cortisol, including, awakening cortisol levels, the CAR, diurnal decline or mean 
diurnal cortisol.  
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The null findings of the current study are difficult to interpret with respect to 
previous literature, which is limited by mixed findings.  The current study failed 
to find significant associations between trait well-being and diurnal decline or 
mean diurnal cortisol.  Based on the factor analysis the well-being component 
included measures of both subjective and psychological well-being.  Others 
have found associations for lower cortisol and psychological well-being but not 
subjective well-being (Ryff et al., 2004).  To ensure that using the well-being 
component did not miss relationships associations between cortisol patterns 
and the individual measures of well-being were also explored; however, no 
relationships were found.  Trait well-being was not a stronger predictor of lower 
mean diurnal cortisol than trait ill-being.  This differs from another study that 
showed well-being but not ill-being was related with lower cortisol across the 
day (Ryff et al., 2006; Ryff et al., 2004).  Previous studies that assessed trait ill-
being typically include negative affect or depression, and these measures were 
separately explored in relation to cortisol patterns.  In the current study the ill-
being component was investigated in relation to cortisol patterns included 
several measures of ill-being (e.g. negative affect, depression and search for a 
meaningful life), again associations with these individual measures and cortisol 
patterns were explored to ensure no relationships were missed.  Other studies 
have found associations with morning cortisol levels and a combination of trait 
well-being/ill-being (Evans et al., 2007).  A combination of well-being/ill-being in 
the current study and cortisol patterns was also explored however no 
associations were observed.   
 
Relationships have been observed between higher aggregated positive affect or 
happiness and lower cortisol over the day (Steptoe & Wardle, 2005; Steptoe et 
al., 2005).  However, cortisol was measured at spot samples over the day 
according to clock time.  In the current study cortisol over the day was 
measured according to awakening time (i.e 3 and 12 hr post-awakening).  The 
lack of associations with trait well-being and the CAR are consistent with 
(Steptoe et al., 2007) who also failed to find an association.  However, did find a 
relationship with aggregated ratings of happiness and a smaller CAR in males.  
In the current study mood was also assessed by aggregated mood ratings over 
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the day, using this measure of well-being but no associations were observed 
with the CAR.  However, the sample was female, previously CAR profiles have 
been shown to differ between males and females (e.g. Kunz-Ebrecht et al., 
2004; Oskis et al., 2009; Pruessner et al., 1997; Wright & Steptoe, 2005).  Other 
studies have also failed to find associations with the CAR and well-being 
measures, which is consistent with the current study.  
 
The null findings in this young sample is consistent with another study which 
also failed to find associations between positive affect and lower cortisol in 
younger females (Jacobs et al., 2007).  Together these studies suggest that the 
relationship between well-being and cortisol is not evident in healthy young 
females.  Studies that have observed relationships between cortisol and well-
being are in middle-aged and older individuals (e.g. Ryff et al., 2004; Steptoe et 
al., 2008; Steptoe & Wardle, 2005; Steptoe et al., 2005).  This suggests that 
these associations are dependent on age of the sample, which supports the 
notion that the relationship between well-being and cortisol may change over 
the life span and may be particularly relevant to older individuals.  
 
The main advantage of this study is the electronic-monitoring of adherence to 
the saliva sampling protocol.  As seen in chapter 4 of this thesis, even moderate 
delays in sampling in the CAR period result in misleading CAR estimates.  
Inclusion of such erroneous CARs question the reliability of previous findings 
which have not accounted for non-adherence.  This is the first study to account 
for the impact of moderate delays in associations of the CAR and psychosocial 
variables.  Thus the lack of associations cannot be explained by non-adherence 
to the saliva sampling protocol since this was considered and accounted for in 
the analyses.  The null findings may be attributed to the age of the participants 
such that well-being/ill-being is not associated with cortisol in young healthy 
females.  It may be particular relevant for middle-aged or older individuals.  
Future research should directly compare associations between well-being and 
middle-aged or older individuals to understand how this relationship operates 
across the lifespan.  
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The study findings should be interpreted with caution.  The intensive nature of 
the study meant that the sample size was quite modest.  Participants were 
female students perceiving themselves as middle class and were educated.  
Further, individuals included exhibited either high or low levels of well-being on 
the trait measures.  All these factors make it difficult to generalise findings.  It 
would be interesting to examine the same associations in a male sample and in 
individuals exhibiting a range of well-being or ill-being scores.  
 
In conclusion, this study failed to replicate previous associations between 
higher levels of well-being and patterns of cortisol secretion despite strict 
monitoring of adherence to protocol.  This was not due to non-adherence since 
the study controlled for electronically monitored non-adherence.  These findings 
may be attributed to the age of the sample, such that associations only emerge 
in middle-aged and older individuals, as previously shown.  It must be 
considered that the findings reported come from a restricted and homogeneous 
sample of only modest size making it difficult to generalize findings.  
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Chapter 7 Study III 
 
 
Exploring relationships between hair cortisol and 
well-being in young and old females 
 
 
 
7.1 Introduction  
 
Measurement of cortisol in saliva samples facilitates accurate investigation of 
the diurnal pattern of cortisol under ambulatory conditions and associations with 
psychosocial variables and health have been explored.  Dysregulation of the 
HPA axis can include both high and low levels of cortisol as well as disrupted 
circadian rhythms.  For example, chronic stress is associated with hyper-
secretory cortisol patterns (high/flat cycles) and abnormally high overall cortisol 
levels are associated with major depression (Holsboer, 2000).  Whilst hypo-
secretory patterns (low/flat cycles) have been reported in patients with post-
traumatic-stress-disorder (Rohleder, Joksimovic, Wolf, & Kirschbaum, 2004) 
and chronic fatigue syndrome (Crofford et al., 2004; Demitrack et al., 1991).  
 
It is becoming increasingly evident that there are gender differences in cortisol 
secretory patterns.  In earlier studies of the CAR, chronic stress was associated 
with a larger CAR in females compared with males (Schulz et al., 1998).  
Females were found to have higher cortisol in the morning compared to males 
(Wust et al., 2000).  Additionally, on workdays, which are associated with more 
stress and less control and happiness CARs were higher compared to weekend 
days.  The effect was more pronounced for females compared to males, on 
workdays (but not weekend days) suggesting that females may be particularly 
more sensitive to stress and anticipation of the day ahead than males (Kunz-
Ebrecht et al., 2004).  More recently, opposite patterns of cortisol secretory 
patterns for stress exposure in females are becoming increasingly evident. For 
example, chronically stressed females showed a smaller CAR and a lower 
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diurnal mean (O’Connor et al., 2009).  Kumari et al. (2010) reported different 
cortisol patterns associated with stress in middle-aged individuals in terms of 
mean cortisol levels.  Males exhibited higher mean cortisol levels and a reduced 
cortisol slope (‘high and flat’ cycle), whilst females had lower mean cortisol 
levels and a reduced cortisol slope (‘low and flat cycle’).  Likewise, depression 
was associated with hypo-cortisolemia in older females and hyper-cortisolemia 
in older males (Bremmer et al., 2007).  Consistent with these findings, self-
reported negative life events were associated with significantly lower cortisol 
levels in females (Witteveen et al., 2010).  Further in a meta-analysis of cortisol 
and post-traumatic-stress-disorders, only females showed lower cortisol 
secretion and not in pooled samples of males and females (Meewisse, Reitsma, 
De Vries, Gersons, & Olff, 2007).  
 
Typically the role of cortisol in ill-being and poor health are investigated.  More 
recently (as discussed in chapter 6), the role of the HPA axis activity as a 
pathway mediating the relationship between well-being and health is being 
increasingly investigated.  However, findings regarding the CAR are mixed, 
some studies showing the association between higher well-being and a smaller 
CAR (Steptoe et al., 2007), while others only find associations with mean levels 
of the CAR (Evans et al., 2007; Steptoe et al., 2007) or lower mean cortisol 
levels over the day (Ryff et al., 2004; Steptoe et al., 2008; Steptoe & Wardle, 
2005).  To the knowledge of the author, Study I (Experiment II, see chapter 6) of 
this thesis was the first to examine the role of the diurnal pattern of cortisol 
secretion in young healthy females (under the age of 30).  In this study, no 
relationships between the diurnal pattern of cortisol and well-being or ill-being 
were observed.  This lack of associations may be attributed to these females 
being young and healthy, supporting the neurotoxicity hypothesis (see Lupien et 
al., 2009), in which the effects of well-being or ill-being take a life time to impact 
on the HPA axis and therefore only becomes apparent in later life.  It is 
proposed that in younger healthy individuals the HPA axis is more resilient to 
the effects of well-being/ill-being.  Support for this is evident from changes in 
cortisol secretory patterns with age.  Evidence suggests that cortisol changes 
with age, older individuals exhibit higher diurnal levels of cortisol than younger 
individuals (e.g. Raskind, Peskind, & Wilkinson, 1994).  In a review of animal 
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and human studies chronic or repeated exposure to stress has enduring effects 
on the brain, through activation of the HPA axis and the release of 
glucocorticoids, with the highest impact on individuals going through age-related 
changes (i.e. adults and aging adults).  In adulthood and old age the brain 
regions that undergo the most rapid decline as a result of aging are highly 
vulnerable to the effects of stress hormones, such as cortisol.  However, the 
interacting vulnerability hypothesis (see Lupien et al., 2009) considers the way 
stress effects the brain in young individuals.  
 
Gender differences are also evident for cortisol patterns and well-being.  For 
instance, higher optimism was associated with less cortisol in the morning 
period for males.  While females with high scores of optimism tended to show 
higher cortisol secretion in the post-awakening period (Lai et al., 2005).  Also, 
females exhibiting low aggregated affect showed a low flat cycle whilst males 
shows a high flat cycle (Polk et al., 2005).  Further, green space and average 
cortisol concentrations (but not the cortisol decline) differed in socially 
disadvantaged males and females.  Higher neighborhood green space was 
related with higher cortisol levels in females but attenuated cortisol levels in 
males (Roe et al., 2013).  
 
Although salivary cortisol enables measurement of the diurnal cortisol pattern, 
measure of cortsiol is acute with secretion of cortisol over minutes.  The new 
method of assessment of cortisol in hair samples provides a retrospective trait 
measure of cortisol secretion over several months.  Cortisol is incorporated into 
the hair shaft and hair grows approximately 1cm per month, thus 1cm of hair 
equates to one month of cortisol exposure (see chapter 2 for an overview of 
cortisol measurement in hair samples, including its validity as a measure of trait 
cortisol secretion).  Unlike salivary cortisol there are no issues with non-
adherence to the protocol since the researcher collects the hair sample.  In this 
study measuring cortisol in hair enabled studying associations between cortisol 
and well-being in a larger sample allowing for comparison between young and 
old female samples. This is more difficult with salivary cortisol studies, largely 
due to participant non-adherence to the saliva sampling protocol, cost and 
timely nature of repeated saliva sampling.  HCC has been investigated in 
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relations to ill-being, however, weak and inconsistent associations between 
HCC and stress-related psychosocial measures are observed even when the 
scores of these measures are consistently higher than controls (e.g. Stalder, 
Steudte, Alexander, et al., 2012; Van Uum et al., 2008; Yamada et al., 2007).  
Importantly, despite not showing associations between HCC and self-report 
measures, elevated HCC was evident in conditions assumed to exhibit 
increased levels of stress (Van Uum et al., 2008; Yamada et al., 2007).  No 
studies have investigated associations between hair cortisol and well-being. 
 
7.1.1 Aims  
 
The aim of this study was to explore associations between HCC and well-being 
or ill-being in healthy females and to compare those associations between 
young and old females.  The specific aims and objectives of the current study 
are displayed below (see Table 7.1).  
 
Table 7.1 Specific aims and objectives of Study III 
 
Aims Objectives 
Explore the structure of ill-being and 
subjective/psychological well-being  
Conduct factor analysis to explore the 
structure of the trait ill-being and 
subjective/psychological well-being 
measures  
Explore relationships between HCC 
and  trait well-being independent of 
ill-being in young and old individuals  
Explore associations between HCC 
and trait wellbeing and ill-being for 
the young and old sample. For any 
significant effects of well-being on 
HCC control for ill-being.  
Investigate age differences in the 
relationship between HCC and well-
being  
Compare associations between HCC 
and well-being independent of ill-
being between the young and old 
sample  
 
7.1.2 Hypotheses  
 
It was hypothesised that although there would be no relationship between HCC 
and well-being or ill-being in the young sample, there would be a significant 
relationship between HCC and well-being/ill-being in the old sample.  The 
  132 
direction of this relationship could not be predicted since both hyper- and hypo-
secretory cortisol patterns have been observed in relation to well-being/ill-being 
in females. 
 
7.2 Method  
 
7.2.1 Participants  
 
The young female participants (N = 91) were recruited from amongst the 
Psychology department at the University of Westminster, participant age ranged 
between 18-26 (19±2.1) years.  The majority (86%) were single; ethnicity was 
mixed with the majority from a White (35%) or Asian background (38%).  Only 
16% were currently taking oral contraceptives.  Requests from volunteers from 
among undergraduate psychology students were made via the Research 
Participation Scheme, in which participants received course credits for 
participating in the study.  Wider recruitment was undertaken via 
announcements or flyers to postgraduate psychology students (including MSc 
and PhD level).  Volunteers received no incentive to participate in the study.  
The older participants (N = 27) were recruited from among the University of the 
Third Age and Women’s Institute.  Participants recruited for the study were over 
the age of 65 (78±6.8) years and were retired or in part-time employment.  The 
majority were widowed (52%) and all White British/Irish.  The older participants 
were offered a small monetary award of a £10 high street voucher (7 
participants received the voucher).  All participants were selected on the basis 
that they were not pregnant, they had not taken any corticosteroids medication 
or had suffered from adrenocortical dysfunction in the last year and they had not 
taken any illicit drugs in the last 6 months.  The majority of the sample (91%) 
was educated to at least A-level.  The University of Westminster ethics 
committee approved the protocol and all participants provided informed written 
consent.  
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7.2.2 Psychosocial Measures  
 
Information about demographic variables (age, smoking status, body mass 
index, ethnicity, education level, and employment status and medication or 
illness history) and hair-specific characteristics (washes per week, type of hair, 
hair treatment and natural hair colour) were obtained via self-report.  
Participants rated their general health as excellent, very good, good, fair or poor.  
In addition, they rated their perceived social status using the 1—10 ‘ladder’ 
measure (Goodman et al., 2001).  In relation to education, occupation and 
wealth participants indicated on a 1-10 step ladder their standing in society, with 
the top of the ladder represented a higher social standing.  
 
Well-being and ill-being were assessed using validated scales (details provided 
in chapter 3).  Subjective well-being was assessed using the 4-item subjective 
happiness scale (SHS; Lyubomirsky & Lepper, 1999) and the 5-item satisfaction 
with life scale (SWLS; Diener et al., 1985).  Higher scores indicated higher 
subjective well-being.  Eudemonic well-being was assessed by Ryff’s well-being 
scales (Ryff, 1989), of which four dimensions were used including 
environmental mastery (EM), personal growth (PG), purpose in life (PIL), and 
self-acceptance (SA).  Higher scores indicated higher psychological well-being. 
Ill-being was assessed using the 4-item perceived stress scale (PSS; Cohen et 
al., 1983) (PSS), and the 20-item depression, anxiety and stress scale (DASS; 
Lovibond & Lovibond, 1995).  Higher scores indicated higher ill-being.  All of the 
young participants completed these measures via an online questionnaire one 
week before or after providing the hair sample.  The older participants had the 
choice of completing the questionnaire in the week before providing the hair 
sample via the online questionnaire or by pen-paper on the day of providing the 
hair sample.  
 
7.2.3 Sample and collection preparation  
 
Hair samples were taken near the scalp from a posterior vertex position.  
Cortisol concentrations were determined from the 3-cm hair segment most 
proximal to the scalp.  Each segment was assumed to represent hair grown 
over a 3-month period, based on an average hair growth rate of 1-cm per month.  
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Hair samples were stored in labeled foil packages in a dry place.  Samples were 
analysed by the Technical University in Dresden Germany.  The wash and 
steroid extraction procedures followed the laboratory protocol described in detail 
in Stalder, Steudte, Miller, et al. (2012). Cortisol levels were determined using a 
commercially available immunoassay with chemiluminescence detection (CLIA, 
IBL-Hamburg, Germany), see Chapter 3 for more details.  
 
7.2.4 Statistical Analysis  
 
Comparisons of demographic, hair-related, health and psychological variables 
between the young and old groups were conducted.  Factor analysis was 
conducted to explore the structure of the trait well-being and ill-being indicators.  
The well-being and ill-being indicators were analysed by means of principle 
component analysis, with varimax rotation.  The various indicators of 
factorability indicated good factorability and the residuals indicated a good 
solution.  For example, the KMO and Bartletts test was significant (statistic 
= .854, p < .001) indicating that there was a good amount of variance within the 
data explained by the factors.  The anti-image covariance values were small 
which is indicative of good factor structure and the correlations showed that the 
KMO statistic for each variable included in factor analysis were all above .7 
indicating that it was not necessary to drop any of the measures. 
  
Kolmogorov–Smirnov tests revealed that cortisol data were not normally 
distributed.  Log transformations were applied which effectively reduced the 
skewness statistic, and for three outliers log transformed values were 
winsorised.  For illustration purposes Figure 7.4 presents the means and 
standard errors in original units (pg/mg).  Pearson correlations or tests of 
differences were conducted between the demographic, well-being and ill-being 
components and HCC.  
 
To assess the relationship between HCC and well-being and ill-being Pearson’s 
correlations were conducted separately for the young and old groups.  Mixed 
modelling regression analyses were conducted to investigate the relationship 
between HCC and well-being or ill-being components and participant age.  
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Using the mixed modelling command interaction effects between well-being or 
ill-being and age on HCC were also investigated. 
 
7.3 Results  
 
7.3.1 Participant Characteristics  
 
Table 7.2 illustrates differences in participant characteristics such as 
demographic, and health variables among the young and old groups.  No group 
differences emerged in perceived social status, although there was a trend for 
the older individuals to perceive their social status higher on the ladder measure.  
The older group reported their health status to be poorer in comparison to the 
younger group.  There were few occasional or ex-smokers therefore smoking 
was recorded as a dichotomous variable to indicate current smoker or non-
smoker.  There were significantly more individuals categorized as a current 
smoker in the younger group.  Ethnicity was mixed in the young sample with the 
majority from a white (49%) or Asian (32%) background.  All females in the 
older group were white. 
 
Table 7.2 Demographic, and health characteristics of young and old samples 
 
 Young  Old  Group differences  
SES M (SD)  5.9 (1.4)  6.5 (1.4)  F = 3.849,  
p = .052 
White ethnicity N (%)  31 (35) 27 (100) Χ2 = 32.875,  
p < .001 
Self-reported health status 
M (SD) 
2.58 (0.9) 3.12 (0.9)  F = 7.177,  
p = .008 
Taking regular Medication 
N (%)  
13 (14) 19 (76) Χ2 = 36.914,  
p = <.001 
Diagnosed illness N (%) 9 (10) 12 (50) Χ2 = 19.580,  
p <.001 
Non-smoker N (%)  70 (73)  26 (100) Χ2 = 6.564,  
p = .010 
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There were no effects of medication use or suffering from an illness, on HCC 
(p > .05).  Additionally hair characteristics, such as, hair treatments (e.g. colour, 
tints or perms), hair type (e.g. curly, wavy or straight), hair colour or number of 
hair washes per week did not influence HCC.  
 
7.3.2 Structure of well-being and ill-being indicators  
 
The measures of well-being and ill-being exhibited good reliability statistics (see 
Table 7.3).  The well-being and ill-being indicators correlated in the expected 
direction (see Table 7.4).  The well-being indicators were positively associated 
with each other and the ill-being measures were positively associated with each 
other.  The well-being measures were negatively associated with the ill-being 
measures; except for the DASS stress measure, which was not associated with 
either personal growth or purpose in life.  These associations suggest shared 
variance among the well-being and ill-being measures.  
 
Table 7.3 Reliability and descriptives statistics for psychosocial measures  
 
Scale  α Mean (SD)  Min-max  
SHS  .828 5.0 (1.1) 3-7  
SWLS  .851 23.8 (6.0)  8-35 
EM  .833 37.7 (7.6) 19-53 
PG  .776 40.6 (6.7) 27-53 
PIL  .751 38.5 (7.0)  21-54 
SA  .849 37.3 (8.3)  16-54 
PSS  .749 6.5 (2.9) 0-15 
DASS stress  .836 13.0 (8.3) 0-38 
DASS anxiety  .778 8.1 (7.5) 0-36 
DASS 
depression  
.859 8.7 (8.0) 0-40 
 
SHS = subjective happiness scale; SWLS = satisfaction with life scale; EM = environmental 
mastery; PG = personal growth; PIL = purpose in life; SA = self-acceptance, PSS = perceived 
stress scale; DASS-D = Depression;  DASS-A = anxiety; DASS-S = stress.  
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Table 7.4 Pearson’s correlations for the well-being and ill-being indicators 
 
 SWLS EM PG PIL SA PSS DASS-
S 
DASS-
A 
DASS-
D 
SHS  .492* .525* .388* .528* .566* -.423* -.432* -.342* -.589* 
SWLS  .626* .259* .259* .466* .670* -.530* -.309* -.269** -.450 
EM    .464* .603* .727* -.626* -.502* -.507* -.536* 
PG     .754* .581* -.254* -.126 -.186* -.326* 
PIL      .655* -.330* -.134 -.186*** -.414* 
SA       -.539* -.434* -.370* -.607* 
PSS        .507* .451* .550* 
DASS-S        .632* .696* 
DASS-A          .602* 
* < .0001, ** p, .01, ***  p < .05. SHS = subjective happiness scale; SWLS = satisfaction with life scale;  
EM = environmental mastery; PG = personal growth; PIL = purpose in life; SA = self-acceptance,  
PSS = perceived stress scale; DASS-D = Depression; DASS-A = anxiety; DASS-S = stress.  
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In order to explicitly test the structure of the well-being and ill-being indicators 
exploratory factor analysis was conducted by means of principle component 
analysis.  Two components with an eigenvalue greater than 1.0 were found. 
The screen plot (see Figure 7.1) also indicated two components.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.1 Scree plot showing the eigenvalues (> 1) 
 
 
Table 7.5 displays the component matrix, which shows the loadings of each 
measure on the components 1 and 2 prior to rotation.  The majority of measures 
were correlated with component 1.  The pattern matrix shows the factor 
loadings after rotation, it shows the unique relationship between each 
component and each measure.  The PSS, depression, anxiety and stress 
(DASS) scales are strongly associated with component 1.  The SHS, SWLS, 
EM, PG, PIL and SA are strongly associated with component 2. 
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Table 7.5 Factor analysis of measures of SWB, PWB and IB.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. Presented is the component matrix showing the correlations between 
components 1 and 2 before rotation and the rotated component matrix correlation 
between component 1 and 2 after rotation. SWB = subjective well-being; PWB = 
psychological well-being; IB = ill-being; SHS = subjective happiness scale; SWLS = 
satisfaction with life scale; EM = environmental mastery; PG = personal growth; PIL = 
purpose in life; SA = self-acceptance, PSS = perceived stress scale; DASS-D = 
Depression; DASS-A = anxiety; DASS-S = stress. 
 
 
 
The two components accounted for 69% of the total variance explained by the 
solution to the factor analysis.  Component 1 accounted for 53% and 
component 2 accounted for 15%.  Figure 7.2 shows the component plot in 
rotated space.  Component 1 represents ill-being and component 2 represents 
well-being.  On the components a positive values indicates a high score and 
negative value indicates a low score.  These components were explored in 
relation to demographic variables and HCC in the young and old groups.  
 
 
 
 
 
 
 
 
 
 Component 
Matrix 
Rotated 
component  
matrix 
Measure Component Component 
 1 2 1 2 
SHS  .746 -.032 -.567 .486 
SWLS  .716 .118 -.442 .475 
EM .848 .070 -.572 .630 
PG .576 .608 -.006 .838 
PIL .688 .608 -.087 .914 
SA .858 .236 -.465 .758 
PSS  -.729 .210 .676 -.344 
DASS-D -.804 .299 .791 -.331 
DASS-A -.620 .504 .797 -.055 
DASS-S -.660 .583 .880 -.025 
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Figure 7.2 Component plot in rotated space 
 
 
Differences in scores on the well-being and ill-being components among the 
young and old groups were investigated.  Scores on the well-being component 
did not differ between the two groups (F  = 1.513, df = 1, 115, p = .218).  Scores 
on the ill-being component were significantly higher for the younger group (F = 
13.895, df = 1, 115p < .001).  Figure 7.3 displays the differences in means 
(±SEM) of the well-being and ill-being components.   
 
 
 
 
 
 
 
 
 
 
Figure 7.3 Means (± SEM) differences in well-being and ill-being components 
for young and old groups *p < .001 
 
 
* 
* 
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The well-being component was not associated with perceived social status (r 
= .140, p = 152) or self-reported health status (r = -.150, p = .108).  Also there 
were no differences in well-being scores between smokers and non-smokers (F 
= .025, df = 1, 114, p = .874) or white and other ethnic groups (F = .186, df = 1, 
112, p = .667).  Ill-being was associated with lower perceived social status (r = -
.353, p < .001) and poorer self-reported health (r = .195, p = .036).  Ill-being 
was higher in smokers compared to non-smokers (F = 24.868, df = 1, 114, p = 
<.001) and lower in white females compared to other ethnic groups (F = 6.166, 
df = 1, 112, p = .015).  
 
7.3.3 Hair cortisol concentrations: relationships with participant 
characteristics 
 
Differences in HCC between the young and old groups were investigated.  HCC 
differed between the young and old groups (F = 5.087, df = 1, 114, p = .026).  
The older group secreted significantly more cortisol over the past three months 
compared to the younger group (see Figure 7.4).  HCC was not significantly 
associated self-reported health status (r = .065, p = .494) or with perceived 
social status (r = -.001, p = .992).  HCC did not significantly differ among 
smokers or non-smokers (F = 1.486, df = 1, 111, p = .225).   
 
 
 
 
 
 
 
 
 
Figure 7.4 Mean (±SEM) differences in HCC for young and old groups  
*p < .001 
 
 
 
* 
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7.3.4 Hair cortisol concentrations: relationships with well-being 
and ill-being components  
 
Relationships between HCC and the well-being and ill-being components were 
conducted separately for the young and old groups.  In the young group, HCC 
was not significantly related with the well-being (r = .140, p = .193) or ill-being (r 
= .159, p = .139) components.  In the older group, HCC was significantly 
positively related with the well-being component (r = .501, p =.009) but not the 
ill-being component (r = -.229, p = .260).  In older individuals higher HCC was 
associated with higher levels of well-being (see Figure 7.5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.5 Scatterplot showing the relationship between HCC and well-being 
in older individuals - higher HCC is associated with experiencing 
higher well-being 
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7.3.5 Age differences: associations between HCC and well-
being/ill-being  
 
 
The relationship between HCC and well-being in both age groups was 
investigated by means of mixed regression analysis.  This analysis was deemed 
most appropriate since an interaction between two continuous variables was 
being explored.  The questions asked of the data were whether there were main 
effects of both well-being and age on HCC and if there was an interaction effect 
of well-being and age on HCC.  
 
There was a main effect of participant age on HCC (F = 9.649, df = 1, 109, p 
= .002).  The younger group secreted significantly less cortisol (M = 0.11, SE 
= .002) than the older group.  There was a main effect of well-being on HCC (F 
= 12.144, df = 1, 109, p = .001).  An increase in scores on the well-being 
component was associated with increases in HCC (M = 0.108, SE = .032).  A 
significant interaction between age and well-being score on HCC was found (F 
= 5.829, df = 1,109, p = .017).  The interaction effect shows that higher well-
being was associated with higher HCC in the old group but not the young group 
(see Figure 7.6.).  The same analysis was conducted exploring the effect of ill-
being and age on HCC.  There was no main effect of ill-being (F = 0.913, df = 1, 
109, p = .350) or age (F = .882, df = 1, 109, p = .341) on HCC.  There was a 
trend for an interaction effect of ill-being and age on HCC (F = 3.369, df = 1, 
109, p = .069).  When ill-being was included in the analysis of age and well-
being effects on HCC in order to ensure the effects observed were independent 
of ill-being, the results were unchanged.   
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Figure 7.6 Interaction effect of age and well-being on HCC  
It shows higher well-being is associated with higher HCC in the 
older individuals but not for younger individuals. The red vertical 
lines represent X=0 (and also X= 2) and the red horizontal lines 
represent the correct intercept points 
 
 
7.4 Discussion  
 
The main aim of this study was to compare the association between HCC and 
well-being or ill-being in two distinct age groups; younger (aged between 18-26 
years) and older (ager +65 years) females.  As hypothesized no relationship 
with HCC and well-being or ill-being were evident in the group of young females.  
Whilst for the older group, higher levels of well-being were associated with 
higher HCC, but no association for ill-being and HCC was found.  The 
relationship found between HCC and well-being was independent of ill-being 
suggesting that well-being has a unique relationship with cortisol in the older 
age group.  
 
Previously studies have shown that higher levels of psychological well-being 
was related with lower cortisol in older females (Ryff et al., 2004).  Also 
aggregated ratings of positive affect were associated with lower mean daily 
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cortisol in middle-aged males and females (Steptoe et al., 2008; Steptoe et al., 
2005).  In Study I (Experiment II) of this thesis (chapter 6) cortisol and well-
being were not related in healthy young females.  The current study was the 
first to directly investigate age-differences in the relationship between well-being 
and cortisol.  The finding that well-being or ill-being are not associated with 
HCC in young healthy females is consistent with findings from Study I 
(Experiment II).  These findings provide evidence for the neurotoxicity 
hypothesis.  In a healthy population without any psychopathology well-being or 
ill-being may not exert their effects on the HPA axis early in adulthood.  In this 
study, the younger females exhibited significantly lower levels of ill-being than 
the older group but this was not enough to exert effects on the HPA axis.  The 
finding that well-being is associated with HCC only in older individuals suggests 
that the effects of well-being are not exerted until later in life in healthy 
individuals.  The finding that ill-being is not related with HCC in these older 
females suggests that the effects of well-being are a stronger predictor of 
cortisol activity than ill-being. 
 
There was a trend for an interaction between age and ill-being on cortisol.  The 
direction of the relationship between ill-being and cortisol in older females is in 
line with previous literature suggesting that lower levels of cortisol is associated 
with ill-being in females (e.g. Bremmer et al., 2007; Kumari et al., 2010; 
Witteveen et al., 2010).  In a larger sample or with poorer levels of ill-being this 
interaction may have been significant thus a relationship between ill-being and 
HCC cannot be ruled out.  However, this is consistent with previous studies, in 
which weak or no relationships are found for psychosocial stress measures and 
HCC (see Stalder, Steudte, Alexander, et al., 2012).  It may also be possible 
that in normal healthy populations it is difficult to relate aberrant cortisol levels 
with trait variables.  Further to this, the lack of association may be a 
methodological issue with the measurement of trait variables and hair cortisol.  
The ill-being measures used in this study are limited by a short recall period 
whereas the measure of hair cortisol is over several months.  As suggested 
previously, alterations in long-term cortisol secretion as measured by HCC may 
assess a distinct aspect of chronic stress exposure than captured by individuals’ 
subjective experience (Stalder, Steudte, Alexander, et al., 2012).  No study to 
date has investigated associations between well-being and HCC.  This is the 
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first study to show that well-being is related with HCC.  The well-being 
measures used in this study do not specify a recall period; participant’s general 
feelings of well-being were assessed and so may relate more strongly to HCC.  
A more intensive study of measuring ill-being using the EMA method may help 
understand how ill-being such as stress and depression are related with HCC.  
 
Smoking has been associated with higher cortisol levels (Badrick et al., 2007), 
however, this is unlikely to explain the finding of higher cortisol in older females 
since all older females reported being non-smokers.  Others have found that 
higher cortisol is associated with sleep problems, such as shorter sleep duration 
(Spiegel, Leproult, & Van Cauter, 1999).  This is an important consideration 
since impairments in sleep quality (e.g. poorer sleep efficiency, greater sleep 
disturbances) are associated with aging (for a review, see Bloom et al., 2009).  
From this study it cannot be determined if sleep quality had a role in higher 
HCC as sleep quality was not investigated so this association cannot be ruled 
out completely. 
 
In this sample of healthy females it is possible that higher cortisol secretion is 
indicative of being busier and energised.  It may be that cortisol is acting as an 
energiser in older females with higher levels of well-being.  Evidence for cortisol 
as an energiser is suggestive from studies showing that hypo-cortisolism is 
associated with pathologies characterized by exhaustion and fatigue.  For 
example low levels of cortisol are implicated in chronic fatigue syndrome 
(Crofford et al., 2004; Demitrack et al., 1991).  Further to this low levels of 
cortisol are associated with fatigue in normal healthy populations and not just 
clinical populations.  For instance, low cortisol in the morning predicted fatigue 
later in the day in (Adam et al., 2006).  In a longitudinal analysis of the Whitehall 
II cohort of community dwelling adults, lower waking cortisol levels and flatter 
daily cortisol slope was associated with fatigue (Kumari et al., 2009).   
 
Evidence for cortisol acting as a energiser in normal healthy populations comes 
from the finding that a more responsive HPA axis in terms of higher cortisol 
levels was associated with better physical functioning in older males (Gardner 
et al., 2011).  Thus the findings indicate that higher cortisol levels in a normal  
healthy older sample may be indicative of a healthier HPA axis.  The CAR is 
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also thought of as a ‘boost’ enabling individuals to deal with the upcoming 
demands of the day.  Adam et al. (2006) suggests that the CAR is an adaptive 
response that helps individuals to meet anticipated demands of the day ahead.  
Evidence to support this comes from larger CARs evident in healthy individuals 
(Kudielka & Kirschbaum, 2003) and the CAR can be larger on work compared 
to week days (Kunz-Ebrecht et al., 2004; Schlotz et al., 2004).  Further the CAR 
was associated with study-day anticipations of the level of obligations; days 
anticipated to be busier were associated with an elevated CAR (Stalder, Evans, 
et al., 2010; Stalder et al., 2011).  Of course HCC is a blunt measure, as it does 
not illuminate any dynamic of cortisol secretion: we cannot deduce associations 
with the CAR or any other aspect of the circadian cycle.  However it is clear that 
HCC can be determined by a variety of different circadian patterns and low post 
awakening cortisol may be an important contributor in this study.  Such a 
possibility deserves further investigation. 
 
In this study higher well-being was restorative of cortisol levels in older females.  
This is consistent with previous studies showing that in females higher cortisol 
was associated with positive affect (Polk et al., 2005) and green space (Roe et 
al., 2013).  Thus in this sample of older healthy females well-being was 
associated with healthy cortisol levels in terms of having higher levels of cortisol 
which may be characteristic of being highly functioning, outgoing and busy and 
the finding that ill-being was not associated with HCC suggests that the females 
in this study were well balanced and not at risk of cortisol pathologies.  
 
Although this study was cross-sectional in design and therefore cannot 
demonstrate causality, it provides evidence to help untangle the complex 
interaction between age, well-being and health.  This study was limited by the 
unequal group sizes of the young and old females.  However, the effect of well-
being was strong enough to be detected in this small group of older females.  
The sample may not be representative of the population as a whole; the older 
females in this study were of middle social-economic status as perceived by 
themselves and were healthy and highly functioning.  Thus, the relationship 
observed between well-being and cortisol may not extend to other female 
populations.  The young group was ethnically diverse, but the females in the old 
group were all white.  To ensure that results were not influenced by ethnicity in 
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the younger sample, comparison of cortisol, well-being and ill-being were made 
between the different ethnic groups.  Only ill-being differed between ethnicity 
group, White individuals exhibited lower scores on ill-being compared to other 
ethnic groups.  Analyses were conducted on just white young females and the 
result remained unchanged therefore, it is unlikely that the mixed ethnic groups 
in amongst the younger females influenced the findings.   
 
Future work could examine the cognitive function of this population of 
individuals exhibiting better well-being and higher cortisol.  Previous research 
has shown that poorer cognitive performance is associated with an attenuated 
CAR and lower decline in cortisol over the day (Evans et al., 2011).  It is likely 
that in this sample of healthy females the high cortisol levels would not be at a 
high enough level to impact on cognitive function and they are within the healthy 
range and are not dangerous levels instead they are restorative and healthy.  
Table 7.6 compares HCC of the current sample with study of alcoholics. 
Determination of HCC was in the same laboratory so values can be compared.  
HCC is higher than healthy controls, however, the controls were a younger 
sample and HCC is known to be higher in older adults (Dettenborn, Tietze, et al., 
2012).  The HCC was not high enough as found in the alcoholic patients.  This 
provides support for the assumption that the high HCC found in the current 
study are within healthy range.  
 
Table 7.6 HCC in healthy adults and clinical samples  
 
 HCC mg/pg 
M, SD  
Age of sample  
Current study  
Healthy older females  
30.0 ± 11.8  78 ± 6.8 
aAlcoholics  
Matched controls  
52 ± 43 
16 ± 13 
44 ± 11 
44 ± 11 
a values from (Stalder, Kirschbaum, et al., 2010) 
 
  
It is unknown from this study at what age the effects of well-being start to exert 
its effects on the HPA axis since comparisons were only made between young 
and older females.  Future research would benefit from including a group of 
middle-aged individuals or even better a longitudinal analysis to tease out the 
point in which well-being or ill-being exert its effect on the HPA axis. 
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In conclusion, this study showed that in these healthy young females, there 
were no relationships between hair cortisol and ill-being or well-being.  This 
indicated that healthy young females tend to be resilient, and thus no impact on 
their physiology, in terms of cortisol.  In these healthy older females, ill-being 
was not related with hair cortisol either.  However in this group there were 
associations between higher hair cortisol and well-being.  The results provide 
support for the neurotoxicity hypothesis.  They indicate that in healthy aging 
well-being, rather than ill-being, is more closely associated with the health-
related hormone cortisol.  These results indicate that high levels of well-being in 
older people may have a role as an energizer.  
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Chapter 8  General Discussion  
 
 
The importance of cortisol cannot be doubted; it is the only hormone that we 
cannot live without.  It is a product of neuroendocrine system activity, released 
in response to internal and external triggers that activate the HPA axis.  
However, what makes cortisol particularly interesting and important for healthy 
functioning is its primary and essential role as a master hormone with 
responsibility for regulating physiological function around the 24-hour light/dark 
cycle.  In healthy individuals, cortisol exhibits a marked circadian rhythm 
characterised by peak levels following morning awakening (known as the 
cortisol awakening response: CAR) and declining levels thereafter, reaching 
lowest levels in early sleep.  Dysregulation of cortisol secretion is attributed to 
the cumulative effect of chronic stress and is thought to be a prime mediator of 
associations between stress and adverse health outcomes (Clow & Hamer, 
2010).  More recently, cortisol is thought to mediate the effects of well-being on 
favourable health outcomes (Dockray & Steptoe, 2010).  The current work 
expands on previous published literature on the role of cortisol in the beneficial 
effects of well-being in healthy females.  Along with this it highlights and 
identifies methodological issues involved in measurement of the CAR.  In doing 
so it challenges previous findings of what constitutes a tolerable delay in saliva 
sampling for measurement of the CAR and informs best practice methodology 
for the ever-increasing interest in CAR research.  The studies presented in this 
thesis should be viewed as components of an overall research programme.  
The rationale for study II and III were borne out of findings from study I.  
Accordingly, in this chapter an attempt is made to discuss and integrate the 
results of the three studies as a whole.  
  
8.1 Participant non-adherence to saliva sampling protocol  
 
Participants were encouraged to collect saliva samples according to the desired 
times (i.e. 0, 15, 30 and 45 min, and 3 and 12 hr post-awakening).  They were 
encouraged to be honest and accurate in reporting their awakening and saliva 
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sampling times and were aware that electronic devices would be used to verify 
these timings.  Participants were adherent to the protocol in terms of reporting 
accurate saliva sampling times, and collecting samples (after awakening) 
according to the desired protocol intervals.  This is mostly likely due to 
participants ‘aware status’, previous research shows that informing participants 
of electronically monitoring saliva sampling times increases their adherence to 
protocol in terms of collecting samples in accord with the desired sampling 
times and reporting accurate saliva sampling times (Broderick et al., 2004; 
Kudielka et al., 2003).  Together these findings provide support for informing 
participants of electronic monitoring as a method of increasing their adherence 
to the protocol. 
 
Participant self-reported awakening times were not accurate; self-reports were 
significantly later than actigraph.  This is consistent with previous research 
showing discrepancies in awakening times between self-reported and actigraph 
(DeSantis et al., 2010; Dockray et al., 2008).  This resulted in a delay in 
collecting the first ‘awakening’ sample, and delay for the CAR period was 
attributed to this period, since S2-4 (15, 30 and 45 min post-awakening) were 
collected very closely in accordance with the desired 15 minute intervals.  The 
fact that participants were accurate and honest in reporting their saliva sampling 
times suggests that they were not deliberately reporting inaccurate awakening 
times.  Participants’ self-reported awakening times may have been accurate to 
the best of their knowledge, but they were not aware of the exact timing of 
awakening and this may be related with a co-incident sleep inertia, but this 
needs to be tested in future research.  
 
Moderate delay (average 8 min) between awakening and collection of the 
‘awakening’ sample resulted in misleading CAR measurements; no difference in 
cortisol concentrations at S1, but magnitude of the cortisol increase was 
overestimated in the first 45 minutes post-awakening and the peak in cortisol 
was earlier at 30 minutes compared to the more typical female peak at 45 
minute post-awakening (Oskis et al., 2009).  These findings differ from previous 
research showing opposite effects of delay on the CAR (i.e. higher S1 and 
attenuated CAR).  The novelty of these findings is that previously thought 
‘tolerable’ moderate delays lead to erroneous CAR measurements and raises 
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serious concerns over the validity and reliability of previous research on the 
CAR magnitude and the more recent interest in timing of the CAR peak.  These 
findings were indicative of a hypothesised time lag in cortisol secretion between 
awakening and the start of increased cortisol secretion characteristic of the 
CAR.  This hypothesis was tested with frequent saliva sampling in the CAR 
period.  Sampling every five minutes for 30 minutes following awakening, 
showed that cortisol does not start to significantly increase until 15 minutes 
post-awakening.  The impact of inaccuracy of participant-estimated awakening 
time and the consequent delay in collection of S1 on CAR measurement 
emphasises the need for electronic measures of awakening in CAR research; 
self-reported estimates at this time are not sufficiently reliable.  The effect of 
delay on the CAR was not due to situational or participant variables (e.g. study 
day, awakening time, psychosocial variables).  A person could be adherent on 
one day and non-adherent on the other day.   
 
The observed 10 minute time lag between awakening and rise in cortisol levels 
explains the finding that awakening cortisol levels were not different between 
the adherent and moderately non-adherent day data in Study I (Experiment I).  
A moderate delay (5-15mins) in collection of samples would lead to the 
assumed ‘awakening’ sample being collected during the time lag period when 
cortisol levels are relatively stable (i.e. no dynamic increase during this time).  
The over-estimated CAR magnitude found in Study I (Experiment I) would be a 
consequence of the real-time CAR-assessment period being shifted just 
sufficiently along the time axis to maximise the average level of cortisol 
measured in subsequent samples relative to the first sample but not being 
shifted sufficiently for that average to be influenced unduly by significantly lower 
post-peak values (unlike for longer delays > 15 min).  The peak of cortisol 
secretion would occur up to 15 minutes earlier than if the first sample was 
actually collected at the moment of awakening, which explains why the timing of 
the peak is earlier.  This time lag could be explained in terms of the ultradian 
pulsatile pattern of HPA activity and the conversion of cholesterol to cortisol 
following stimulation of ACTH at the adrenal cortex. 
 
Normative cortisol concentrations for the CAR have been reported in healthy 
adults; however the values of salivary free cortisol concentration vary between 
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studies (see Clow et al., 2004).  The cortisol values in Study I fell within the 
range of previous studies (4.7-18.5 nmol/l for awakening sample, and 8.6-21.9 
nmol/l for samples collected at 30 min post-awakening), however values in 
Study I are generally in the lower range for normative data (see Table 8.1).  
This variation may be due to the different assay protocols, an issue that has 
been explored in an inter-laboratory comparison employing different methods 
for determination of salivary cortisol (Garde, Hansen, & Nikolajsen, 2003).   
 
Despite these variations in absolute values the reported change in cortisol 
concentration from awakening till 30 minutes post-awakening in healthy adults 
is relatively consistent between studies with an approximate average increase 
of 9.3 nmol/l (±3.1 nmol/ l), ranging between 4.0-15.0 nmol/l, representing 
percentage increases of between 50-160% (see Clow et al., 2004).  The mean 
increase is lower in study I is significantly lower than the normative data (see 
table I).  This could be due to the mean increase in Study I being based on 
adherent data (< 5 min delay in collection of awakening sample), whereas the 
normative data may include moderate delays in collecting the awakening 
sample resulting in overestimation in mean increase during the first 45 minutes 
post awakening (as shown above).  
 
Table 8.1 Cortisol concentrations and mean increase from 0 to 30 min post-
awakening for adherent data from Study I and normative values 
derived from 12 published studies (see Clow et al., 2004) 
 
 Saliva samples  
(collected post-awakening) 
Cortisol 
MnInc 
(nmol/l)  
 0 min  15 min  30 min  45 min   
Study Ia 8.3 9.9 11.2 12.4 3.0 
Mean (±SD) of 
normative data  
11.6(4.6) 
 
16.3(5.6)  
 
20.0 (5.9) 18.9 (6.5) 6.8 
 
a Adherent data in Study I (< 5 min delay between awakening and collection of S1)  
 
 
Delay in collecting saliva samples across the day (at least at 3 and 12 hrs post-
awakening) did not impact on the diurnal decline or mean diurnal cortisol.  This 
was expected given the steady decline in cortisol levels over the day.  This is 
consistent with another study, which showed that delays in random spot 
samples collected over the day did not result in misleading diurnal cortisol 
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measures (Jacobs et al., 2005).  However, other studies have shown that the 
diurnal decline was flatter when sampling was delayed but the diurnal decline 
was anchored from the CAR, which was flat due to delays (>10-15 min) in the 
post-awakening period (Broderick et al., 2004; Kudielka et al., 2003).  It is a 
convenient finding that non-adherence is not an issue for diurnal cortisol 
measures and may help explain why more consistent relationships with the 
diurnal cortisol profile and psychosocial variables have been found compared 
with  the CAR.  In this study the diurnal cortisol profile was calculated as the 
simple measure of decline from 3 to 12 hr post-awakening.  Additional samples 
points (i.e. 6, and 9 hrs post-awakening) provide the best measure of the diurnal 
cortisol profile.  It cannot be determined from this study that delay in collection 
of saliva samples for these times would result in misleading measurements of 
diurnal cortisol profile measured with all these samples. 
 
8.1.1 Measurement of cortisol in hair samples  
 
Cortisol in hair samples is a relatively new area of research.  It is important to 
examine how HCC relates to previously published studies.  In study III, two 
distinct age groups were recruited, a young and old group, HCC differed among 
these groups.  HCC was examined for the young women in comparison to a 
published study.  In study III the sample were young healthy female students, 
and HCC was examined in relation to healthy young adults.  The comparison 
sample were mostly university students (i.e. similar age range), utilised the 
same inclusion criteria and laboratory for determining HCC (see Stalder, 
Steudte, Alexander, et al., 2012), making it an appropriate comparison.  Table 
8.2 presents the HCC for the three samples.  HCC obtained in study III of this 
thesis were generally higher than HCC obtained in the study of Stalder, Steudte, 
Alexander, et al. (2012).  This may be due to differences in time of year of 
sampling between the two studies.  The students in the study III of this thesis 
provide their hair samples during the first three months of university, reflecting 
the summer and autumn period.  Although in this study the authors did not 
specify the time of year the study took place (Stalder, Steudte, Alexander, et al., 
2012) it may be that samples were collected following a more intensive period 
of the academic year. 
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Table 8.2 HCC values for two samples of young healthy adults  
 
Sample of students  Hair cortisol in pg/mg  
M (SD)  
Study III of this thesis 27.5 (12.3) 
Stalder, Steudte, Alexander et al. (2012) 20.0 (11.6) 
  
 
In study III, two distinct age groups of females were recruited, and differences in 
HCC were found in line with previous research.  For example, Dettenborn, 
Tietze et al. (2012) found higher HCC in older individuals.  This suggests that 
studies with samples with a wide age range need to consider differences in 
HCC with age.  In line with previous findings (Dettenborn, Tietze, et al., 2012; 
Stalder, Steudte, Alexander, et al., 2012) smoking status, medication intake, 
hair colour, hair treatments had no influence on HCC.  
 
8.1.2 Measurement of well-being and ill-being   
 
In Study I (Experiment II) and III, measures of self-reported trait well-being or ill-
being were obtained.  Factor analysis showed that ill-being and well-being were 
inversely correlated but were indeed separate components.  This provides 
support for the ‘independence’ hypothesis and further supports the argument of 
measuring ill-being alongside well-being in order to test if well-being is uniquely 
related to cortisol measures.  The factor analysis did not reveal separate 
aspects of subjective or psychological well-being.  The subjective and 
psychological measures included in both studies loaded on the same 
component in the factor analysis of Study I (Experiment II) and Study III.  These 
findings suggest that subjective and psychological well-being were not distinct 
aspects of well-being.  Accordingly the well-being or ill-being measures were 
explored in relation to the cortisol measures obtained in this thesis.  
 
To assess day-to-day variations in positive and negative mood in Study I: 
(Experiment II), the EMA method was used.  This method was chosen since it is 
regarded as the gold standard for measurement of mood in natural settings, 
since questionnaire measures may be influenced by retrospective biases, 
availability heuristics and other factors (Kahneman & Krueger, 2006).  Further, 
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more robust associations between well-being and biology have previously been 
found when affect is assessed repeatedly in everyday life with the EMA method 
than with questionnaire measures (Steptoe et al., 2007).  Typically EMA ratings 
are completed using pen-pencil diaries. In Study I (Experiment II) electronic 
mood ratings were obtained to ensure participants were compliant and mood 
ratings were completed in real time.  Using the actiwatch-score device, 
participants were signalled at random times between 10:00 and 21:00, to 
complete eight positive and negative mood ratings.  Previously, electronic EMA 
ratings using the actiwatch-score device have been shown to be successful in 
assessing fatigue.  For instance, using the actiwatch-score device participants 
completed 87% of responses.  In Study I (Experiment II) the response rate was 
slightly lower, 73% of participants completed the eight mood ratings at least four 
times on each study day.  This lower response rate may be explained by the 
demand placed on participants; participants were required to complete eight 
mood ratings five times a day.  In the study assessing fatigue, participants were 
only required to complete one item three times over the day.  Considering the 
increased demand placed participants in Study I (Experiment II) the response 
rate for the EMA mood ratings were relatively high.  
 
8.2 Cortisol measures: relationships with well-being/ill-being  
 
In Study I (Experiment II) and Study III associations between the cortisol 
measures and well-being or ill-being were investigated.  In Study I (Experiment 
II) salivary cortisol enabled measurement of the CAR and diurnal cortisol profile.  
It has been discussed throughout this thesis, the importance of adherence to 
the saliva sampling protocol.  Given the misleading CAR estimates obtained 
from including non-adherent data, analyses involving the CAR were conducted 
on data in which long delays between awakening and collection of S1 were 
excluded (i.e. > 15 min), and moderate delays (5-15 min) were controlled for 
statistically.  Although non-adherence did not have an impact on the diurnal 
cortisol profile or mean diurnal cortisol, to ensure accuracy, analyses were also 
conducted controlling for delayed sampling for S5 and S6.   
 
In healthy young females, no relationships with the CAR and well-being or ill-
being were evident.  This is consistent with previous studies, which also failed 
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to observe relationships between well-being and the CAR in older individuals 
(Evans et al., 2007; Steptoe et al., 2008).  However, it contrasts with others who 
found a smaller CAR associated with higher levels of happiness in middle-aged 
males (Steptoe et al., 2007).  The difference in findings may be attributed to the 
age and gender of the sample.  Neither were there any associations between 
the diurnal profile of cortisol or mean diurnal cortisol and well-being or ill-being 
observed.  Again this contrast with previous research showing associations 
between higher levels of trait well-being and a stepper decline in cortisol across 
the day (Evans et al., 2007; Ryff et al., 2004) and associations between higher 
levels of happiness and lower cortisol across the day (Steptoe & Wardle, 2005; 
Steptoe et al., 2005).  Differences in findings may be attributed to the different 
methodologies applied between studies.  Findings are consistent with Jacobs et 
al. (2007) who also did not observe an associations between well-being and 
lower cortisol in younger healthy females.  It is likely that the relationship 
between cortisol and well-being is not evident in young healthy individuals.   
 
Females in this study were recruited based on their levels of trait well-being or 
ill-being.  This was necessary to increase the statistical power of the study given 
the large amount of data collected per participant.  Although the high well-being 
and low well-being participants recruited onto the study exhibited significantly 
different levels of well-being and ill-being, there was little range and variation of 
state well-being and ill-being.  The recruitment of participants exhibiting low 
levels of well-being was difficult since they were likely to be taking medication or 
have received a diagnosed illness and due the influence of medications on 
salivary cortisol they were not recruited onto the study.  Participants who were 
taking medication may have been exhibiting significantly lower levels of well-
being or higher levels of ill-being, and state well-being may have been more 
varied in these individuals.  It cannot be ruled out that diurnal cortisol patterns 
may have been associated with well-being or ill-being in participants exhibiting 
more variation in well-being or ill-being over the four study days.   
 
To directly test the hypothesis that associations between well-being and cortisol 
are not evident in healthy young females, associations were compared in young 
and old participants (Study III).  There are clear advantages of measurement of 
cortisol in saliva, one of which is the repeated saliva sampling in the domestic 
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setting enabling measurement of the diurnal pattern of cortisol in participant’s 
natural settings conferring high ecological validity.  However, the issue of 
participant non-adherence to protocol presents a major problem in this line of 
research.  Given the cost and complexity of monitoring adherence to the saliva 
protocol, the new measure of cortisol in hair samples presented an appropriate 
alternative to salivary cortisol.  It provided a trait measure of cortisol secretion 
with a one-off hair sample.  Although it provides a trait measure of cortisol and 
does not provide information of the diurnal cortisol patterns it is a good starting 
point for comparing associations between well-being and cortisol in young and 
old females.  In line with Study I (Experiment II) HCC was not associated with 
well-being or ill-being in the young healthy female sample.  But in the older 
group well-being was associated with higher HCC, however ill-being was not 
associated with HCC in this group.  Recruitment of females in study III was less 
strict than the criteria applied to Study I, only individuals that suffered from any 
condition of adrenocortical dysfunction and/or took any glucocorticoid-
containing medication were excluded.  Further, given the ease of measuring 
cortisol in hair sample, a larger sample was recruited which meant selection of 
high and low well-being was not necessary.  However, the difficulty in terms of 
recruitment in this study was the recruitment of older participants resulting in the 
smaller number of participants in this age group.   
 
These findings provide evidence that within a healthy female population 
associations between well-being and cortisol are evident only in older females 
and not young females.  Together these findings provide support for the 
neurotoxicity hypothesis from a positive aspect.  In a healthy population without 
any psychopathology the effects of well-being may not exert their effects on the 
HPA axis until later in adulthood.  Ill-being and aberrant cortisol profiles have 
been found in younger adults this could be explained by the interacting 
vulnerability hypothesis (see Lupien et al., 2009) which suggests that in 
vulnerable individuals (e.g. insecure attachment styles and/or exposure to early 
life stress) the HPA-axis is programmed during childhood to make it more 
vulnerable to dysregulation.  In vulnerable individuals dysfunction of the HPA-
axis may precede and predict later psychopathology (e.g. ill-being, low well-
being aberrant cortisol profiles).  Measures of vulnerability (such as attachment 
style and life events) may tease out vulnerable individuals and different 
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associations between ill-being or well-being and cortisol measures may be 
observed to those reported here.  
 
These findings are based on all female adults and results may not generalise to 
male adults.  Gender differences are evident in diurnal cortisol patterns, and 
thus an all female sample was deemed necessary since within a modest sized 
sample comparisons between males and females would not have been possible. 
The finding that higher levels of well-being were associated with higher HCC 
adds to the growing body of literature showing gender differences between 
cortisol patterns and associations with ill-being or well-being measures 
(Bremmer et al., 2007; Kumari et al., 2010; Witteveen et al., 2010).  Previous 
reports of hyper-cortisolism and well-being are evident for females, whereas 
males show the opposite (Roe et al., 2013). Such gender differences in the 
cortisol secretory patterns may account for some of the variation in findings in 
the literature, as such future studies should account for gender differences 
either by having a large enough sample to make comparisons between gender 
or restrict sample to one gender so that a greater understanding of the cortisol 
secretory activity in relations to psychosocial variables can be gained.  It is an 
interesting finding that higher cortisol secretion is associated with well-being.  It 
is possible that in healthy females higher cortisol secretion is indicative of being 
busier and energised.  Table 8.3 provides a summary of the strengths and 
novelty of the programme of research  
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Table 8.3 A summary of the strengths and novelty of the programme of 
research  
 
Encouraging 
adherence to 
saliva sampling 
protocol  
- One of the first studies to use electronic devices to 
measure both awakening and saliva sampling times 
and not simply rely on self-reports.   
- The real sampling times identified non-adherent data, 
which was accounted for in analyses involving diurnal 
cortisol patterns and psychosocial variables.  
- Self-reports of awakening were inaccurate and 
resulted in delayed collection of the first ‘awakening’ 
sample  
- Informing participants that their saliva sampling times 
will be verified by an electronic device increased 
participants accuracy in their self-reports  
- Prompts (via text messages) were provided to 
participants to remind them to collect the day saliva 
samples, prepare for their upcoming study day and 
wear actiwatch-score to bed the night prior to study 
day  
 
Measurement of 
the diurnal 
cortisol patterns 
(CAR and diurnal 
decline)  
- Saliva sampling was synchronised to awakening and 
not clock time  
- The CAR was measured in saliva samples at 0, 15, 
30 and 45 min post-awakening providing optimal 
assessment of the CAR on each study day  
- Diurnal decline was measured as the decline from 3 
hr to 12 hour post-awakening and did not include the 
CAR period  
- Measurement of diurnal cortisol patterns was on four 
study days which allowed for statistical analyses of 
state as well as trait variation  
 
Electronically 
determined non-
adherence and 
the CAR  
- Challenges the assumption that delay between 
awakening and collection of S1 less than 10-15 min 
are acceptable to obtain accurate measures of the 
CAR magnitude  
- Confirmed the prediction that delays between 
awakening and collection of S1 of just 8 min (5-15 
min) do not impact on ‘awakening’ cortisol levels, but 
they do result in overestimated CAR magnitude and 
earlier timing of the peak in cortisol  
- First study to investigate impact of sampling delay on 
the timing of the CAR peak, and growing interest in 
timing of CAR peak is evident 
 
CAR time lag   - First study to measure salivary cortisol intensively in 
the immediate post-awakening period (i.e. every 5 
min for the first 30 min following awakening)  
- First study to show that cortisol does not rise linearly 
immediately after awakening.  Increase in cortisol is 
observed 15 minutes following awakening  
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Non-adherence 
and diurnal 
cortisol 
measures 
- First study to measure diurnal decline or mean 
diurnal cortisol measured at 3 and 12 hours post-
awakening and show it was not influenced by delay 
in collecting samples 
 
  
Expands well-
being research  
 
- Traditionally the focus of psychology research has 
been on ill-being.  This work attempts to understand 
how well-being exerts its effects on good health 
- Ill-being and well-being were independent 
components, highlights the need for investigating ill-
being along well-being 
- Pays particular attention to the definition of well-being 
– assesses both subjective and psychological 
aspects of well-being, which have been shown to be 
related differently to physiological functions (but not 
in this work) 
 
Measurement of 
well-being  
- Measures trait and state well-being or ill-being.  Most 
studies focus on trait measures of well-being failing 
to assess the day-to-day variations in mood, which 
may be more strongly related with diurnal cortisol 
patterns  
- EMA method used to assess state well-being, uses 
electronic devices to ensure that participants 
complete mood ratings at the desired times and not 
retrospectively  
 
Trait measure of 
cortisol  
 
- Utilised a new measure of cortisol, HCC provided a 
retrospective assessment of cortisol secretion 
- Previous studies have failed to link HCC with 
psychosocial measures, such as, stress, anxiety and 
depression.  First study to observe relationships 
between HCC and measures of well-being but not ill-
being 
 
Cortisol patterns 
and well-being 
across the life 
span  
- Relationships between diurnal patterns of cortisol 
and well-being in healthy participants are evident at 
later points in life (i.e. older age).  But does not 
extend to younger healthy females.  
- Support for neurotoxicity hypothesis from a positive 
aspect (i.e. the effects of well-being are not evident 
until later in life)  
 
Statistical 
analysis  
- Instead of using traditional approaches (i.e. general 
linear model), the new approach of mixed regression 
analysis was used, which is the method deemed 
most appropriate for multiple repeated measures 
over time.   
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8.3 Future directions  
 
The focus of this work has been upon reliable measurement of cortisol and 
relationships with trait psychosocial variables and daily variations in positive and 
negative mood in a healthy female sample.  Future research on diurnal patterns 
of cortisol needs to consider the methodological issues raised in this thesis and 
adopt similar methodological rigor.  The importance of participant adherence to 
protocol has been emphasised.  Thorough briefing of the protocol, emphasising 
the importance of participant adherence is not enough for accurate 
measurement of the CAR.  Accurate measurement of the CAR requires 
accurate awakening cortisol levels at S1.  Self-reported awakening times are 
inaccurate which may not be through fault of the participant but due to them 
being in a state of sleep inertia.  More objective measures of awakening can 
easily be obtained using electronic devices such as actigraph, which can be 
worn on the wrist with relatively no discomfort.  Self-reports alone will not 
identify moderate but significant delays between awakening and collection of S1.  
 
Informing participants that their adherence to the protocol is being electronically 
monitored increases their adherence to the saliva sampling protocol.  In Study I, 
(Experiment I) although participants delayed collecting the first ‘awakening’ 
sample it was proposed not to be intentional since participants collected the 
remaining samples within the desired interval time (and sampling time was 
synchronised to their inaccurate sampling time).  Thus in terms of collecting 
their samples from the time that participants were awake on the whole 
participants did this correctly.  The finding that saliva sampling times were 
accurate should be interpreted cautiously.  The sample was comprised of 
undergraduate students who were receiving credits from their participation and 
so may have been motivated to be honest regarding their self-reported 
adherence to protocol.  However, this is unlikely to be the case since financial 
incentives have not be shown to increase participant adherence to the saliva 
sampling protocol (Halpern et al., 2012).  Also, this was a sample of young 
females; it is necessary to investigate if accuracy of self-reports is evident in a 
male sample or older adults.  It is the recommendation here that, wherever 
possible saliva sampling times should be electronically monitored with 
awakening times since using these devices together will provide real sampling 
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times.  If cost is an issue, at the very least if electronic devices such as track 
caps are not available dummy devices should be used and participants should 
be informed that their sampling times are being monitored electronically.  
 
It may be conceived at first that CAR research is more difficult with the finding 
that moderate delays between awakening and collection of S1, however, it is 
the recommendation of this work that real sampling times (obtained with 
electronically determined awakening and saliva sampling times) can be used to 
adjust data involving the CAR and not waste the data.  Analyses involving 
timing of the CAR peak can map the actual timing to participants real sampling 
times and calculation of the CAR magnitude can be conducted using real 
sampling times rather than the protocol desired times.  
 
Although participant non-adherence is not a problem for the analysis of hair 
cortisol, this area of research is relatively new.  Studies in this thesis have 
demonstrated how sensitive the CAR is to non-adherence, which has only 
recently been considered despite the extensive research on the CAR.  This 
highlights how important it is to understand the measure being used. 
Methodological considerations should continue to be explored with regards to 
HCC as it is possible that there may be variables that distort results from HCC.  
One such variable could be the assumed time line of cortisol based on the 
average growth of hair. Currently 1-cm of hair is assumed to equate to one 
month cortisol secretion.  However, it could be possible that variations in hair 
growth could influence HCC.  Thus, future research should investigate how 
different factors influence HCC before providing a body research of associations 
between HCC and psychosocial variables that may be meaningless and limited 
by inconsistent and conflicting findings as is the case with the CAR literature.  
 
The causal pathways between well-being and health cannot be determined from 
day-to-day or cross-sectional studies.  It is crucial to understand the pathways 
mediating these associations, so as to formulate better methods of reducing 
morbidity and enhancing the well-being and sustained productivity of the nation.  
It is possible that the effects of well-being on health work through stimulating 
healthy cortisol patterns and if these persist in the long-term it will result in 
favorable health outcomes.  However, it is also possible that cortisol patterns 
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could influence mood.  For example, medications that reduce cortisol may lead 
to improvements in mood, although the evidence is very inconsistent (Gallagher 
et al., 2008).  The causal pathways can be best untangled through manipulating 
mood through intervention studies.  Although our happiness is determined in 
part by genetic and developmental factors, and in part by life circumstances, 
there is growing evidence that intentional activities and cognitions also 
contribute (Lyubomirsky et al., 2005).  A growing body of evidence 
demonstrates the effectiveness of positive psychological interventions in 
enhancing individual’s mood (Seligman et al., 2005).  Intervention studies in 
which well-being is enhanced by deliberate actions could determine the effects 
on cortisol.  Future research will need to determine if the techniques for 
enhancing well-being has beneficial effects on cortisol.  Comparisons between 
young and older groups are only the first step to investigating the associations 
between well-being and cortisol over the lifespan, longitudinal studies are 
needed to determine this over the life span.  Longitudinal evidence for the 
effects of well-being on health are evident but longitudinal investigation of the 
physiological pathways mediating this relationship across the life span is 
needed.  This is an exciting field of research that offers promise both in the 
understanding of connections between the mind and body, and for the relief of 
suffering and the postponement of ill health.  
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Appendices 
Appendix 1 
Information sheet and consent form for Study I (Phase I): online questionnaire 
 
 
 
 
The ‘happi’ Study 
Health and Positive Psychological Interventions 
Participant information sheet 
 
What is the study about?  
 
This study explores the relationship between health, attachment styles and well-
being, looking at how our attachment styles relate to our well-being and the way 
well-being relates to our health. We believe that secure attachment styles are 
related to positive well-being and positive well-being is associated with good 
health, while more negative emotional states may contribute to ill-health. 
 
What will happen during the study?  
 
This study involves completing an online questionnaire about yourself, your 
well-being and your health, which should take approximately 30 minutes to 
complete.  
 
Who can take part? 
 
This study is being carried out with full- and part-time students; if you have 
access to a computer (public or private) with internet connection you can take 
part.  
 
What if I change my mind during the study? 
 
You have the right to withdraw from the study at any time, including withdrawing 
your data prior to publication, without explanation. 
 
What happens to the information? 
 
Any information you give will be treated in the strictest confidence and used 
only for this study. All information you provide will be stored in such a manner 
that no specific details will be linked to individuals. Although we will not be able 
to give feedback on individual data, we will provide all participants with a 
summary of the overall findings.  
 
 
 
Please Copy and paste this information so that you can either 
print or save it so you can refer to it if you need to. 
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Part II: Consent:  
 
Please select when you have read the above information.  By selecting this box 
you are confirming that you understand the study and that you agree to 
participate in it. 
 
 
Do you agree to take part in the study?  
 
Yes  
 
 
 
Please do not hesitate to contact Nina Smyth if you have any 
questions or problems 
 
020 7911 5000 ext. 2184 or nina.smyth@my.westminster.ac.uk
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Appendix 2:   
Information sheet and consent form for Study I (Phase II): salivary cortisol & mood 
phase  
 
   
 
 
The ‘happi’ Study:  
Health and Positive Psychological Interventions 
Participant information sheet 
 
Part I: Study Overview:  
 
What is the study about?  
 
This study explores the association between low and high wellbeing and cortisol. 
Cortisol is known as a stress hormone, as it is produced in response to psychological 
stress. It is also essential for normal physiological functioning. It has a marked 
24hour rhythm, with peak levels about 45 minutes following awakening and low 
levels in the early part of sleep. Abnormal cortisol rhythms have been implicated in 
psychological (e.g. depression) and physical ill health. Cortisol is also thought to play 
a role in the association between well-being and good health. The study is part of a 
PhD being undertaken by Nina Smyth at the University of Westminster, Psychology 
Department.  The main supervisor is Professor Angela Clow. 
 
What will happen during the study?  
 
The hormone cortisol can be measured in saliva. The study requires you to take 
saliva samples every 15 minutes for the first 45mins after awakening and samples at 
approximately 3 and 12 hours after awakening on each study day. You will be 
required to rate your mood throughout each study day. Additionally, you will also 
complete an evening and morning diary about your anticipations, sleep and saliva 
sampling times.  You will also be asked to wear a watch to bed which will record your 
awakening time.  To monitor saliva sampling times, the cotton swabs used on saliva 
sampling will be stored in an electronic cap, each opening of the cap will indicate the 
time you collected the sample. 
 
You will be provided with detailed instructions (verbal and written) on the research 
procedure, saliva sampling packs for each study day and the study equipment.  You 
will be able to ask as many questions as you like and contact the researcher with 
problems if and when they arise throughout the process of the study. 
 
 
Who can take part? 
 
Full- or part-time students that participated in the online ‘happi’ questionnaire. 
Students must be healthy, not suffering from any serious medical or psychiatric 
illness or taking prescribed medication.  
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What if I change my mind during the study? 
 
You have the right to withdraw from the study at any time, including withdrawing your 
data without explanation. 
 
What happens to the information? 
 
Any information you give will be treated in the strictest confidence and used only for 
this study. All information you provide will be stored in such a manner so that no 
specific details will be linked to individuals. Your saliva will only be tested for the 
hormone cortisol. Although we will not be able to give feedback on individual data, 
we will provide all participants with a summary of the overall findings. 
 
 
 
 
Please do not hesitate to contact Nina Smyth if you have any 
questions or problems 
 
020 7911 5000 ext. 2184 or nina.smyth@my.westminster.ac.uk  
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Part II: Consent:  
 
 Please circle  
Have you read the information sheet about this study?  
YES / NO 
Have you had the opportunity to ask questions, and 
received satisfactory answers to your questions? 
 
YES / NO 
Have you received enough information about the study?  
YES / NO 
Do you agree to your saliva being tested for the hormone 
cortisol? 
 
YES / NO 
Do you understand that you are free to withdraw from the 
study at any time, without giving a reason for withdrawal?  
 
YES / NO 
Do you agree with the publication of the results of this 
study in appropriate outlets? 
 
YES / NO 
Do you agree to take part in the study?  
YES / NO 
Do you agree to be contacted about future research?  
YES / NO 
 
 
 Print name  Signature  Date 
Participant   
 
 
  
Researcher  
 
 
  
 
 
Please provide your contact details; this will be stored separately from any 
data you provide so that your responses remain anonymous  
 
 
ID (student / staff)   
Name   
Tel   
Email   
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Appendix 3: 
Information sheet and consent form for Study II  
 
 
 
 
 
 
 
Part I: Study Overview:  
 
What is the study about?  
 
This study is investigating cortisol secretion within the first 30 min of awakening.  In 
healthy individuals cortisol exhibits a marked circadian rhythm characterised by peak 
levels following morning awakening (known as the cortisol awakening response: 
CAR) and declining levels thereafter, reaching lowest levels in early sleep.  We 
assume that cortisol arises immediately on awakening, however, this has not been 
directly tested, thus the aim of the study aimed to explore this. The study is part of a 
PhD being undertaken by Nina Smyth at the University of Westminster, Psychology 
Department.  The main supervisor is Professor Angela Clow. 
 
What will happen during the study?  
 
The hormone cortisol can be measured in saliva. The study requires you to collect 
saliva samples every 5 minutes for the first 30 mins after awakening.  Additionally, 
you will also complete a diary recoding your awakening and saliva sampling times.  
You will also be asked to wear a watch to bed which will record your awakening time.  
To monitor saliva sampling times, the cotton swabs used on saliva sampling will be 
stored in an electronic cap, each opening of the cap will indicate the time you 
collected the sample.  You will be provided with detailed instructions on the research 
procedure, saliva sampling packs for each study day and the study equipment.  You 
will be able to ask as many questions as you like and contact the researcher with 
problems if and when they arise throughout the process of the study. 
 
Who can take part? 
 
Male or female adults who are healthy, not suffering from any serious medical or 
psychiatric illness or taking prescribed medication.  
 
What if I change my mind during the study? 
 
You have the right to withdraw from the study at any time, including withdrawing your 
data without explanation. 
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What happens to the information? 
 
Any information you give will be treated in the strictest confidence and used only for 
this study. All information you provide will be stored in such a manner so that no 
specific details will be linked to individuals. Your saliva will only be tested for the 
hormone cortisol. Although we will not be able to give feedback on individual data, 
we will provide all participants with a summary of the overall findings. 
 
Please do not hesitate to contact Nina Smyth if you have any 
questions or problems: 020 7911 5000 ext. 2184 or 
nina.smyth@my.westminster.ac.uk 
 
 
 
194 
 
Part II: Consent:  
 
 Please circle  
Have you read the information sheet about this study?  
YES / NO 
Have you had the opportunity to ask questions, and 
received satisfactory answers to your questions? 
 
YES / NO 
Have you received enough information about the study?  
YES / NO 
Do you agree to your saliva being tested for the hormone 
cortisol 
 
YES / NO 
Do you understand that you are free to withdraw from the 
study at any time, without giving a reason for withdrawal?  
 
YES / NO 
Do you agree with the publication of the results of this 
study in appropriate outlets? 
 
YES / NO 
Do you agree to take part in the study?  
YES / NO 
Do you agree to be contacted about future research?  
YES / NO 
 
 
 Print name  Signature  Date 
Participant   
 
 
  
Researcher  
 
 
  
 
 
Please provide your contact details; this will be stored separately from any 
data you provide so that your responses remain anonymous  
 
 
ID (student / staff)   
Name   
Tel   
Email   
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Appendix 4:  
Information sheet and consent form for Study III 
 
 
 
 
 
ROOTS OF STRESS:  
 
Hair cortisol concentrations in relation to age, stress and genotype. 
 
PARTICIPANT INFORMATION SHEET  
 
Part I: Study Overview:  
 
What is the study about?  
 
Cortisol is a stress hormone - it is produced in response to stressful situations, 
however, it is also essential for normal functioning. Aberrant levels of cortisol have 
been implicated in poorer physical and mental health (e.g. cardiovascular disease, 
depression) particularly in older people. In this study we will explore the relationship 
between current as well as early life stress and cortisol levels.   We are interested in 
this because research indicates that early life stress, as well as recent life stress, 
may be an important determinant of well-being.  Another important role is genetics; 
research shows that genes and environment interact to predict vulnerability to the 
effects of stress.  Brain-derived neurotropic factor (BDNF) is an important brain 
chemical.  Its role is to promote brain health and it is known as a ‘nerve growth 
factor’.  Genes influence the levels of BDNF in the brain and depending upon your 
BDNF genetic makeup life stress may have different effects throughout life. The 
study will explore the relationships between the BDNF genotype and environmental 
stress across the lifespan.  It is part of a PhD being undertaken by Nina Smyth at the 
University of Westminster, Psychology Department.  The main supervisor is 
Professor Angela Clow. 
 
What will happen during the study?  
 
The hormone cortisol and the BDNF-gene can be measured in hair samples. We will 
collect a small piece of hair from as close as possible to your scalp. The required 
amount of hair is quite small (see picture below), which is cut from the posterior 
region of your scalp, without leaving a trace. We will also ask you to provide 
information on yourself (i.e. birth weight, age etc) hair characteristics, your current 
well-being/ill-being and your experience of early life stress this should take 
approximately 30 minutes to complete. 
 
You will be provided with detailed instructions (verbal and written) on the research 
procedure.  You will be able to ask any questions you have about this research and 
you can contact the researcher with problems if and when they arise. 
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Example of hair sampling process 
 
 
Who can take part? 
 
We are looking for females between 18 and 26 years of age and older women over 
65 years of age. Participants must be healthy, not suffering from any serious medical 
or psychiatric illness or taking prescribed medication containing corticosteroid during 
the last year. Also participants should not be pregnant or abuse drugs. 
 
What if I change my mind during the study? 
 
You have the right to withdraw from the study at any time, including withdrawing your 
data without explanation. 
 
What happens to the information? 
 
All of the data will be treated in the strictest confidence and will be stored in such a 
manner so that no specific details will be linked to you. Although we cannot give 
feedback on individual data, if you wish we can provide you with a summary of the 
overall findings. 
 
Please do not hesitate to contact Nina Smyth if you have any 
questions or problems 
020 7911 5000 ext. 2184 or rootsofstress@gmail.com  
 
 
 
197 
 
Part II: Consent:  
 
 Please circle 
Have you read the information sheet about this study?  YES / NO 
Have you had the opportunity to ask questions, and 
received satisfactory answers to your questions?  
YES / NO 
Have you received enough information about the study?  YES / NO 
Do you agree to your hair being tested for the hormone 
cortisol? 
YES / NO 
Do you agree to your hair being tested for the BDNF 
gene? 
YES / NO 
Do you understand that you are free to withdraw from the 
study at any time, without giving a reason for withdrawal?  
YES / NO 
Do you agree with the publication of the results of this 
study in appropriate outlets? 
YES / NO 
Do you agree to take part in the study?  YES / NO 
Do you agree to be contacted about future research? YES / NO 
 
 
Consent to store and use hair samples in future research.  
 
 Please circle  
I give permission for my hair sample to be stored after this 
research.  
YES / NO 
AND (if the sample is to be stored) 
I give my permission for my hair sample to be stored and 
used in future research of any type which has been 
properly approved  
YES / NO 
 
 
 Print name  Signature  Date 
Participant   
 
  
Researcher  
 
  
 
Please provide your contact details; this will be stored separately from any 
data you provide so that your responses remain anonymous  
Name   
Tel   
Email   
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Appendix 5  
Study advert for Study I (Phase I): online questionnaire  
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Appendix 6  
Study advert for Study I (Phase II): salivary cortisol and mood phase  
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Appendix 7:   
Study advert for Study III  
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Appendix 8:   
Article for Study III  
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Appendix 9:     
Letter to University of the third age 
 
Participant address  
 
 
 
 
Professor Angela Clow 
Department of Psychology  
University of Westminster 
309 Regent Street 
London W1B 2UW 
 
 
 
Dear ….............  
 
 
 
Thank you again for participating in the West Focus study at the University of 
Westminster. Your participation in this study was very valuable, directly leading to 4 
scientific publications as well as several conference presentations. The work has 
generated much interest in the scientific community and advanced understanding of 
the links between well-being and health in active aging.  Of course no single study 
can answer all the questions! As a result we are now seeking to explore the lifespan 
in more depth, investigating a wider range of age groups.  We are hoping that this 
new study may be of interest to you.  This time however we are seeking female 
volunteers only (sorry chaps!).  This is to simplify the study as males and females 
have been shown to have differing relationships between well-being and health.  So, 
in the first instance we are seeking to understand females and then return to study 
males at a later date. The study has been approved by ethics committee at the 
University of Westminster.  
 
 
 
The study involves measuring the hormone cortisol again but this time it is much 
easier to participate.  In the last study you kindly collected several saliva samples 
over the course of 2 days.  This time we want to measure cortisol in a single small   
sample of your hair.  The procedure requires cutting a small hair sample near the 
scalp at the back of the head and leaves no visible sign. This new technique   
provides a measure of cortisol secretion over several months (1-cm equates to 1 
months hair growth and cumulative cortisol secretion). The study would also involve 
you completing a questionnaire about your early life and your current well-being. 
Completion of the questionnaire would take approximately 20-30 minutes.  If you 
wish you can ask to your female friends and relatives if they would like to participate 
with you to the study.  
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Enclosed is some extra information on the research study for your interest. If you are 
interested in this study we would need you to come to the University of Westminster, 
located in central London, Regents Street (about 100 yards from Oxford Circus tube 
station). If you like you could come with a friend, who may also like to participate.  
 
 
 
We would offer you a £10 high-street voucher for your kind contribution. If you are 
interested in participating, or if you have any questions, curiosities or would like more 
information before deciding, please contact our research team: 
 
 
 
Nina Smyth or Matilde Bianchin by email rootsofstress@gmail.com or by 
telephone on 02079115000 Ext. 2184 or myself on clowa@wmin.ac.uk. 
 
 
 
Thank you for your time, and we look forward to hearing from you.  
 
 
Best Regards 
 
 
 
Professor Angela Clow 
Roots of stress research team.  
University of Westminster,  
Psychophysiology and Stress Research Team.  
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Appendix 10 
Study guidelines for Study I (Phase II)  
 
 
 
 
 
 
 
 STUDY SAMPLING 
GUIDELINES 
 
 
 
 
 
 
Project ID       
 
Date  / /  
 
 
 
If you have questions at any time,  
Please contact Nina Smyth on  
020 7911 5000 Ext. 2184 (business hours)  
07796177392 (out of hours)  
nina.smyth@my.westminster.ac.uk. 
 
200 
 
Study Overview:  
 
What is involved in the study:  
 
Over the course of the study week, you will collect saliva samples on four days: 
these include two weekdays (Tuesday and Wednesday) and the weekend 
(Saturday and Sunday). During these days you will collect six saliva samples 
throughout the day, these times will be based on your waking time.  
 
Throughout these study days you will be asked to rate your mood using the 
Actiwatch-Score.  
Additionally you will complete an evening diary the evenings prior to your study 
days plus the study days and a morning diary after your fourth cortisol sample. 
You will be sent an SMS message to your mobile phone reminding you to 
prepare for the study day and complete your evening diary. You will also be 
sent an SMS message during the morning to remind you to complete your 
morning diary.  
 
 
You will be given an Actiwatch-score which you’ll be required to wear the nights 
prior to your study days and during your study days. You will be given four 
cortisol packs; each pack will include six salivettes (labelled for each sampling 
day and time). You will also be provided with a MEMSCap bottle which will 
contain 24 cotton swabs. To prepare for your study days you should ensure that 
you are wearing the Actiwatch-score when you go to bed and place the salivette 
tubes and MEMSCap bottle next to your bed to ensure that you collect your 
morning sample as soon as you wake up. 
201 
 
Study protocol:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Day 1  Day 2  Day 3  Day 4  
- Study 
preparation 
- Complete 
evening 
diary  
- 6 saliva samples  
- Mood ratings  
- Morning & 
evening diary   
- 6 saliva 
samples  
- Mood ratings  
- Morning & 
evening diary   
- 6 saliva samples  
- Mood ratings  
- Morning & 
evening diary   
- 6 saliva 
samples  
- Mood ratings  
- Morning & 
evening diary   
- Return study 
equipment  
- Return study 
material 
(cortisol 
samples & 
diaries)    
START  
END  
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Saliva sampling instructions:  
 
Do not eat or drink, smoke, brush your teeth or exercise for 30 minutes before 
you collect each of the saliva samples. You can drink water only.  
 
Open the MEMSCap bottle and take one cotton swab, place the cotton swab in 
your mouth. Close the MEMSCap bottle.  
 
Gently chew on the swab until it is soaked, this will usually take about 2 minutes.   
 
Once the swab is soaked, place it back in the salivette tube (NOT the 
MEMSCap bottle), trying not to use your hands. Put the cap on securely, and 
place the tube in the plastic bag provided for that sampling day.  
 
Store the tube in a cold place or in a refrigerator.  
 
Placing the cotton swab in the salivette tube:  
 
DO: Place in the smaller inner tube  
 
DO NOT: don’t remove the smaller, inner tube and place the swab in the larger 
inner tube.  
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Cortisol Packs:  
 
You have 4 cortisol packs, one for each study day, it is very important that you 
put your cortisol tubes in the appropriate bags. The packs are colour coded:  
 
Day 1 (Tuesday) = Baby blue  
Day 2 (Wednesday) = Yellow  
Day 3 (Saturday) = Grey  
Day 4 (Sunday) = Green  
 
It is very important that you place the cotton tubes in the appropriate salivette 
tubes. Each tube is clearly labelled and is colour coded:  
 
Tube 1 (0 mins) = Purple  
Tube 2 (15 mins) = Green  
Tube 3 (30 mins) = Blue  
Tube 4 (45 mins) = Orange  
Tube 5 (3 hrs) = Pink  
Tube 6 (12 hrs) = Red  
 
MEMSCaps Bottles  
 
A total of 24 cotton swabs (total for the study week) are stored in the 
MEMSCaps bottle. Only open this bottle when you are collecting your saliva 
samples.  
 
Place the cotton swab in the salivette tube for that sampling time and day.  
 
DO NOT put it back in this bottle.  
 
These bottles record the times the bottle was opened, this will be used to check 
that you collected the saliva sample at the appropriate time.  
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Saliva cortisol sampling times:  
On each of the study days you will collect six saliva samples, the times depend 
on your waking time.  The first samples will be collected as soon as you wake, 
please do this STRAIGHT away, even if you are a little sleepy. Please do not 
dose back to sleep because you will need to complete your samples 15, 30, and 
45 minutes after you wake up. Then 3, & 12 hours after you wake up.  
 
This table gives you an overview of each of the saliva sampling times (left side) 
and gives you examples of calculating your sampling times based on your 
waking times (right side). Your sampling times will vary on weekdays and the 
weekend because you may get up later on the weekend, so please calculate 
the times based on your awakening.  
Sampling times  Examples of calculating your 
sampling times based on 
your waking times  
Sample 
No. 
Sample Time Instructions e.g. weekday 
sampling 
times  
e.g. 
weekend 
sampling 
times  
Sample 
1 
Awakening   This first sample 
should be collected 
as soon as you 
wake up and before 
you get out of bed. 
Even if you are still 
half asleep you 
should still take it.  
6.00 9.00 
Practice    
Sample 
2 
Waking plus 
15 minutes   
This second sample 
should be collected 
15 minutes after you 
have woken up.   
6.15 9.15 
Practice    
Sample 
3 
Waking plus 
30 minutes 
Take this sample 30 
minutes after your 
awakening sample.  
6.30 9.30 
Practice    
Sample 
4 
Waking plus 
45 minutes 
Take this sample 45 
minutes after your 
awakening sample.  
6.45 9.45 
Practice    
Sample 
5 
Waking plus 3 
hours  
Take this sample 3 
hours after your 
awakening sample.  
9.00 12.00 
Practice    
Sample 
6 
Waking plus 
12 hours  
Take this sample 12 
hours after your 
awakening sample.  
18.00 21.00 
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Mood ratings using the Actiwatch-Score:  
 
Do’s & don’ts:  
 
DO:  
Wear this watch whilst in bed (the watch records your activity which will indicate 
your sleep and waking times).  
Wear the watch throughout the day (the watch needs to be worn throughout the 
study days because you will be presented with five random prompts asking you 
to rate your mood. 
 
DO NOT:  
Wear the watch in the shower because it is not waterproof.  
 
Using the watch to rate your mood:  
 
Between the hours of 10 am and 9 pm you will be presented with five random 
prompts. These prompts will present you with a series of questions that are 
about your mood in the last hour.  
 
For each question a letter will appear on the screen this letter will symbolise a 
mood adjective, for each of these you should rate the extent to which you have 
experienced them in the last hour on a scale 1 (not at all) to 5 (very much).  
The mood adjectives will be presented in the following order and will be 
presented by the following letters.  
 
 
Pleased  P  
Stressed  S (this looks like a 5 on the screen)  
Down  d 
In control  C 
Happy  H 
Busy   b 
Frustrated  F 
Goal directed  g  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rate the extent have you 
felt the following in the 
last hour? 1 = not at all - 
5 very much  
P = Pleased  
S = Stressed  
d = Down  
C = In control  
H = Happy 
b = Busy   
F = Frustrated  
g = Goal directed  
 
 
Refer to these codes if you do 
not remember what each letter 
stands for  
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This screen will present you 
with each of the mood 
adjectives.  
Use this button to move between 
the mood ratings. Once you have 
the number that you want leave it 
for 5 seconds and the watch will 
record it and will present you with 
     
How to rate your mood using the watch:  
The watch will beep to prompt you to complete 
your mood ratings.  
Press the ○S on the watch, this will start the 
scale, starting with the number 1 
Press the○S  to move through the scale 
When the number that represents your mood 
appears on the screen wait for the Actiwatch-
score to record this number, this will take a few 
seconds.  
If you pass the number that you want, carry on 
pressing the ○S to take you through the 
numbers  
When the prompt is presented the watch will 
beep, it will only beep for about a minute or so, 
so please try and respond straight away 
otherwise that data will be missing. 
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Diaries:  
 
Morning Diary:  
 
The morning diary asks you to report your calculated and actual saliva sampling 
times for the morning and about your sleep and anticipations of the day ahead.   
You need to complete this on the mornings of the four study days (after the forth 
saliva sample). You will be reminded by an SMS message to complete this.  
 
Evening Diary: 
 
The evening diary asks you to report your calculated and actual saliva sampling 
times (fifth & sixth saliva samples) and about your anticipations of the following 
day.  
You need to complete the evening diary at the following times:  
  Type of questions to answer  
Preparation for study day 1 Monday 
           
Anticipations of the following 
day  
Study day 1  Tuesday Times of cortisol samples  
 Anticipations of the following 
day   
Study day 2  Wednesday   Times of cortisol samples  
Preparation for study day 3 Friday  Anticipations of the following 
day   
Study day 3  Saturday  Times of cortisol samples  
 Anticipations of the following 
day   
Study day 4  Sunday   Times of cortisol samples 
 
You will receive a text message reminding you to complete the evening diary.   
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Study days & Sampling times:  
 
The study will run for one week, your four sampling days are on a Tuesday  
(               ), Wednesday (               ), Saturday (               ), and Sunday 
(               ). On these days you will be required to collect salivary cortisol, rate 
your mood and complete the diaries. Apart from completing the evening diary 
the day before your study days (Monday and Friday) you do not need to collect 
saliva samples, rate your mood or complete the morning diary on the remaining 
days of the week. You will need to complete the evening diary the evenings 
prior to the first and third sampling day (you will be reminded to do so with an 
SMS message). On these evenings you will also need to make sure that you 
are wearing the Actiwatch-score and that your cortisol pack and MEMSCap 
bottle is placed by your bed.  
Study Days:  
This is an overview of what you will need to do throughout the study week:  
Type of Day   Date  What you need to do  
Preparation 
for study day 
1  
Monday (               )        
           
Complete evening diary  
Wear Actiwatch-Score to bed  
Place bottles & salivettes next to 
bed  
Study day 1  Tuesday (               ) 6 Cortisol samples  
Momentary mood ratings  
Morning diary  
Evening diary  
Study day 2  Wednesday (               ) 6 Cortisol samples  
Momentary mood ratings  
Morning diary  
Evening diary – only questions 
about saliva samples   
Preparation 
for study day 
3 
Friday (               ) Complete evening diary  
Wear Actiwatch-Score to bed  
Place bottles & salivettes next to 
bed 
Study day 3  Saturday (               ) 6 Cortisol samples  
Momentary mood ratings  
Morning diary  
Evening diary 
Study day 4  Sunday (               ) 6 Cortisol samples  
Momentary mood ratings  
Morning diary 
Evening diary – only questions 
about saliva samples   
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Returning your Saliva Samples, diaries & equipment  
 
At the end of the study week you will need to return your saliva samples, the 
study equipment and your diaries.  
 
These need to be returned to:  
Nina Smyth  
Regents St Campus  
Room 556 (upper 5th floor)  
020 7911 5000 ext. 2184  
nina.smyth@my.westminster.ac.uk 
 
A convenient time can be arranged to drop these back, it is very important that 
these are returned straight after the study so the equipment can be used for 
other participants  
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Thank you for taking the time to read the sampling guidelines. It is very 
important that you understand the instructions and are able to clearly follow the 
sampling instructions. 
 
The content of this guidebook has be covered thoroughly in the initial 
introductory meeting however, if you have any questions regarding the 
procedure of this research project, or need to clarify something, this guidebook 
will serve as a useful reminder of all necessary information to complete this 
study. 
 
However, should you have any additional questions not covered by the content 
of this guidebook, please do not hesitate to contact Nina Smyth on any of the 
following numbers:  
 
020 7911 5000 ext. 2184 
07796177392 (out of hours) 
 
Or by email: 
nina.smyth@my.westminster.ac.uk  
 
Alternatively pop into room 556 
 
Thank you very much for participating in 
this study! 
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Appendix 11 
Self report diary used by participants in Study I (phase II)  
 
 
Pre Study day 1: ............................... 
 
EVENING DIARY:  
Please complete this the evening before your first study day  
 
How busy do you expect tomorrow to be? 
 
1 = not at all busy – 5 = very busy.................................................. 
 
How do you feel about tomorrow? 
 
1 = very negative - 5 = very positive .............................................. 
 
 
Study Day 1:  .................................. 
 
MORNING DIARY:  
Please complete after your 45 minutes post-awakening sample 
 
 
What time did you wake up? ................... 
 
Please calculate your collection times and state the actual times that you 
collected your saliva samples. Please be honest as you can.  
 
Tube Collection 
time (post-
awakening)  
Calculated 
collection 
time  (24hr) 
Actual 
collection 
time (24hr)  
Problems 
with sampling  
1 Awake  0 min   
2 15 mins     
3 30 mins     
4 45 mins     
 
Your honesty is very important to us in analysing the data. Therefore, please 
state your actual collection times for each sample, even if it is different to the 
designated time, and answer the questions as accurately as possible.  
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What was the approximate time you went to sleep latest night? 
 
...................................(24 hr)  
 
How easy was it for you to determine the exact moment you woke up?  
 
1 = very difficult, 5 = very easy ....................................... 
 
How did you wake this morning? 
 
(please circle)  
Alarm clock / radio  
Somebody I asked to wake me                      
Noises  
Just woke 
 
Compared to usual, how was your quality of sleep last night? 
 
Much better than usual  
A bit better than usual  
Same as usual  
A bit worse than usual  
Much worse than usual 
 
How busy do you expect the day ahead to be? 
 
1 = not at all busy – 5 = very busy ...................................... 
 
How do you feel about the day ahead? 
 
1 = very negative - 5 = very positive ................................... 
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EVENING DIARY:  
Please complete after your 12 hours post-awakening sample 
 
Please calculate your collection times and state the actual times that you 
collected your saliva samples, please be honest as you can 
 
Tube Collection 
time (post-
awakening)  
Calculated 
collection 
time  (24hr) 
Actual 
collection 
time (24hr)  
Problems 
with sampling  
5 3 hr     
6 12 hr     
 
How busy do you expect tomorrow to be? 
 
1 = not at all busy – 5 = very busy.................................................. 
 
How do you feel about tomorrow? 
 
1 = very negative - 5 = very positive .............................................. 
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Study Day 2:  .................................. 
 
MORNING DIARY:  
Please complete after your 45 minutes post-awakening sample 
 
 
What time did you wake up? ................... 
 
Please calculate your collection times and state the actual times that you 
collected your saliva samples. Please be honest as you can.  
 
Tube Collection 
time (post-
awakening)  
Calculated 
collection 
time  (24hr) 
Actual 
collection 
time (24hr)  
Problems 
with sampling  
1 Awake  0 min   
2 15 mins     
3 30 mins     
4 45 mins     
 
Your honesty is very important to us in analysing the data. Therefore, please 
state your actual collection times for each sample, even if it is different to the 
designated time, and answer the questions as accurately as possible.  
 
What was the approximate time you went to sleep latest night? 
 
...................................(24 hr)  
 
How easy was it for you to determine the exact moment you woke up?  
 
1 = very difficult, 5 = very easy ....................................... 
 
How did you wake this morning? 
 
(please circle)  
Alarm clock / radio  
Somebody I asked to wake me                      
Noises  
Just woke 
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Compared to usual, how was your quality of sleep last night? 
 
Much better than usual  
A bit better than usual  
Same as usual  
A bit worse than usual  
Much worse than usual 
 
How busy do you expect the day ahead to be? 
 
1 = not at all busy – 5 = very busy ...................................... 
 
How do you feel about the day ahead? 
 
1 = very negative - 5 = very positive ................................... 
 
 
EVENING DIARY:  
Please complete after your 12 hours post-awakening sample 
 
Please calculate your collection times and state the actual times that you 
collected your saliva samples, please be honest as you can 
 
Tube Collection 
time (post-
awakening)  
Calculated 
collection 
time  (24hr) 
Actual 
collection 
time (24hr)  
Problems 
with sampling  
5 3 hr     
6 12 hr     
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Pre Study day 3: ............................... 
 
EVENING DIARY:  
Please complete this the evening before your third study day  
 
 
How busy do you expect tomorrow to be? 
 
1 = not at all busy – 5 = very busy.................................................. 
 
How do you feel about tomorrow? 
 
1 = very negative - 5 = very positive .............................................. 
 
 
 
Study Day 3:  .................................. 
 
 
MORNING DIARY:  
Please complete after your 45 minutes post-awakening sample 
 
 
What time did you wake up? ................... 
 
Please calculate your collection times and state the actual times that you 
collected your saliva samples. Please be honest as you can.  
 
Tube Collection 
time (post-
awakening)  
Calculated 
collection 
time  (24hr) 
Actual 
collection 
time (24hr)  
Problems 
with sampling  
1 Awake  0 min   
2 15 mins     
3 30 mins     
4 45 mins     
 
Your honesty is very important to us in analysing the data. Therefore, please 
state your actual collection times for each sample, even if it is different to the 
designated time, and answer the questions as accurately as possible.  
 
 
What was the approximate time you went to sleep latest night? 
 
 
217 
 
 
...................................(24 hr)  
 
How easy was it for you to determine the exact moment you woke up?  
 
1 = very difficult, 5 = very easy ....................................... 
 
How did you wake this morning? 
 
(please circle)  
Alarm clock / radio  
Somebody I asked to wake me                      
Noises  
Just woke 
 
Compared to usual, how was your quality of sleep last night? 
 
Much better than usual  
A bit better than usual  
Same as usual  
A bit worse than usual  
Much worse than usual 
 
How busy do you expect the day ahead to be? 
 
1 = not at all busy – 5 = very busy ...................................... 
 
How do you feel about the day ahead? 
 
1 = very negative - 5 = very positive ................................... 
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EVENING DIARY:  
Please complete after your 12 hours post-awakening sample 
 
Please calculate your collection times and state the actual times that you 
collected your saliva samples, please be honest as you can 
 
Tube Collection 
time (post-
awakening)  
Calculated 
collection 
time  (24hr) 
Actual 
collection 
time (24hr)  
Problems 
with sampling  
5 3 hr     
6 12 hr     
 
How busy do you expect tomorrow to be? 
 
1 = not at all busy – 5 = very busy.................................................. 
 
How do you feel about tomorrow? 
 
1 = very negative - 5 = very positive .............................................. 
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Day 4:  .................................. 
 
MORNING DIARY:  
Please complete after your 45 minutes post-awakening sample 
 
 
What time did you wake up? ................... 
 
Please calculate your collection times and state the actual times that you 
collected your saliva samples. Please be honest as you can.  
 
Tube Collection 
time (post-
awakening)  
Calculated 
collection 
time  (24hr) 
Actual 
collection 
time (24hr)  
Problems 
with sampling  
1 Awake  0 min   
2 15 mins     
3 30 mins     
4 45 mins     
 
Your honesty is very important to us in analysing the data. Therefore, please 
state your actual collection times for each sample, even if it is different to the 
designated time, and answer the questions as accurately as possible.  
 
What was the approximate time you went to sleep latest night? 
 
...................................(24 hr)  
 
How easy was it for you to determine the exact moment you woke up?  
 
1 = very difficult, 5 = very easy ....................................... 
 
How did you wake this morning? 
 
(please circle)  
Alarm clock / radio  
Somebody I asked to wake me                      
Noises  
Just woke 
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Compared to usual, how was your quality of sleep last night? 
 
Much better than usual  
A bit better than usual  
Same as usual  
A bit worse than usual  
Much worse than usual 
 
How busy do you expect the day ahead to be? 
 
1 = not at all busy – 5 = very busy ...................................... 
 
How do you feel about the day ahead? 
 
1 = very negative - 5 = very positive ................................... 
 
 
EVENING DIARY:  
Please complete after your 12 hours post-awakening sample 
 
Please calculate your collection times and state the actual times that you 
collected your saliva samples, please be honest as you can 
 
Tube Collection 
time (post-
awakening)  
Calculated 
collection 
time  (24hr) 
Actual 
collection 
time (24hr)  
Problems 
with sampling  
5 3 hr     
6 12 hr     
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Appendix 12 
Self-reported diary used by participants in Study II 
 
 
Participants ID ………………………  
Date…………………………………… 
 
 
Recording Saliva Sampling Collection:  
 
What time did you wake up? ............................. 
What time did you go to bed? ............................. 
 
Tube  Sampling 
Time  
Calculated 
Collection 
time  
Actual 
collection time  
Any problems with 
sampling  
1 Awake  0 min    
 
2 5 mins     
 
3 10 mins     
 
4 15 mins     
 
5 20 mins     
 
6 25 mins     
 
7 30 mins     
 
8 35 mins     
 
9 40 mins     
 
10 45 mins     
 
11 60 mins     
 
 
Please describe how you are feeling this morning (i.e. how your sleep was 
last night, how awake/drowsy you are feeling, how easy it was to 
determine when you were awake)  
...............................................................................................................................
............................................................................................................................... 
Please describe what it feels like to participate in the study, and report 
any problems with the protocol.  
...............................................................................................................................
................................................................................................................................  
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Appendix 13 
Demographic questions  
 
This section has a series of questions that ask about you and your current 
situation.  
 
Participant/student ID: ……………………. 
 
 
How old are you? …………………………. 
 
 
What is your sex?     Male   
 Female  
 Do not wish to answer  
 
What is your marital status?  
 
 Currently married and living together, or living together in a marital-
like situation 
 Single  
 Separated/divorced/formerly lived with someone in a marital-like 
situation 
 Widowed 
 Do not wish to answer  
 
 
To which of these ethnic groups do you consider you belong? 
 
 
 
 
 
 
 
 White British  White and Black 
Caribbean 
 Indian 
 
 
 
White Irish  
 
 
 
White and Black 
African 
 
 
 
Pakistani 
 
 
 
Any other white 
background 
 
 
 
White and Asian 
 
 
 
Bangladeshi 
 
 
 
Caribbean 
 
 
 
Any other Mixed 
background 
 
 
 
Any other Asian 
background 
 African  Chinese  Any other 
 
 
 
 
Any other Black 
background 
 
 
 
 
Do not wish to answer  
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What is your student status?  Full-time    
 Part-time 
 Do not wish to answer  
 
 
Are you in paid employment?   Full-time    
 Part-time 
 Do not wish to answer  
 
 
What are your highest educational qualifications? Please select your highest 
qualification? 
 
 
 None  
 
Modern apprenticeship 
 CSEs or equivalent  
 
Diploma 
 GCSEs, O Levels, etc or 
equivalent 
 
 
Degree 
 A levels  
 
Postgraduate  (e.g. MBA, PhD) 
 HNC/HND  Other (please specify) 
 
 
 
 
 
GNVQ 
 Do not wish to answer  
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Imagine that this ladder pictures how society is set up. At the top of the ladder 
are the people who are best off – they have the most money, the highest 
amount of schooling, and the jobs that bring the most respect. At the bottom are 
people who are the worst off - they have the least money, little or no education, 
no job or jobs that no one wants or respects. Now think about your family. 
Please tell us where you think you would be on this ladder. What step of the 
ladder best represents where you would be on the ladder ……………………….. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
225 
 
Please specify your cigarette/tobacco smoking status 
 
 Current smoker 
 Occasional Smoker 
 Ex-smoker 
 Never smoked 
 Do not wish to answer 
 
 
Are you on any prescribed medication?   
 No    
 Yes (please specify)  
 Do not wish to answer  
 
 
 
In general, how would you say that your health has been in the past month?  
 
 Excellent  
 Very good  
 Good  
 Fair  
 Poor  
 Do not wish to answer  
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Appendix 14 
Hair characteristics  
 
Medication history    
List any prescribed 
medication  
 
 
Any corticosteroids 
medication in the 
last year?  
 Yes  
 No  
Any history of illicit 
Drug history in the 
last 6 months e.g. 
cannabis etc  
 No  
 Yes (please specify)  
………………………………………………………………… 
………………………………………………………………… 
………………………………………………………………… 
Illness history   
Any diagnosed 
illnesses 
 No  
 Yes (please specify)  
………………………………………………………………… 
………………………………………………………………… 
………………………………………………………………… 
Have you suffered 
from adrenocortical 
dysfunction in the 
last year? 
 No  
 Yes (please specify)  
………………………………………………………………… 
………………………………………………………………… 
………………………………………………………………… 
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Participant ID: ………………..Date of research Session: …………………. 
 
A FEW QUESTIONS ABOUT YOU  
 
 
A FEW 
QUESTIO
NS ABOUR YOUR HAIR 
 
What is your natural hair colour?   
…………………................................................................................................ 
 
Is your hair naturally (please tick)   curly  
  straight  
  wavy  
On average how many times a week do you wash your hair?  
 
…………………................................................................................................ 
Do you use colour or tint products to change the colour of your hair?  
Yes/No 
 
If yes, approximately when was last time you did this? ……………………… 
 
Is the colour or tint:  
 Permanent (e.g. peroxide)  
 Semi-permanent (e.g. (e.g. washes out typically in 4-5 shampoos)  
 Temporary (e.g. wash out typically after 1 shampoo)  
 
 
 
 
 
Age  …………………...... DOB …………………...... 
Pregnant  …………………......   
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Do you bleach your hair (e.g. paroxide)? 
 
If yes, when was last time you bleached your hair? ................................... 
If this is known, please specify the name and degree of lightning? 
……………………………………………………………………………………… 
Do you use any of the following hair treatments (please tick and specify how 
often)                           
 Hair drying  
…………………................................................................................................ 
 Hair straightening  
…………………................................................................................................ 
 Heated rollers  
…………………................................................................................................ 
 Hair growth stimulators  
…………………................................................................................................ 
 Hair products e.g. gel, spray etc  
…………………................................................................................................ 
 Other (please specify)  
…………………................................................................................................ 
 
Please specify any other hair treatments you have used in the last 6 months. 
  
…………………………………………………………………………………………… 
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Appendix 15 
Subjective Happiness Scale  
 
For each of the following statements and/or questions, please select the 
response that you feel is most appropriate in describing you.  
For each of the following statements and/or questions, please select the 
response that you feel is most appropriate in describing you.  
 
In general, I consider myself 
Not a 
very 
happy 
Person 
1 
 
 
2 
 
 
3 
 
 
4 
 
 
5 
 
 
6 
A very 
happy 
person 
7 
       
Compared to most of my peers, I consider myself 
Less 
happy 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
More 
happy  
7 
         
Some people are generally very happy. They enjoy life regardless of what 
is going on, getting the most out of everything. To what extent does this 
characterisation describe you? 
Not at 
all  
1 
 
2 
 
3 
 
4 
 
5 
 
6 
A great 
deal 
7 
         
Some people are generally not very happy. Although they are not 
depressed, they never seem as happy as they might be. To what extent 
does this characterisation describe you? 
Not at 
all  
1 
 
2 
 
3 
 
4 
 
5 
 
6 
A great 
deal  
7 
         
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Appendix 16 
Positive and negative affect schedule  
 
Below are a number of words that describe different feelings and emotions.  Read each word and then indicate how much you felt that way 
during the past WEEK by selecting the appropriate box for that word.  
 
  very 
slightly / 
not at all 
 
a little 
 
 
moderately 
 
 
quite a 
bit 
 
extremely 
 
Do not 
wish to 
answer 
Interested       
Upset       
Scared       
Proud       
Ashamed       
Determined       
Active       
Distressed       
Strong       
Hostile       
Irritable       
Inspired       
Attentive       
Afraid       
Excited       
Guilty       
Enthusiastic       
Alert       
Nervous       
Jittery       
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Appendix 17 
Satisfaction with Life Scale  
 
Below are five statements with which you may agree or disagree. Using the 1-7 scale below, Please indicate how much you agree or disagree 
with the following statements your agreement with each item. Please be open and honest in your responding.  
 Strongly 
disagree 
 
1 
Disagree 
 
 
2 
Slightly 
disagree 
 
3 
Neither 
disagree 
or agree 
4 
Slightly 
agree 
 
5 
Agree 
 
 
6 
Strongly 
agree 
 
7 
In most ways my life is close to my 
ideal  
       
The conditions of my life are excellent         
I am satisfied with my life         
So far I have gotten the important 
things I want in life  
       
If I could live my life over again I 
would change almost nothing  
       
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Appendix 18 
Meaning in Life Scale  
 
Please take a moment to think about what makes your life and existence feel important and significant to you. Please respond to the following 
statements as truthfully and accurately as you can, and also please remember that these are very subjective questions and that there are no right 
or wrong answers. Please select the response that describes you the most:  
 Absolutely 
untrue 
1 
Mostly 
untrue 
2 
Somewhat 
untrue 
3 
Can’t say 
true or false 
4 
Somewhat 
true 
5 
Mostly 
true 
6 
Absolut
ely true 
7 
I understand my life’s meaning         
I am looking for something that makes 
my life feel meaningful  
       
I am always looking to find my life’s 
purpose  
       
My life has a clear sense of purpose         
I have a good sense of what makes my 
life meaningful  
       
I have discovered a satisfying life 
purpose  
       
I am always searching for something 
that makes my life feel significant  
       
I am seeking a purpose or mission in 
my life  
       
My life has no clear purpose         
I am searching for meaning in my life         
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Appendix 19 
Ryffs’ scales of psychological well-being 
 
For each of the following items, indicate how often you have felt like this by selecting an item, using the response choices listed just below.     
 Strongly 
disagree 
Moderately 
disagree 
Slightly 
disagree 
Slightly 
agree 
Moderately 
agree 
Strongly 
agree 
In general I feel I am in charge of the situation 
in which I live. 
      
 
I am not interested in activities that will expand 
my horizons. 
 
      
I live life one day at a time and don’t really think 
about the future. 
 
      
When I look at the story of my life, I am pleased 
with how things have turned out. 
 
      
The demands of everyday life often get me 
down. 
 
      
I don’t want to try new ways of doing things – 
my life is fine the way it is. 
 
      
I tend to focus on the present, because the 
future nearly always brings me problems. 
 
      
In general, I feel confident and positive about 
myself. 
 
      
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 Strongly 
disagree 
Moderately 
disagree 
Slightly 
disagree 
Slightly 
agree 
Moderately 
agree 
Strongly 
agree 
I do not fit very well with the people and 
community around me. 
      
I think it is important to have new experiences 
that challenge how you think about yourself 
and the world. 
 
 
 
 
 
 
 
 
 
 
 
 
 
My daily activities often seem trivial and 
unimportant to me. 
 
 
 
 
 
 
 
 
 
 
 
 
 
I feel like many of the people I know have 
gotten more out of life than I have. 
 
      
 
I am quite good at managing the many 
responsibilities of my daily life. 
 
      
When I think about it, I haven’t really improved 
much as a person over the years. 
 
      
I don’t have a good sense of what it is I’m trying 
to accomplish in life. 
 
      
I like most aspects of my personality. 
 
      
I often feel overwhelmed by my responsibilities. 
 
      
I have the sense that I have developed a lot as 
a person over time. 
      
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 Strongly 
disagree 
Moderately 
disagree 
Slightly 
disagree 
Slightly 
agree 
Moderately 
agree 
Strongly 
agree 
I used to set goals for myself, but now that 
seems like a waste of time 
 
      
I made some mistakes in the past, but I feel 
that all in all everything has worked out for the 
best. 
      
I generally do a good job of taking care of my 
personal finances and affairs. 
 
      
I do not enjoy being in new situations that 
require me to change my old familiar ways of 
doing things. 
 
      
I enjoy making plans for the future and working 
to make them a reality. 
 
      
In many ways, I feel disappointed about my 
achievements in life. 
 
      
I am good at juggling my time so that I can fit 
everything in that needs to get done. 
 
      
For me, life has been a continuous process of 
learning, changing and growth. 
 
      
I am an active person in carrying out the plans I 
set for myself. 
      
 
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 Strongly 
disagree 
Moderately 
disagree 
Slightly 
disagree 
Slightly 
agree 
Moderately 
agree 
Strongly 
agree 
My attitude about myself is probably not as 
positive as most people feel about themselves. 
 
     
 
 
 
I have difficulty arranging my life in a way that 
is satisfying to me. 
 
      
I gave up trying to make big improvements or 
changes in my life a long time ago. 
 
      
Some people wander aimlessly through life, but 
I am not one of them. 
 
      
The past had its ups and downs, but in general, 
I wouldn’t want to change it. 
 
      
I have been able to build a home and lifestyle 
that is much to my liking. 
 
      
There is truth to the saying that you can’t teach 
an old dog new tricks. 
 
      
I sometimes feel as if I’ve done all there is to do 
in life. 
 
      
When I compare myself to friends and 
acquaintances, it makes me feel good about 
how I am. 
      
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Appendix 20 
Perceived Stress Scale 
 
These questions ask you about your feelings and thoughts during the last month. In each case, you will be asked to indicate how often you felt 
or thought a certain way. Although some of these questions are similar, there are differences between them and you should treat each one as a 
separate question. The best approach is to answer each question fairly quickly. That is, don't try to count up the number of times you felt a 
particular way, but rather indicate the alternative that seems like a reasonable estimate. Please select the response that is most appropriate for 
you: 
 
In the last month, how often have you Never 
 
0 
Almost 
never 
1 
Sometimes 
 
2 
Fairly often 
 
3 
Very 
often 
4 
been upset because of something that happened un-expectantly?      
felt that you were unable to control the important things in your life?       
felt nervous and ‘stressed’?       
felt confident about your ability to handle your personal problems?      
felt that things were going your way?       
found that you could not cope with all things that you had to do?       
been able to control irritations in your life?        
felt that you were on top of things?       
been angered because of things that happened that were outside of your 
control?  
     
felt difficulties were piling up so high that you could not overcome them?       
 
Items 2, 4, 5, 10 = 4 item PSS 
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Appendix 21  
Centre for Epidemologic Studies Depression Scale 
 
Below is a list of the ways you might have felt or behaved in the past week.  For 
each of the following items, indicate how often you have felt like this in the past 
week by circling one response, using the response choices listed just below.  
 
 Rarely  
or none 
of the 
time  
(less 
than 1 
day) 
Some 
or  
a little 
of the 
time  
(1-2 
days) 
Occasion
ally / a 
moderate 
amount of 
time  
(3-4 days) 
Most  
or all of 
the time   
(5-7 
days) 
I was bothered by things that 
don’t usually bother me. 
    
I did not feel like eating; my 
appetite was poor. 
    
I felt that I could not shake 
off the blues even with help 
from my family or friends. 
    
I felt that I was just as good 
as other people.  
    
I had trouble keeping my 
mind on what I was doing. 
    
I felt depressed.     
I felt that everything I did 
was an effort.  
    
I felt hopeful about the 
future.    
    
I thought my life had been a 
failure. 
    
I felt fearful.     
My sleep was restless.     
I was happy.     
I talked less than usual.     
I felt lonely.     
People were unfriendly.     
I enjoyed life.     
I had crying spells.     
I felt sad.     
I felt that people dislike me.     
I could not get going. 
 
    
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Appendix 22 
Depression Anxiety and Stress Scale 
 
Please read each statement and circle a number 0, 1, 2 or 3 which indicates how much the statement applied to you over the past week. There 
are no right or wrong answers. Do not spend too much time on any statement. 
 
 Did not 
apply to 
me 
0 
Applied to me to 
some degree, or 
some of the time 
1 
Applied to me to a 
considerable degree, 
or a good part of time 
2 
Applied to me 
very much, or 
most of the time 
3 
I found it hard to wind down     
 
I was aware of dryness of my mouth     
 
I couldn't seem to experience any positive 
feeling at all 
    
 
I experienced breathing difficulty (eg, 
excessively rapid breathing, 
breathlessness in the absence of physical 
exertion) 
    
I found it difficult to work up the initiative to do 
things 
    
I tended to over-react to situations     
 
I experienced trembling (eg, in the hands)     
 
I felt that I was using a lot of nervous energy 
 
 
    
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 Did not 
apply to 
me 
0 
Applied to me to 
some degree, or 
some of the time 
1 
Applied to me to a 
considerable degree, 
or a good part of time 
2 
Applied to me 
very much, or 
most of the time 
3 
I was worried about situations in which I might 
panic and make 
a fool of myself 
    
I felt that I had nothing to look forward to     
 
 
I found myself getting agitated     
 
I found it difficult to relax     
 
I felt down-hearted and blue     
 
I was intolerant of anything that kept me from 
getting on with what I was doing 
    
I felt I was close to panic     
 
I was unable to become enthusiastic about 
anything 
    
I felt I wasn't worth much as a person     
 
I felt that I was rather touchy     
 
I was aware of the action of my heart in the 
absence of physicaL exertion (eg, sense of 
heart rate increase, heart missing a beat) 
 
    
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 Did not 
apply to 
me 
0 
Applied to me to 
some degree, or 
some of the time 
1 
Applied to me to a 
considerable degree, 
or a good part of time 
2 
Applied to me 
very much, or 
most of the time 
3 
I felt scared without any good reason     
 
I felt that life was meaningless     
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Appendix 23  
Extra tables for Study I (Experiment II) 
 
Table 1 Situational or demographic effects on the CAR and awakening level  
 
 MnInc  S1 (SQRT)  Diurnal 
decline  
 Average 
cortisol  
 
Fixed effect Coefficient 
(SE) 
p  Coefficient 
(±SEM) 
p  Coefficient 
(±SEM) 
p  Coefficient 
(±SEM) 
p  
Intercept  6.529 (2.538) <.003 1.961  
(0.378)  
<.001 2.743 
(1.773)  
<.001 4.691  
(1.028)  
<.001 
Day of study   -0.459 (0.913)  .617 0.218 
(0.128)  
.095 0.169 
(0.660) 
.798 -0.159 
(0.389)  
.684 
Study start 
tues  
-0.540 (1.223)  .661 -0.0450 
(0.235)  
.849 1.128 
(0.772) 
.149 0.569 
(0.722) 
.435 
Weekend -0.742 (2.061)  .720 0.394 
(0.300)  
.193 1.410 
(0.151)  
.354 1.028 
(0.954) 
.283 
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Table 2 Main effect and interaction effect of well-being/ill-being on cortisol measures 
  
 MnInc  S1 (SQRT)  Diurnal decline   Average cortisol   
Fixed effect Coefficient 
(SE) 
p  Coefficient 
(±SEM) 
p  Coefficient 
(±SEM) 
p  Coefficient 
(±SEM) 
p  
  Intercept 5.188 
(0.854) 
<.001 2.491 
(0.154)  
<.001 4.484 (0.413) <.001 5.211 (0.392)  <.001 
  State WB 1.028 
(1.570) 
.514 0.202 
(0.241)  
.405 -0.742 (0.996) .458 -0.320 (0.674) .636 
  State IB -0.665 
(1.243)  
.549 -0.070 
(0.194) 
.720 0.487 (0.896)  .544 0.816 (0.601) .177 
  State WB 
X State 
IB  
0.1997 
(2.251)  
.929  0.493 
(0.139) 
.889 2.512 (1.458) .087 0.341 (1.026)  .740 
  Intercept 5.671 
(0.862) 
<.001 2.453 
(0.158)  
,.001 4.090 (0.410) <.001 5.097 (0.386) <.001 
  Trait WB 0.111 (.495) .824 -0.509 
(0.098) 
.607 -0.257 (0.326) .434 0.149 (0.307) .048 
  Trait IB 0.367 
(0.495) 
.574 0.064 
(0.128)  
.621 -0.079 (0.414) .849 -0.151 (0.391) .702 
  Trait WB 
X Trait IB  
1.231 
(0.612) 
.049 -0.050 
(0.118)  
.673 -0.393 (0.369) .294 -0.392 (0.348) .266 
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